cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
HNSC	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-18.8	4.75e-59	-0.77	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-18.8	4.75e-59	-0.77	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-18.8	4.75e-59	-0.77	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-18.8	4.75e-59	-0.77	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-18.75	8.67e-59	-0.76	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-18.75	8.67e-59	-0.76	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-18.65	2.34e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-18.65	2.34e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-18.56	6.16e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-18.56	6.16e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-18.56	6.47e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-18.56	6.47e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	18.56	6.68e-58	0.77	0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	18.56	6.68e-58	0.77	0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-18.55	7.49e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-18.55	7.49e-58	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-18.44	2.25e-57	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-18.44	2.25e-57	-0.77	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-18.35	6.13e-57	-0.76	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-18.35	6.13e-57	-0.76	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-18.31	8.99e-57	-0.76	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-18.31	8.99e-57	-0.76	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	18.26	1.52e-56	0.75	0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	18.26	1.52e-56	0.75	0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-18.08	1.07e-55	-0.75	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-18.08	1.07e-55	-0.75	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-17.73	4.5e-54	-0.76	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-17.73	4.5e-54	-0.76	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-17.55	2.89e-53	-0.75	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-17.55	2.89e-53	-0.75	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-17.55	2.95e-53	-0.75	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-17.55	2.95e-53	-0.75	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-17.48	6.36e-53	-0.74	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-17.48	6.36e-53	-0.74	-0.63	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-16.88	3.41e-50	-0.74	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-16.88	3.41e-50	-0.74	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-16.02	2.8e-46	-0.71	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-16.02	2.8e-46	-0.71	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-15.93	7.17e-46	-0.71	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-15.93	7.17e-46	-0.71	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-15.93	7.17e-46	-0.71	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-15.93	7.17e-46	-0.71	-0.59	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-14.85	4.35e-41	-0.67	-0.57	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-14.85	4.35e-41	-0.67	-0.57	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-14.57	7.36e-40	-0.69	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-14.57	7.36e-40	-0.69	-0.56	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-14.25	1.76e-38	-0.73	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-14.25	1.76e-38	-0.73	-0.55	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
HNSC	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	11.03	2.68e-25	0.94	0.46	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
HNSC	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-9.73	1.75e-20	-0.65	-0.41	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-9.73	1.75e-20	-0.65	-0.41	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-9.51	9.96e-20	-0.64	-0.4	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-9.51	9.96e-20	-0.64	-0.4	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
HNSC	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	9.43	2e-19	0.47	0.4	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	9.43	2e-19	0.47	0.4	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	9.43	2e-19	0.47	0.4	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	9.4	2.44e-19	0.47	0.4	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs4044435	MIMAT0021017	hsa-miR-4999-5p	9.35	3.78e-19	0.48	0.4	HDL cholesterol;	chr19:8383293	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	9.33	4.26e-19	0.47	0.4	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	9.33	4.34e-19	0.47	0.4	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	9.33	4.34e-19	0.47	0.4	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	9.33	4.34e-19	0.47	0.4	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	9.33	4.34e-19	0.47	0.4	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
HNSC	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	9.32	4.83e-19	0.47	0.4	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs62117510	MIMAT0021017	hsa-miR-4999-5p	9.18	1.44e-18	0.47	0.39	HDL cholesterol;	chr19:8387729	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.965	rs28729307	MIMAT0021017	hsa-miR-4999-5p	9.18	1.44e-18	0.47	0.39	HDL cholesterol;	chr19:8387858	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.894	rs10413136	MIMAT0021017	hsa-miR-4999-5p	9.18	1.44e-18	0.47	0.39	HDL cholesterol;	chr19:8387995	chr19:8389340~8389360:-
HNSC	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	9.18	1.44e-18	0.47	0.39	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
HNSC	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	8.64	9.18e-17	0.55	0.37	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	8.58	1.41e-16	0.55	0.37	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
HNSC	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-8.45	3.69e-16	-0.44	-0.37	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
HNSC	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	8.41	5.16e-16	0.53	0.36	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	8.33	8.99e-16	0.27	0.36	Migraine;	chr10:103263177	chr10:103394301~103394322:-
HNSC	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-8.22	2.08e-15	-0.43	-0.36	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-8.15	3.35e-15	-0.43	-0.35	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
HNSC	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-8.14	3.61e-15	-0.55	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-8.14	3.61e-15	-0.55	-0.35	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
HNSC	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	8.12	4.31e-15	0.51	0.35	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
HNSC	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	8.12	4.31e-15	0.51	0.35	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
HNSC	cis	rs1014286	0.706	rs10196579	MIMAT0019926	hsa-miR-4772-5p	8.08	5.77e-15	0.4	0.35	Serum protein levels (sST2);	chr2:102553722	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.706	rs2310295	MIMAT0019926	hsa-miR-4772-5p	8.08	5.77e-15	0.4	0.35	Serum protein levels (sST2);	chr2:102554607	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.706	rs2058656	MIMAT0019926	hsa-miR-4772-5p	8.06	6.65e-15	0.4	0.35	Serum protein levels (sST2);	chr2:102520567	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.706	rs4851612	MIMAT0019926	hsa-miR-4772-5p	8.06	6.65e-15	0.4	0.35	Serum protein levels (sST2);	chr2:102521421	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.706	rs4851608	MIMAT0019926	hsa-miR-4772-5p	8.03	8.24e-15	0.4	0.35	Serum protein levels (sST2);	chr2:102509525	chr2:102432300~102432321:+
HNSC	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	8.03	8.38e-15	0.3	0.35	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-8.03	8.38e-15	-0.3	-0.35	Migraine;	chr10:103254113	chr10:103394341~103394361:-
HNSC	cis	rs1014286	0.665	rs1523204	MIMAT0019926	hsa-miR-4772-5p	8.02	8.68e-15	0.4	0.35	Serum protein levels (sST2);	chr2:102519178	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.66	rs1476999	MIMAT0019926	hsa-miR-4772-5p	8.01	9.32e-15	0.4	0.35	Serum protein levels (sST2);	chr2:102515220	chr2:102432300~102432321:+
HNSC	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	7.99	1.06e-14	0.5	0.35	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
HNSC	cis	rs1014286	0.706	rs4851019	MIMAT0019926	hsa-miR-4772-5p	7.98	1.12e-14	0.39	0.35	Serum protein levels (sST2);	chr2:102561106	chr2:102432300~102432321:+
HNSC	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	7.98	1.13e-14	0.3	0.35	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
HNSC	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-7.97	1.22e-14	-0.45	-0.35	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
HNSC	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	7.97	1.24e-14	0.5	0.35	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-7.96	1.35e-14	-0.3	-0.35	Migraine;	chr10:103295206	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-7.96	1.35e-14	-0.3	-0.35	Migraine;	chr10:103296155	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-7.94	1.51e-14	-0.3	-0.35	Migraine;	chr10:103286932	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-7.94	1.52e-14	-0.3	-0.35	Migraine;	chr10:103286250	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	7.91	1.96e-14	0.5	0.34	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
HNSC	cis	rs1014286	0.706	rs10194822	MIMAT0019926	hsa-miR-4772-5p	-7.89	2.11e-14	-0.39	-0.34	Serum protein levels (sST2);	chr2:102549045	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	7.85	2.99e-14	0.3	0.34	Migraine;	chr10:103236031	chr10:103394341~103394361:-
HNSC	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	7.84	3.02e-14	0.49	0.34	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
HNSC	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-7.83	3.28e-14	-0.44	-0.34	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
HNSC	cis	rs1014286	0.706	rs4851615	MIMAT0019926	hsa-miR-4772-5p	-7.83	3.33e-14	-0.39	-0.34	Serum protein levels (sST2);	chr2:102530540	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-7.83	3.39e-14	-0.3	-0.34	Migraine;	chr10:103315955	chr10:103394341~103394361:-
HNSC	cis	rs1014286	0.706	rs10171438	MIMAT0019926	hsa-miR-4772-5p	-7.83	3.44e-14	-0.39	-0.34	Serum protein levels (sST2);	chr2:102558917	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-7.82	3.67e-14	-0.29	-0.34	Migraine;	chr10:103365694	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-7.82	3.67e-14	-0.29	-0.34	Migraine;	chr10:103369141	chr10:103394341~103394361:-
HNSC	cis	rs1014286	0.706	rs2216000	MIMAT0019926	hsa-miR-4772-5p	7.81	3.73e-14	0.39	0.34	Serum protein levels (sST2);	chr2:102516181	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-7.81	3.86e-14	-0.3	-0.34	Migraine;	chr10:103394332	chr10:103394341~103394361:-
HNSC	cis	rs1014286	0.706	rs10202404	MIMAT0019926	hsa-miR-4772-5p	-7.79	4.39e-14	-0.38	-0.34	Serum protein levels (sST2);	chr2:102560955	chr2:102432300~102432321:+
HNSC	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	7.79	4.53e-14	0.49	0.34	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
HNSC	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	7.79	4.53e-14	0.49	0.34	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
HNSC	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	7.75	5.71e-14	0.25	0.34	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-7.75	5.71e-14	-0.25	-0.34	Migraine;	chr10:103254113	chr10:103394301~103394322:-
HNSC	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	7.73	6.6e-14	0.41	0.34	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-7.71	7.48e-14	-0.43	-0.34	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-7.7	8.3e-14	-0.3	-0.34	Migraine;	chr10:103415374	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-7.7	8.49e-14	-0.42	-0.34	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-7.7	8.53e-14	-0.29	-0.34	Migraine;	chr10:103338267	chr10:103394341~103394361:-
HNSC	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	7.69	9.05e-14	0.43	0.34	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-7.68	9.36e-14	-0.41	-0.34	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-7.67	1e-13	-0.42	-0.34	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-7.66	1.09e-13	-0.25	-0.34	Migraine;	chr10:103365694	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-7.66	1.09e-13	-0.25	-0.34	Migraine;	chr10:103369141	chr10:103394301~103394322:-
HNSC	cis	rs1014286	0.641	rs10172553	MIMAT0019926	hsa-miR-4772-5p	7.65	1.18e-13	0.38	0.33	Serum protein levels (sST2);	chr2:102536516	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.706	rs6761291	MIMAT0019926	hsa-miR-4772-5p	7.65	1.18e-13	0.38	0.33	Serum protein levels (sST2);	chr2:102538610	chr2:102432300~102432321:+
HNSC	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-7.65	1.18e-13	-0.43	-0.33	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-7.63	1.38e-13	-0.42	-0.33	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
HNSC	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	7.62	1.44e-13	0.47	0.33	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-7.6	1.67e-13	-0.25	-0.33	Migraine;	chr10:103315955	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-7.6	1.68e-13	-0.25	-0.33	Migraine;	chr10:103338267	chr10:103394301~103394322:-
HNSC	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	7.58	1.92e-13	0.29	0.33	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
HNSC	cis	rs1014286	0.73	rs2215998	MIMAT0019926	hsa-miR-4772-5p	7.58	1.95e-13	0.38	0.33	Serum protein levels (sST2);	chr2:102549584	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-7.57	1.97e-13	-0.25	-0.33	Migraine;	chr10:103394332	chr10:103394301~103394322:-
HNSC	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	7.57	2e-13	0.29	0.33	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
HNSC	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-7.57	2.05e-13	-0.42	-0.33	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	7.56	2.12e-13	0.42	0.33	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-7.54	2.51e-13	-0.41	-0.33	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-7.54	2.51e-13	-0.41	-0.33	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-7.54	2.53e-13	-0.25	-0.33	Migraine;	chr10:103286250	chr10:103394301~103394322:-
HNSC	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-7.53	2.69e-13	-0.42	-0.33	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
HNSC	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	7.53	2.76e-13	0.47	0.33	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
HNSC	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-7.51	3.11e-13	-0.41	-0.33	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
HNSC	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-7.5	3.26e-13	-0.42	-0.33	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
HNSC	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	7.5	3.36e-13	0.47	0.33	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
HNSC	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	7.49	3.53e-13	0.47	0.33	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
HNSC	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-7.47	3.97e-13	-0.4	-0.33	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
HNSC	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	7.47	4.01e-13	0.46	0.33	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
HNSC	cis	rs79387448	0.638	rs74731686	MIMAT0019926	hsa-miR-4772-5p	-7.47	4.06e-13	-0.54	-0.33	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-7.47	4.08e-13	-0.4	-0.33	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
HNSC	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	7.46	4.27e-13	0.46	0.33	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
HNSC	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-7.45	4.52e-13	-0.4	-0.33	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
HNSC	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-7.45	4.68e-13	-0.42	-0.33	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
HNSC	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	7.43	5.18e-13	0.46	0.33	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
HNSC	cis	rs79387448	0.638	rs6741230	MIMAT0019926	hsa-miR-4772-5p	-7.43	5.18e-13	-0.53	-0.33	Gut microbiota (bacterial taxa);	chr2:102453171	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.638	rs78123896	MIMAT0019926	hsa-miR-4772-5p	-7.43	5.18e-13	-0.53	-0.33	Gut microbiota (bacterial taxa);	chr2:102458957	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.638	rs11465670	MIMAT0019926	hsa-miR-4772-5p	-7.42	5.57e-13	-0.53	-0.33	Gut microbiota (bacterial taxa);	chr2:102417980	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-7.41	5.98e-13	-0.4	-0.33	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
HNSC	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	7.41	6.05e-13	0.46	0.33	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
HNSC	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	7.41	6.05e-13	0.46	0.33	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
HNSC	cis	rs79387448	0.638	rs76255660	MIMAT0019926	hsa-miR-4772-5p	-7.4	6.28e-13	-0.55	-0.33	Gut microbiota (bacterial taxa);	chr2:102474569	chr2:102432300~102432321:+
HNSC	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	7.4	6.44e-13	0.47	0.32	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
HNSC	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	7.39	6.96e-13	0.46	0.32	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
HNSC	cis	rs79387448	0.638	rs11465698	MIMAT0019926	hsa-miR-4772-5p	-7.38	7.25e-13	-0.54	-0.32	Gut microbiota (bacterial taxa);	chr2:102438117	chr2:102432300~102432321:+
HNSC	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-7.38	7.49e-13	-0.29	-0.32	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.638	rs116055209	MIMAT0019926	hsa-miR-4772-5p	-7.38	7.57e-13	-0.54	-0.32	Gut microbiota (bacterial taxa);	chr2:102415729	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-7.36	8.19e-13	-0.24	-0.32	Migraine;	chr10:103415374	chr10:103394301~103394322:-
HNSC	cis	rs79387448	0.638	rs7600961	MIMAT0019926	hsa-miR-4772-5p	-7.36	8.45e-13	-0.53	-0.32	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-7.35	8.73e-13	-0.24	-0.32	Migraine;	chr10:103295206	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-7.35	8.73e-13	-0.24	-0.32	Migraine;	chr10:103296155	chr10:103394301~103394322:-
HNSC	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	7.34	9.86e-13	0.28	0.32	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	7.34	9.86e-13	0.28	0.32	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	7.34	9.86e-13	0.28	0.32	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	7.34	9.86e-13	0.28	0.32	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	7.34	9.86e-13	0.28	0.32	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	7.34	9.86e-13	0.28	0.32	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-7.34	9.9e-13	-0.24	-0.32	Migraine;	chr10:103286932	chr10:103394301~103394322:-
HNSC	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	7.33	1.02e-12	0.29	0.32	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
HNSC	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-7.33	1.03e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-7.33	1.03e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-7.33	1.03e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-7.33	1.03e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	7.33	1.05e-12	0.24	0.32	Migraine;	chr10:103236031	chr10:103394301~103394322:-
HNSC	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	7.33	1.06e-12	0.29	0.32	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-7.32	1.11e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
HNSC	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	7.32	1.12e-12	0.28	0.32	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	7.32	1.12e-12	0.28	0.32	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	7.32	1.12e-12	0.28	0.32	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	7.32	1.12e-12	0.28	0.32	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	7.32	1.12e-12	0.28	0.32	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	7.32	1.12e-12	0.28	0.32	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
HNSC	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	7.32	1.12e-12	0.28	0.32	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.626	rs80256362	MIMAT0019926	hsa-miR-4772-5p	-7.31	1.17e-12	-0.54	-0.32	Gut microbiota (bacterial taxa);	chr2:102409041	chr2:102432300~102432321:+
HNSC	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	7.31	1.2e-12	0.46	0.32	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
HNSC	cis	rs6681460	1	rs1536115	MIMAT0014979	hsa-miR-3117-3p	-7.3	1.28e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66655318	chr1:66628485~66628505:+
HNSC	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-7.3	1.3e-12	-0.4	-0.32	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	7.29	1.33e-12	0.28	0.32	Migraine;	chr10:103263177	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-7.27	1.57e-12	-0.36	-0.32	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
HNSC	cis	rs6681460	1	rs7532173	MIMAT0014979	hsa-miR-3117-3p	-7.26	1.63e-12	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66620428	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	7.25	1.7e-12	0.39	0.32	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-7.25	1.71e-12	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-7.25	1.81e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-7.24	1.82e-12	-0.4	-0.32	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-7.22	2.08e-12	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-7.22	2.13e-12	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.866	rs1856318	MIMAT0014979	hsa-miR-3117-3p	-7.21	2.27e-12	-0.41	-0.32	Presence of antiphospholipid antibodies;	chr1:66558532	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6588207	MIMAT0014979	hsa-miR-3117-3p	-7.19	2.57e-12	-0.38	-0.32	Presence of antiphospholipid antibodies;	chr1:66600872	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-7.17	2.97e-12	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-7.17	3.01e-12	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-7.17	3.01e-12	-0.39	-0.32	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
HNSC	cis	rs2871473	1	rs1030024	MIMAT0019926	hsa-miR-4772-5p	7.15	3.34e-12	0.44	0.32	Blood protein levels;	chr2:102489310	chr2:102432300~102432321:+
HNSC	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-7.13	3.76e-12	-0.37	-0.31	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.585	rs4655642	MIMAT0014979	hsa-miR-3117-3p	-7.13	3.77e-12	-0.37	-0.31	Menopause (age at onset);	chr1:66624400	chr1:66628485~66628505:+
HNSC	cis	rs2871473	1	rs2871473	MIMAT0019926	hsa-miR-4772-5p	-7.13	3.77e-12	-0.44	-0.31	Blood protein levels;	chr2:102490821	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	7.13	3.87e-12	0.35	0.31	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	7.13	3.87e-12	0.35	0.31	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	7.13	3.87e-12	0.35	0.31	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	7.13	3.87e-12	0.35	0.31	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	7.13	3.87e-12	0.35	0.31	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	7.13	3.87e-12	0.35	0.31	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	7.13	3.87e-12	0.35	0.31	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
HNSC	cis	rs6681460	1	rs964574	MIMAT0014979	hsa-miR-3117-3p	-7.12	4e-12	-0.39	-0.31	Presence of antiphospholipid antibodies;	chr1:66597202	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-7.12	4.12e-12	-0.37	-0.31	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs1562217	MIMAT0014979	hsa-miR-3117-3p	7.11	4.29e-12	0.38	0.31	Presence of antiphospholipid antibodies;	chr1:66607883	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-7.11	4.32e-12	-0.4	-0.31	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.585	rs12062570	MIMAT0014979	hsa-miR-3117-3p	-7.11	4.46e-12	-0.37	-0.31	Menopause (age at onset);	chr1:66620602	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	7.11	4.52e-12	0.35	0.31	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
HNSC	cis	rs2871473	0.951	rs1030025	MIMAT0019926	hsa-miR-4772-5p	-7.1	4.6e-12	-0.44	-0.31	Blood protein levels;	chr2:102489152	chr2:102432300~102432321:+
HNSC	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-7.1	4.62e-12	-0.39	-0.31	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs10889634	MIMAT0014979	hsa-miR-3117-3p	7.09	4.91e-12	0.38	0.31	Presence of antiphospholipid antibodies;	chr1:66600228	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	7.09	4.96e-12	0.35	0.31	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	7.09	4.96e-12	0.35	0.31	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	7.09	4.96e-12	0.35	0.31	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	7.09	4.96e-12	0.35	0.31	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
HNSC	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	7.09	5.04e-12	0.45	0.31	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	7.08	5.26e-12	0.35	0.31	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	7.08	5.44e-12	0.35	0.31	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
HNSC	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-7.07	5.55e-12	-0.38	-0.31	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-7.07	5.55e-12	-0.38	-0.31	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	7.07	5.81e-12	0.35	0.31	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	7.07	5.81e-12	0.35	0.31	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
HNSC	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	7.06	6.31e-12	0.28	0.31	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	7.05	6.71e-12	0.35	0.31	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
HNSC	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	7.04	6.92e-12	0.49	0.31	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
HNSC	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-7.04	7.03e-12	-0.39	-0.31	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.604	rs11208920	MIMAT0014979	hsa-miR-3117-3p	-7.03	7.35e-12	-0.38	-0.31	Presence of antiphospholipid antibodies;	chr1:66609629	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	7.03	7.38e-12	0.35	0.31	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
HNSC	cis	rs6681460	0.866	rs996123	MIMAT0014979	hsa-miR-3117-3p	-7.03	7.47e-12	-0.4	-0.31	Presence of antiphospholipid antibodies;	chr1:66559660	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	7.02	7.8e-12	0.35	0.31	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	7.02	7.8e-12	0.35	0.31	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	7.02	7.8e-12	0.35	0.31	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	7.02	7.8e-12	0.35	0.31	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	7.02	7.8e-12	0.35	0.31	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	7.02	7.83e-12	0.35	0.31	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
HNSC	cis	rs6681460	1	rs10789210	MIMAT0014979	hsa-miR-3117-3p	-7.02	7.84e-12	-0.38	-0.31	Presence of antiphospholipid antibodies;	chr1:66600347	chr1:66628485~66628505:+
HNSC	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	7.01	8.45e-12	0.52	0.31	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
HNSC	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-6.99	9.53e-12	-0.38	-0.31	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs4655636	MIMAT0014979	hsa-miR-3117-3p	-6.98	1e-11	-0.37	-0.31	Presence of antiphospholipid antibodies;	chr1:66602854	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs7524818	MIMAT0014979	hsa-miR-3117-3p	-6.98	1e-11	-0.37	-0.31	Presence of antiphospholipid antibodies;	chr1:66606348	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	6.94	1.28e-11	0.22	0.31	Migraine;	chr10:103367830	chr10:103394301~103394322:-
HNSC	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-6.91	1.64e-11	-0.38	-0.31	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.934	rs4655631	MIMAT0014979	hsa-miR-3117-3p	-6.89	1.87e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66589224	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.625	rs6679568	MIMAT0014979	hsa-miR-3117-3p	-6.88	1.96e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66608494	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-6.86	2.18e-11	-0.21	-0.3	Migraine;	chr10:103353944	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-6.86	2.18e-11	-0.21	-0.3	Migraine;	chr10:103356299	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-6.86	2.18e-11	-0.21	-0.3	Migraine;	chr10:103358705	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-6.86	2.18e-11	-0.21	-0.3	Migraine;	chr10:103367951	chr10:103394301~103394322:-
HNSC	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	6.86	2.24e-11	0.33	0.3	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
HNSC	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-6.86	2.24e-11	-0.49	-0.3	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
HNSC	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-6.86	2.26e-11	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	6.84	2.56e-11	0.34	0.3	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
HNSC	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-6.83	2.6e-11	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.966	rs10749763	MIMAT0014979	hsa-miR-3117-3p	-6.82	2.79e-11	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66596443	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-6.82	2.81e-11	-0.21	-0.3	Migraine;	chr10:103384531	chr10:103394301~103394322:-
HNSC	cis	rs1867631	0.585	rs9787219	MIMAT0014979	hsa-miR-3117-3p	-6.82	2.89e-11	-0.36	-0.3	Menopause (age at onset);	chr1:66614476	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.585	rs11208922	MIMAT0014979	hsa-miR-3117-3p	-6.82	2.89e-11	-0.36	-0.3	Menopause (age at onset);	chr1:66614543	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-6.82	2.9e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	6.79	3.46e-11	0.34	0.3	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	6.78	3.56e-11	0.33	0.3	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-6.77	3.88e-11	-0.21	-0.3	Migraine;	chr10:103395309	chr10:103394301~103394322:-
HNSC	cis	rs6681460	1	rs4655648	MIMAT0014979	hsa-miR-3117-3p	-6.76	4.22e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66648626	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-6.76	4.26e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	6.76	4.28e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	6.75	4.48e-11	0.33	0.3	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
HNSC	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	6.74	4.58e-11	0.51	0.3	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	6.74	4.58e-11	0.51	0.3	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	6.74	4.58e-11	0.51	0.3	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
HNSC	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-6.74	4.61e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6697088	MIMAT0014979	hsa-miR-3117-3p	6.73	4.96e-11	0.37	0.3	Presence of antiphospholipid antibodies;	chr1:66579041	chr1:66628485~66628505:+
HNSC	cis	rs6681460	1	rs6689864	MIMAT0014979	hsa-miR-3117-3p	-6.73	4.98e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66602429	chr1:66628485~66628505:+
HNSC	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-6.73	5.01e-11	-0.48	-0.3	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
HNSC	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	6.73	5.07e-11	0.37	0.3	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-6.73	5.07e-11	-0.21	-0.3	Migraine;	chr10:103348698	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-6.73	5.07e-11	-0.21	-0.3	Migraine;	chr10:103358719	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-6.73	5.07e-11	-0.21	-0.3	Migraine;	chr10:103367521	chr10:103394301~103394322:-
HNSC	cis	rs79387448	0.626	rs80277428	MIMAT0019926	hsa-miR-4772-5p	-6.73	5.12e-11	-0.52	-0.3	Gut microbiota (bacterial taxa);	chr2:102463596	chr2:102432300~102432321:+
HNSC	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-6.72	5.33e-11	-0.32	-0.3	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-6.72	5.49e-11	-0.21	-0.3	Migraine;	chr10:103379204	chr10:103394301~103394322:-
HNSC	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	6.7	5.96e-11	0.35	0.3	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	6.7	6.11e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	6.69	6.51e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	6.69	6.56e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.932	rs2044399	MIMAT0014979	hsa-miR-3117-3p	-6.68	6.67e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66588397	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.932	rs2044400	MIMAT0014979	hsa-miR-3117-3p	-6.68	6.67e-11	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66588398	chr1:66628485~66628505:+
HNSC	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-6.67	7.13e-11	-0.48	-0.3	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
HNSC	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	6.67	7.16e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	6.67	7.33e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	6.67	7.33e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	6.67	7.33e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	6.67	7.33e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	6.67	7.33e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	6.67	7.33e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-6.66	7.7e-11	-0.32	-0.3	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	6.66	7.71e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	6.66	7.71e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	6.66	7.71e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-6.66	7.71e-11	-0.21	-0.3	Migraine;	chr10:103395888	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	6.66	7.81e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	6.66	7.86e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	6.66	7.86e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	6.66	7.86e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	6.66	7.92e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	6.66	7.92e-11	0.26	0.3	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs78136548	MIMAT0019926	hsa-miR-4772-5p	-6.66	7.94e-11	-0.53	-0.3	Gut microbiota (bacterial taxa);	chr2:102487281	chr2:102432300~102432321:+
HNSC	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-6.65	8.22e-11	-0.34	-0.3	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	6.65	8.29e-11	0.26	0.29	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-6.65	8.38e-11	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
HNSC	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-6.65	8.46e-11	-0.37	-0.29	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
HNSC	cis	rs4851016	0.553	rs4851602	MIMAT0019926	hsa-miR-4772-5p	-6.64	8.95e-11	-0.34	-0.29	Blood protein levels;	chr2:102499846	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.638	rs6759588	MIMAT0019926	hsa-miR-4772-5p	-6.64	8.98e-11	-0.51	-0.29	Gut microbiota (bacterial taxa);	chr2:102423699	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-6.63	9.13e-11	-0.21	-0.29	Migraine;	chr10:103386935	chr10:103394301~103394322:-
HNSC	cis	rs4851016	0.506	rs6543146	MIMAT0019926	hsa-miR-4772-5p	6.63	9.36e-11	0.34	0.29	Blood protein levels;	chr2:102480236	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	6.63	9.49e-11	0.33	0.29	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
HNSC	cis	rs1867631	0.959	rs11208914	MIMAT0014979	hsa-miR-3117-3p	-6.62	9.67e-11	-0.39	-0.29	Menopause (age at onset);	chr1:66584045	chr1:66628485~66628505:+
HNSC	cis	rs1014286	0.505	rs1030026	MIMAT0019926	hsa-miR-4772-5p	6.62	9.68e-11	0.34	0.29	Serum protein levels (sST2);	chr2:102481719	chr2:102432300~102432321:+
HNSC	cis	rs4851016	0.506	rs2140316	MIMAT0019926	hsa-miR-4772-5p	6.62	1.02e-10	0.34	0.29	Blood protein levels;	chr2:102482217	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	6.61	1.04e-10	0.33	0.29	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
HNSC	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-6.6	1.1e-10	-0.35	-0.29	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	6.6	1.12e-10	0.33	0.29	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
HNSC	cis	rs6681460	1	rs1445575	MIMAT0014979	hsa-miR-3117-3p	-6.6	1.13e-10	-0.37	-0.29	Presence of antiphospholipid antibodies;	chr1:66586481	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.934	rs4655628	MIMAT0014979	hsa-miR-3117-3p	-6.6	1.13e-10	-0.37	-0.29	Presence of antiphospholipid antibodies;	chr1:66586926	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-6.6	1.14e-10	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
HNSC	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-6.6	1.16e-10	-0.32	-0.29	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
HNSC	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-6.59	1.17e-10	-0.35	-0.29	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	6.59	1.21e-10	0.33	0.29	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	6.58	1.27e-10	0.33	0.29	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	6.57	1.34e-10	0.33	0.29	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	6.57	1.34e-10	0.33	0.29	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	6.57	1.34e-10	0.33	0.29	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	6.57	1.34e-10	0.33	0.29	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	6.57	1.34e-10	0.33	0.29	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	6.57	1.34e-10	0.33	0.29	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
HNSC	cis	rs79387448	0.701	rs3752659	MIMAT0019926	hsa-miR-4772-5p	-6.56	1.46e-10	-0.48	-0.29	Gut microbiota (bacterial taxa);	chr2:102385138	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	6.55	1.51e-10	0.26	0.29	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
HNSC	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-6.54	1.62e-10	-0.49	-0.29	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
HNSC	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-6.54	1.62e-10	-0.31	-0.29	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.625	rs2312154	MIMAT0014979	hsa-miR-3117-3p	6.54	1.67e-10	0.35	0.29	Presence of antiphospholipid antibodies;	chr1:66607293	chr1:66628485~66628505:+
HNSC	cis	rs1014286	1	rs7581853	MIMAT0019926	hsa-miR-4772-5p	6.53	1.69e-10	0.34	0.29	Serum protein levels (sST2);	chr2:102551265	chr2:102432300~102432321:+
HNSC	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	6.53	1.76e-10	0.32	0.29	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
HNSC	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	6.53	1.77e-10	0.26	0.29	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	6.52	1.8e-10	0.33	0.29	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
HNSC	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	6.52	1.81e-10	0.26	0.29	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.843	rs4400721	MIMAT0005878	hsa-miR-1287-5p	6.52	1.82e-10	0.31	0.29	Metabolite levels;	chr10:98387340	chr10:98395271~98395292:-
HNSC	cis	rs1014286	1	rs4851614	MIMAT0019926	hsa-miR-4772-5p	6.52	1.83e-10	0.34	0.29	Serum protein levels (sST2);	chr2:102523939	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs1357471	MIMAT0019926	hsa-miR-4772-5p	6.52	1.83e-10	0.34	0.29	Serum protein levels (sST2);	chr2:102524013	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	6.52	1.87e-10	0.26	0.29	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	6.52	1.87e-10	0.26	0.29	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
HNSC	cis	rs1014286	1	rs1005043	MIMAT0019926	hsa-miR-4772-5p	-6.51	1.96e-10	-0.33	-0.29	Serum protein levels (sST2);	chr2:102528967	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	6.49	2.23e-10	0.25	0.29	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
HNSC	cis	rs1014286	1	rs2008159	MIMAT0019926	hsa-miR-4772-5p	6.49	2.23e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102532703	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs4241211	MIMAT0019926	hsa-miR-4772-5p	6.49	2.27e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102526700	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.965	rs12712156	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102527561	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs3849364	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102527783	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.965	rs3849365	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102527932	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs3849366	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102528441	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs6739236	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102528485	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs6712696	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102528542	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs1005042	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102528900	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs4851018	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102530156	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs2008157	MIMAT0019926	hsa-miR-4772-5p	6.48	2.28e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102532723	chr2:102432300~102432321:+
HNSC	cis	rs1014286	0.964	rs1003431	MIMAT0019926	hsa-miR-4772-5p	6.47	2.56e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102530797	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs741285	MIMAT0019926	hsa-miR-4772-5p	6.47	2.56e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102531710	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	6.46	2.62e-10	0.32	0.29	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
HNSC	cis	rs6681460	1	rs6656912	MIMAT0014979	hsa-miR-3117-3p	-6.46	2.67e-10	-0.35	-0.29	Presence of antiphospholipid antibodies;	chr1:66617988	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	6.45	2.73e-10	0.26	0.29	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
HNSC	cis	rs1014286	0.965	rs6709284	MIMAT0019926	hsa-miR-4772-5p	6.45	2.83e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102534705	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	6.45	2.84e-10	0.32	0.29	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	6.45	2.84e-10	0.32	0.29	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	6.44	2.91e-10	0.25	0.29	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	6.44	3.02e-10	0.31	0.29	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-6.43	3.1e-10	-0.2	-0.29	Migraine;	chr10:103241568	chr10:103394301~103394322:-
HNSC	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	6.43	3.14e-10	0.34	0.29	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
HNSC	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-6.42	3.27e-10	-0.44	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-6.42	3.27e-10	-0.44	-0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
HNSC	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	6.42	3.35e-10	0.32	0.29	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
HNSC	cis	rs79387448	0.564	rs77375846	MIMAT0019926	hsa-miR-4772-5p	-6.42	3.36e-10	-0.52	-0.29	Gut microbiota (bacterial taxa);	chr2:102538616	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-6.42	3.36e-10	-0.2	-0.29	Migraine;	chr10:103299082	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.677	rs17027087	MIMAT0019927	hsa-miR-4772-3p	6.42	3.45e-10	0.28	0.29	Serum protein levels (sST2);	chr2:102399458	chr2:102432336~102432357:+
HNSC	cis	rs1014286	1	rs1014286	MIMAT0019926	hsa-miR-4772-5p	6.41	3.54e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102532641	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs2287035	MIMAT0019927	hsa-miR-4772-3p	6.41	3.62e-10	0.29	0.29	Serum protein levels (sST2);	chr2:102394070	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	6.4	3.7e-10	0.32	0.28	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	6.4	3.7e-10	0.32	0.28	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	6.4	3.78e-10	0.32	0.28	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
HNSC	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-6.39	4e-10	-0.33	-0.28	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
HNSC	cis	rs4851016	0.506	rs2310303	MIMAT0019926	hsa-miR-4772-5p	6.39	4.1e-10	0.33	0.28	Blood protein levels;	chr2:102487420	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-6.39	4.12e-10	-0.2	-0.28	Migraine;	chr10:103375562	chr10:103394301~103394322:-
HNSC	cis	rs1014286	1	rs2015478	MIMAT0019926	hsa-miR-4772-5p	6.39	4.14e-10	0.33	0.28	Serum protein levels (sST2);	chr2:102524988	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-6.37	4.6e-10	-0.2	-0.28	Migraine;	chr10:103273871	chr10:103394301~103394322:-
HNSC	cis	rs79387448	0.745	rs72993722	MIMAT0019926	hsa-miR-4772-5p	-6.37	4.65e-10	-0.46	-0.28	Gut microbiota (bacterial taxa);	chr2:102508457	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs76746266	MIMAT0019926	hsa-miR-4772-5p	-6.37	4.65e-10	-0.46	-0.28	Gut microbiota (bacterial taxa);	chr2:102508461	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-6.36	4.75e-10	-0.35	-0.28	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.71	rs3732123	MIMAT0019927	hsa-miR-4772-3p	6.36	4.76e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102401617	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.649	rs967325	MIMAT0014979	hsa-miR-3117-3p	-6.36	4.84e-10	-0.37	-0.28	Presence of antiphospholipid antibodies;	chr1:66538039	chr1:66628485~66628505:+
HNSC	cis	rs1014286	0.892	rs2110737	MIMAT0019926	hsa-miR-4772-5p	-6.36	4.86e-10	-0.32	-0.28	Serum protein levels (sST2);	chr2:102555804	chr2:102432300~102432321:+
HNSC	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-6.35	5.13e-10	-0.27	-0.28	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs4851570	MIMAT0019927	hsa-miR-4772-3p	6.35	5.18e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102389927	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs17027060	MIMAT0019927	hsa-miR-4772-3p	6.35	5.18e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102391107	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs55742125	MIMAT0019927	hsa-miR-4772-3p	6.34	5.3e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102403322	chr2:102432336~102432357:+
HNSC	cis	rs1014286	1	rs6737119	MIMAT0019926	hsa-miR-4772-5p	6.34	5.41e-10	0.33	0.28	Serum protein levels (sST2);	chr2:102534650	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs1135354	MIMAT0019927	hsa-miR-4772-3p	6.34	5.42e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102397842	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-6.34	5.43e-10	-0.27	-0.28	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-6.34	5.43e-10	-0.27	-0.28	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-6.34	5.43e-10	-0.27	-0.28	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-6.34	5.43e-10	-0.27	-0.28	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs6709719	MIMAT0019926	hsa-miR-4772-5p	-6.34	5.49e-10	-0.46	-0.28	Gut microbiota (bacterial taxa);	chr2:102528494	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.881	rs2147897	MIMAT0005878	hsa-miR-1287-5p	-6.34	5.51e-10	-0.29	-0.28	Metabolite levels;	chr10:98388056	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.71	rs2270298	MIMAT0019927	hsa-miR-4772-3p	6.34	5.55e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102375619	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs17027037	MIMAT0019927	hsa-miR-4772-3p	6.34	5.55e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102378424	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs2080289	MIMAT0019927	hsa-miR-4772-3p	6.34	5.55e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102378560	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs3821203	MIMAT0019927	hsa-miR-4772-3p	6.34	5.55e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102380412	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs3771162	MIMAT0019927	hsa-miR-4772-3p	6.34	5.55e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102380714	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs11465633	MIMAT0019927	hsa-miR-4772-3p	6.34	5.55e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102381273	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs1035130	MIMAT0019927	hsa-miR-4772-3p	6.34	5.55e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102384942	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-6.34	5.55e-10	-0.27	-0.28	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	6.33	5.88e-10	0.27	0.28	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs12763326	MIMAT0005878	hsa-miR-1287-5p	-6.33	5.9e-10	-0.31	-0.28	Metabolite levels;	chr10:98407639	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	6.33	5.91e-10	0.25	0.28	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
HNSC	cis	rs1014286	1	rs10210658	MIMAT0019926	hsa-miR-4772-5p	6.33	5.95e-10	0.32	0.28	Serum protein levels (sST2);	chr2:102559290	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.966	rs4655650	MIMAT0014979	hsa-miR-3117-3p	-6.32	6.25e-10	-0.35	-0.28	Presence of antiphospholipid antibodies;	chr1:66676603	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	6.32	6.27e-10	0.19	0.28	Migraine;	chr10:103241753	chr10:103394301~103394322:-
HNSC	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-6.31	6.59e-10	-0.31	-0.28	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-6.31	6.6e-10	-0.2	-0.28	Migraine;	chr10:103389790	chr10:103394301~103394322:-
HNSC	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-6.31	6.64e-10	-0.31	-0.28	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
HNSC	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-6.3	6.83e-10	-0.27	-0.28	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs66919607	MIMAT0019927	hsa-miR-4772-3p	6.3	6.93e-10	0.27	0.28	Serum protein levels (sST2);	chr2:102392509	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs4399750	MIMAT0019927	hsa-miR-4772-3p	6.3	7.1e-10	0.25	0.28	Serum protein levels (sST2);	chr2:102301328	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.81	rs76229479	MIMAT0019926	hsa-miR-4772-5p	-6.3	7.12e-10	-0.47	-0.28	Gut microbiota (bacterial taxa);	chr2:102507453	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs1403549	MIMAT0019926	hsa-miR-4772-5p	-6.29	7.23e-10	-0.45	-0.28	Gut microbiota (bacterial taxa);	chr2:102494286	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs997056	MIMAT0019926	hsa-miR-4772-5p	6.29	7.43e-10	0.32	0.28	Serum protein levels (sST2);	chr2:102554460	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs74560841	MIMAT0019926	hsa-miR-4772-5p	-6.29	7.46e-10	-0.49	-0.28	Gut microbiota (bacterial taxa);	chr2:102532751	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs10193009	MIMAT0019926	hsa-miR-4772-5p	6.28	7.71e-10	0.32	0.28	Serum protein levels (sST2);	chr2:102552518	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	6.28	7.74e-10	0.31	0.28	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
HNSC	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	6.28	7.87e-10	0.49	0.28	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
HNSC	cis	rs950880	0.71	rs17027071	MIMAT0019927	hsa-miR-4772-3p	6.28	7.89e-10	0.28	0.28	Serum protein levels (sST2);	chr2:102396214	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.636	rs10199766	MIMAT0014994	hsa-miR-3130-3p	6.28	8.01e-10	0.44	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs10199766	MIMAT0014994_1	hsa-miR-3130-3p	6.28	8.01e-10	0.44	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783277~206783297:+
HNSC	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-6.27	8.17e-10	-0.36	-0.28	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	6.27	8.33e-10	0.31	0.28	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-6.27	8.51e-10	-0.2	-0.28	Migraine;	chr10:103283532	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-6.27	8.51e-10	-0.2	-0.28	Migraine;	chr10:103284207	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.71	rs55883125	MIMAT0019927	hsa-miR-4772-3p	6.26	8.67e-10	0.27	0.28	Serum protein levels (sST2);	chr2:102407871	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.645	rs4851006	MIMAT0019927	hsa-miR-4772-3p	6.26	8.67e-10	0.27	0.28	Serum protein levels (sST2);	chr2:102408278	chr2:102432336~102432357:+
HNSC	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-6.26	8.77e-10	-0.33	-0.28	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
HNSC	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-6.26	8.8e-10	-0.27	-0.28	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.634	rs994396	MIMAT0014979	hsa-miR-3117-3p	-6.25	9.07e-10	-0.36	-0.28	Presence of antiphospholipid antibodies;	chr1:66546553	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.674	rs4134135	MIMAT0014979	hsa-miR-3117-3p	-6.25	9.07e-10	-0.36	-0.28	Presence of antiphospholipid antibodies;	chr1:66547045	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	6.25	9.12e-10	0.32	0.28	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
HNSC	cis	rs1014286	1	rs11123937	MIMAT0019926	hsa-miR-4772-5p	6.25	9.21e-10	0.32	0.28	Serum protein levels (sST2);	chr2:102553223	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.674	rs7543607	MIMAT0014979	hsa-miR-3117-3p	-6.25	9.21e-10	-0.35	-0.28	Presence of antiphospholipid antibodies;	chr1:66546909	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.745	rs7572284	MIMAT0019926	hsa-miR-4772-5p	-6.25	9.3e-10	-0.45	-0.28	Gut microbiota (bacterial taxa);	chr2:102502964	chr2:102432300~102432321:+
HNSC	cis	rs75358501	0.636	rs725980	MIMAT0014994	hsa-miR-3130-3p	6.25	9.39e-10	0.44	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs725980	MIMAT0014994_1	hsa-miR-3130-3p	6.25	9.39e-10	0.44	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783277~206783297:+
HNSC	cis	rs7072216	0.655	rs3830025	MIMAT0005878	hsa-miR-1287-5p	6.25	9.45e-10	0.32	0.28	Metabolite levels;	chr10:98416347	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.655	rs3830024	MIMAT0005878	hsa-miR-1287-5p	6.25	9.45e-10	0.32	0.28	Metabolite levels;	chr10:98416349	chr10:98395271~98395292:-
HNSC	cis	rs1014286	1	rs12712159	MIMAT0019926	hsa-miR-4772-5p	6.24	9.86e-10	0.32	0.28	Serum protein levels (sST2);	chr2:102553523	chr2:102432300~102432321:+
HNSC	cis	rs1014286	1	rs2177317	MIMAT0019926	hsa-miR-4772-5p	6.24	1.01e-09	0.32	0.28	Serum protein levels (sST2);	chr2:102534860	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.668	rs3732126	MIMAT0019927	hsa-miR-4772-3p	6.24	1.02e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102397502	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs3732125	MIMAT0019927	hsa-miR-4772-3p	6.24	1.02e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102397503	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-6.23	1.02e-09	-0.27	-0.28	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs1420090	MIMAT0019927	hsa-miR-4772-3p	6.23	1.04e-09	0.25	0.28	Serum protein levels (sST2);	chr2:102302845	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs7565653	MIMAT0019927	hsa-miR-4772-3p	6.23	1.04e-09	0.25	0.28	Serum protein levels (sST2);	chr2:102302966	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs11683700	MIMAT0019927	hsa-miR-4772-3p	6.23	1.06e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102380345	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs56258475	MIMAT0019927	hsa-miR-4772-3p	6.23	1.06e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102382852	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.674	rs2121051	MIMAT0014979	hsa-miR-3117-3p	-6.23	1.07e-09	-0.36	-0.28	Presence of antiphospholipid antibodies;	chr1:66551494	chr1:66628485~66628505:+
HNSC	cis	rs7894407	0.504	rs7089271	MIMAT0005951	hsa-miR-1307-3p	-6.22	1.08e-09	-0.2	-0.28	White matter hyperintensity burden;	chr10:103417157	chr10:103394301~103394322:-
HNSC	cis	rs79387448	0.745	rs72993720	MIMAT0019926	hsa-miR-4772-5p	-6.22	1.08e-09	-0.45	-0.28	Gut microbiota (bacterial taxa);	chr2:102504810	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.505	rs17027327	MIMAT0019926	hsa-miR-4772-5p	-6.22	1.08e-09	-0.45	-0.28	Gut microbiota (bacterial taxa);	chr2:102506054	chr2:102432300~102432321:+
HNSC	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-6.22	1.09e-09	-0.26	-0.28	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
HNSC	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	6.22	1.09e-09	0.38	0.28	Asthma;	chr2:102344364	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs59694233	MIMAT0019926	hsa-miR-4772-5p	-6.22	1.09e-09	-0.45	-0.28	Gut microbiota (bacterial taxa);	chr2:102500062	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs7601773	MIMAT0019926	hsa-miR-4772-5p	-6.22	1.11e-09	-0.45	-0.28	Gut microbiota (bacterial taxa);	chr2:102504024	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-6.22	1.12e-09	-0.2	-0.28	Migraine;	chr10:103279822	chr10:103394301~103394322:-
HNSC	cis	rs75358501	0.636	rs13427002	MIMAT0014994	hsa-miR-3130-3p	6.22	1.14e-09	0.43	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs13427002	MIMAT0014994_1	hsa-miR-3130-3p	6.22	1.14e-09	0.43	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783277~206783297:+
HNSC	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-6.22	1.14e-09	-0.2	-0.28	Migraine;	chr10:103289348	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.56	rs4090473	MIMAT0019927	hsa-miR-4772-3p	6.21	1.16e-09	0.25	0.28	Serum protein levels (sST2);	chr2:102306527	chr2:102432336~102432357:+
HNSC	cis	rs1014286	1	rs4292112	MIMAT0019926	hsa-miR-4772-5p	6.21	1.19e-09	0.32	0.28	Serum protein levels (sST2);	chr2:102537321	chr2:102432300~102432321:+
HNSC	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-6.21	1.2e-09	-0.26	-0.28	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-6.2	1.23e-09	-0.19	-0.28	Migraine;	chr10:103317367	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-6.2	1.23e-09	-0.19	-0.28	Migraine;	chr10:103319682	chr10:103394301~103394322:-
HNSC	cis	rs79387448	0.745	rs7583683	MIMAT0019926	hsa-miR-4772-5p	6.2	1.24e-09	0.44	0.28	Gut microbiota (bacterial taxa);	chr2:102497304	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs3771172	MIMAT0019927	hsa-miR-4772-3p	6.2	1.25e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102369352	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs3771171	MIMAT0019927	hsa-miR-4772-3p	6.2	1.25e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102369490	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs2160202	MIMAT0019927	hsa-miR-4772-3p	6.2	1.25e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102369694	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	6.19	1.29e-09	0.43	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	6.19	1.29e-09	0.43	0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
HNSC	cis	rs7072216	0.881	rs2147895	MIMAT0005878	hsa-miR-1287-5p	6.19	1.31e-09	0.28	0.28	Metabolite levels;	chr10:98388551	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-6.19	1.34e-09	-0.19	-0.28	Migraine;	chr10:103270083	chr10:103394301~103394322:-
HNSC	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	6.18	1.39e-09	0.31	0.28	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
HNSC	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-6.18	1.39e-09	-0.32	-0.28	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.71	rs2287034	MIMAT0019927	hsa-miR-4772-3p	-6.18	1.43e-09	-0.28	-0.28	Serum protein levels (sST2);	chr2:102394128	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	6.17	1.51e-09	0.2	0.28	Migraine;	chr10:103402122	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.71	rs67723747	MIMAT0019927	hsa-miR-4772-3p	6.16	1.54e-09	0.27	0.28	Serum protein levels (sST2);	chr2:102353347	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs56386507	MIMAT0019927	hsa-miR-4772-3p	6.16	1.54e-09	0.27	0.28	Serum protein levels (sST2);	chr2:102354705	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs11693955	MIMAT0019927	hsa-miR-4772-3p	6.15	1.63e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102412705	chr2:102432336~102432357:+
HNSC	cis	rs74233809	0.748	rs10786736	MIMAT0022727	hsa-miR-1307-5p	-6.15	1.64e-09	-0.36	-0.27	Birth weight;	chr10:103089359	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.966	rs7542924	MIMAT0014979	hsa-miR-3117-3p	-6.15	1.64e-09	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66677372	chr1:66628485~66628505:+
HNSC	cis	rs8064299	0.934	rs895692	MIMAT0017994	hsa-miR-3615	-6.15	1.71e-09	-0.3	-0.27	Monocyte count;	chr17:74770113	chr17:74748663~74748683:+
HNSC	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	6.15	1.72e-09	0.19	0.27	Migraine;	chr10:103238157	chr10:103394301~103394322:-
HNSC	cis	rs7072216	0.922	rs4539242	MIMAT0005878	hsa-miR-1287-5p	6.14	1.74e-09	0.28	0.27	Metabolite levels;	chr10:98388301	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.881	rs2147896	MIMAT0005878	hsa-miR-1287-5p	6.14	1.74e-09	0.28	0.27	Metabolite levels;	chr10:98388419	chr10:98395271~98395292:-
HNSC	cis	rs8064299	0.967	rs878906	MIMAT0017994	hsa-miR-3615	-6.14	1.78e-09	-0.31	-0.27	Monocyte count;	chr17:74773195	chr17:74748663~74748683:+
HNSC	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	6.14	1.79e-09	0.19	0.27	Migraine;	chr10:103240612	chr10:103394301~103394322:-
HNSC	cis	rs79387448	0.745	rs6749440	MIMAT0019926	hsa-miR-4772-5p	-6.14	1.8e-09	-0.45	-0.27	Gut microbiota (bacterial taxa);	chr2:102485387	chr2:102432300~102432321:+
HNSC	cis	rs7072216	1	rs7072216	MIMAT0005878	hsa-miR-1287-5p	6.14	1.81e-09	0.28	0.27	Metabolite levels;	chr10:98397096	chr10:98395271~98395292:-
HNSC	cis	rs79387448	0.745	rs7575867	MIMAT0019926	hsa-miR-4772-5p	-6.14	1.81e-09	-0.43	-0.27	Gut microbiota (bacterial taxa);	chr2:102503720	chr2:102432300~102432321:+
HNSC	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-6.13	1.86e-09	-0.31	-0.27	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.71	rs3771150	MIMAT0019927	hsa-miR-4772-3p	6.12	1.95e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102444391	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	6.12	2.01e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-6.11	2.11e-09	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	6.11	2.12e-09	0.19	0.27	Migraine;	chr10:103248169	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	6.11	2.12e-09	0.19	0.27	Migraine;	chr10:103249329	chr10:103394301~103394322:-
HNSC	cis	rs75358501	0.636	rs12471008	MIMAT0014994	hsa-miR-3130-3p	6.11	2.15e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs12471008	MIMAT0014994_1	hsa-miR-3130-3p	6.11	2.15e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783277~206783297:+
HNSC	cis	rs75358501	0.636	rs768533	MIMAT0014994	hsa-miR-3130-3p	6.11	2.15e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs768533	MIMAT0014994_1	hsa-miR-3130-3p	6.11	2.15e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783277~206783297:+
HNSC	cis	rs12712135	0.706	rs6543114	MIMAT0019927	hsa-miR-4772-3p	6.11	2.16e-09	0.28	0.27	Blood protein levels;	chr2:102309534	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs56117144	MIMAT0019927	hsa-miR-4772-3p	6.11	2.16e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102458191	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs57081652	MIMAT0019927	hsa-miR-4772-3p	6.11	2.16e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102458921	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	6.1	2.18e-09	0.3	0.27	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.904	rs4918007	MIMAT0005951	hsa-miR-1307-3p	6.1	2.2e-09	0.19	0.27	Migraine;	chr10:103347713	chr10:103394301~103394322:-
HNSC	cis	rs79387448	0.745	rs17027341	MIMAT0019926	hsa-miR-4772-5p	-6.09	2.33e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102520100	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.655	rs11891827	MIMAT0019926	hsa-miR-4772-5p	-6.09	2.35e-09	-0.47	-0.27	Gut microbiota (bacterial taxa);	chr2:102334722	chr2:102432300~102432321:+
HNSC	cis	rs8064299	1	rs8064299	MIMAT0017994	hsa-miR-3615	-6.09	2.35e-09	-0.3	-0.27	Monocyte count;	chr17:74766507	chr17:74748663~74748683:+
HNSC	cis	rs950880	0.71	rs12469506	MIMAT0019927	hsa-miR-4772-3p	6.09	2.37e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102349411	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs4140785	MIMAT0019927	hsa-miR-4772-3p	6.07	2.63e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102472057	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs11693204	MIMAT0019927	hsa-miR-4772-3p	6.07	2.66e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102319514	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.677	rs56224165	MIMAT0019927	hsa-miR-4772-3p	6.07	2.66e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102308763	chr2:102432336~102432357:+
HNSC	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-6.06	2.89e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.71	rs10490204	MIMAT0019927	hsa-miR-4772-3p	6.06	2.9e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102440074	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-6.05	2.96e-09	-0.19	-0.27	Migraine;	chr10:103309363	chr10:103394301~103394322:-
HNSC	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-6.05	3.06e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.71	rs66566526	MIMAT0019927	hsa-miR-4772-3p	6.04	3.11e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102431342	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs4851582	MIMAT0019927	hsa-miR-4772-3p	6.04	3.11e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102435098	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs57942521	MIMAT0019926	hsa-miR-4772-5p	-6.04	3.16e-09	-0.45	-0.27	Gut microbiota (bacterial taxa);	chr2:102523390	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs4851011	MIMAT0019927	hsa-miR-4772-3p	-6.04	3.18e-09	-0.27	-0.27	Serum protein levels (sST2);	chr2:102473219	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.655	rs79144324	MIMAT0019926	hsa-miR-4772-5p	-6.04	3.19e-09	-0.47	-0.27	Gut microbiota (bacterial taxa);	chr2:102316354	chr2:102432300~102432321:+
HNSC	cis	rs8064299	0.967	rs7420	MIMAT0017994	hsa-miR-3615	6.04	3.24e-09	0.3	0.27	Monocyte count;	chr17:74769076	chr17:74748663~74748683:+
HNSC	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	6.04	3.25e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	6.04	3.25e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
HNSC	cis	rs7072216	0.922	rs2296438	MIMAT0005878	hsa-miR-1287-5p	6.03	3.26e-09	0.27	0.27	Metabolite levels;	chr10:98387138	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.922	rs10786415	MIMAT0005878	hsa-miR-1287-5p	6.03	3.36e-09	0.28	0.27	Metabolite levels;	chr10:98391509	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.922	rs942814	MIMAT0005878	hsa-miR-1287-5p	6.03	3.36e-09	0.28	0.27	Metabolite levels;	chr10:98391548	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.922	rs6584191	MIMAT0005878	hsa-miR-1287-5p	6.03	3.36e-09	0.28	0.27	Metabolite levels;	chr10:98392298	chr10:98395271~98395292:-
HNSC	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-6.03	3.39e-09	-0.3	-0.27	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	6.02	3.49e-09	0.39	0.27	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-6.02	3.56e-09	-0.19	-0.27	Migraine;	chr10:103262005	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.71	rs17027006	MIMAT0019927	hsa-miR-4772-3p	-6.01	3.72e-09	-0.27	-0.27	Serum protein levels (sST2);	chr2:102348872	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs3771177	MIMAT0019927	hsa-miR-4772-3p	6.01	3.74e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102339400	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs3732129	MIMAT0019927	hsa-miR-4772-3p	6.01	3.74e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102341072	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs7593444	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102542102	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs17027421	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102543423	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs7582378	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102545804	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs72995626	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102546121	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs17027428	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102546716	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs17027430	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102546778	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs1523196	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102547241	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs1523197	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102547273	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs79107058	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.82e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102547798	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.649	rs6691033	MIMAT0014979	hsa-miR-3117-3p	-6.01	3.83e-09	-0.34	-0.27	Presence of antiphospholipid antibodies;	chr1:66541746	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.745	rs59126438	MIMAT0019926	hsa-miR-4772-5p	-6.01	3.86e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102548683	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.922	rs4488133	MIMAT0005878	hsa-miR-1287-5p	-6	4.03e-09	-0.27	-0.27	Metabolite levels;	chr10:98399379	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.71	rs873022	MIMAT0019927	hsa-miR-4772-3p	6	4.06e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102339223	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.636	rs57600974	MIMAT0014994	hsa-miR-3130-3p	5.99	4.14e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs57600974	MIMAT0014994_1	hsa-miR-3130-3p	5.99	4.14e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783277~206783297:+
HNSC	cis	rs7072216	0.881	rs2182168	MIMAT0005878	hsa-miR-1287-5p	5.99	4.2e-09	0.28	0.27	Metabolite levels;	chr10:98388596	chr10:98395271~98395292:-
HNSC	cis	rs6681460	0.649	rs967322	MIMAT0014979	hsa-miR-3117-3p	-5.99	4.21e-09	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66537763	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.745	rs1880000	MIMAT0019926	hsa-miR-4772-5p	-5.99	4.25e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102483494	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.56	rs6721346	MIMAT0019927	hsa-miR-4772-3p	5.98	4.36e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102309860	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.636	rs16838834	MIMAT0014994	hsa-miR-3130-3p	5.98	4.36e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs16838834	MIMAT0014994_1	hsa-miR-3130-3p	5.98	4.36e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783277~206783297:+
HNSC	cis	rs6681460	0.933	rs7554101	MIMAT0014979	hsa-miR-3117-3p	5.98	4.37e-09	0.33	0.27	Presence of antiphospholipid antibodies;	chr1:66690789	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.745	rs2310294	MIMAT0019926	hsa-miR-4772-5p	-5.98	4.38e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102549247	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs72995652	MIMAT0019926	hsa-miR-4772-5p	-5.98	4.43e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102555192	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.649	rs7540195	MIMAT0014979	hsa-miR-3117-3p	5.98	4.46e-09	0.34	0.27	Presence of antiphospholipid antibodies;	chr1:66536723	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	5.98	4.48e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs76720903	MIMAT0019926	hsa-miR-4772-5p	-5.98	4.5e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102546367	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.922	rs59667296	MIMAT0005878	hsa-miR-1287-5p	5.98	4.53e-09	0.27	0.27	Metabolite levels;	chr10:98386556	chr10:98395271~98395292:-
HNSC	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-5.98	4.56e-09	-0.37	-0.27	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
HNSC	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	5.98	4.57e-09	0.22	0.27	Migraine;	chr10:103367830	chr10:103394341~103394361:-
HNSC	cis	rs79387448	0.745	rs1989399	MIMAT0019926	hsa-miR-4772-5p	-5.97	4.62e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102550283	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.56	rs6706844	MIMAT0019927	hsa-miR-4772-3p	5.97	4.72e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102323952	chr2:102432336~102432357:+
HNSC	cis	rs6841433	0.632	rs7685523	MIMAT0003242	hsa-miR-577	-5.97	4.74e-09	-0.31	-0.27	Hemoglobin concentration;	chr4:114621913	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.881	rs1079179	MIMAT0005878	hsa-miR-1287-5p	5.97	4.81e-09	0.27	0.27	Metabolite levels;	chr10:98389589	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.881	rs7916469	MIMAT0005878	hsa-miR-1287-5p	5.97	4.81e-09	0.27	0.27	Metabolite levels;	chr10:98388896	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.881	rs755126	MIMAT0005878	hsa-miR-1287-5p	5.97	4.81e-09	0.27	0.27	Metabolite levels;	chr10:98389194	chr10:98395271~98395292:-
HNSC	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	5.96	4.94e-09	0.25	0.27	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.636	rs4673363	MIMAT0014994	hsa-miR-3130-3p	5.96	4.94e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs4673363	MIMAT0014994_1	hsa-miR-3130-3p	5.96	4.94e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783277~206783297:+
HNSC	cis	rs1014286	1	rs10490202	MIMAT0019926	hsa-miR-4772-5p	5.96	4.95e-09	0.31	0.27	Serum protein levels (sST2);	chr2:102544373	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	5.96	5.13e-09	0.18	0.27	Migraine;	chr10:103237257	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-5.96	5.13e-09	-0.19	-0.27	Migraine;	chr10:103292867	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-5.96	5.13e-09	-0.19	-0.27	Migraine;	chr10:103293183	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-5.96	5.13e-09	-0.19	-0.27	Migraine;	chr10:103293219	chr10:103394301~103394322:-
HNSC	cis	rs75358501	0.636	rs957414	MIMAT0014994	hsa-miR-3130-3p	5.95	5.15e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs957414	MIMAT0014994_1	hsa-miR-3130-3p	5.95	5.15e-09	0.42	0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783277~206783297:+
HNSC	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	5.95	5.22e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs1159509	MIMAT0019926	hsa-miR-4772-5p	-5.95	5.25e-09	-0.44	-0.27	Gut microbiota (bacterial taxa);	chr2:102552614	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.649	rs1338184	MIMAT0014979	hsa-miR-3117-3p	5.95	5.32e-09	0.33	0.27	Presence of antiphospholipid antibodies;	chr1:66539389	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.585	rs11208940	MIMAT0014979	hsa-miR-3117-3p	5.95	5.34e-09	0.31	0.27	Menopause (age at onset);	chr1:66661559	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.834	rs2916	MIMAT0014979	hsa-miR-3117-3p	5.95	5.4e-09	0.32	0.27	Presence of antiphospholipid antibodies;	chr1:66751014	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.834	rs1280310	MIMAT0014979	hsa-miR-3117-3p	5.95	5.4e-09	0.32	0.27	Presence of antiphospholipid antibodies;	chr1:66751140	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.614	rs985523	MIMAT0019926	hsa-miR-4772-5p	-5.95	5.4e-09	-0.46	-0.27	Gut microbiota (bacterial taxa);	chr2:102337916	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs12470867	MIMAT0019927	hsa-miR-4772-3p	5.94	5.49e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102309906	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	5.94	5.58e-09	0.24	0.27	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs3821204	MIMAT0019927	hsa-miR-4772-3p	5.94	5.76e-09	0.26	0.27	Serum protein levels (sST2);	chr2:102343821	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.701	rs11465586	MIMAT0019926	hsa-miR-4772-5p	-5.93	5.82e-09	-0.47	-0.27	Gut microbiota (bacterial taxa);	chr2:102366249	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs56331791	MIMAT0019927	hsa-miR-4772-3p	5.92	6.11e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102431697	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs11681718	MIMAT0019927	hsa-miR-4772-3p	5.92	6.11e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102434684	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-5.92	6.14e-09	-0.22	-0.27	Migraine;	chr10:103348698	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-5.92	6.14e-09	-0.22	-0.27	Migraine;	chr10:103358719	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-5.92	6.14e-09	-0.22	-0.27	Migraine;	chr10:103367521	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-5.92	6.15e-09	-0.22	-0.27	Migraine;	chr10:103379204	chr10:103394341~103394361:-
HNSC	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-5.92	6.28e-09	-0.25	-0.26	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-5.92	6.28e-09	-0.25	-0.26	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-5.92	6.28e-09	-0.25	-0.26	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-5.92	6.28e-09	-0.25	-0.26	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs7576324	MIMAT0019926	hsa-miR-4772-5p	-5.92	6.31e-09	-0.42	-0.26	Gut microbiota (bacterial taxa);	chr2:102526535	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	5.92	6.31e-09	0.19	0.26	Migraine;	chr10:103242040	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-5.92	6.43e-09	-0.22	-0.26	Migraine;	chr10:103395309	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.649	rs1947083	MIMAT0014979	hsa-miR-3117-3p	-5.91	6.47e-09	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66539118	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	5.91	6.57e-09	0.18	0.26	Migraine;	chr10:103261506	chr10:103394301~103394322:-
HNSC	cis	rs6681460	0.608	rs10889624	MIMAT0014979	hsa-miR-3117-3p	-5.91	6.79e-09	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66540124	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-5.9	6.87e-09	-0.22	-0.26	Migraine;	chr10:103353944	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-5.9	6.87e-09	-0.22	-0.26	Migraine;	chr10:103356299	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-5.9	6.87e-09	-0.22	-0.26	Migraine;	chr10:103358705	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-5.9	6.87e-09	-0.22	-0.26	Migraine;	chr10:103367951	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.503	rs4425400	MIMAT0003242	hsa-miR-577	-5.9	7.05e-09	-0.32	-0.26	Hemoglobin concentration;	chr4:114613788	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	5.9	7.1e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.701	rs76943877	MIMAT0019926	hsa-miR-4772-5p	-5.9	7.18e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102354217	chr2:102432300~102432321:+
HNSC	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-5.9	7.19e-09	-0.3	-0.26	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	5.89	7.23e-09	0.18	0.26	Migraine;	chr10:103244344	chr10:103394301~103394322:-
HNSC	cis	rs75358501	0.636	rs11895370	MIMAT0014994	hsa-miR-3130-3p	5.89	7.39e-09	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs11895370	MIMAT0014994_1	hsa-miR-3130-3p	5.89	7.39e-09	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783277~206783297:+
HNSC	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	5.89	7.4e-09	0.31	0.26	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.881	rs4345897	MIMAT0005878	hsa-miR-1287-5p	5.89	7.4e-09	0.27	0.26	Metabolite levels;	chr10:98387303	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.71	rs55927292	MIMAT0019927	hsa-miR-4772-3p	5.89	7.41e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102348401	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-5.89	7.41e-09	-0.22	-0.26	Migraine;	chr10:103395888	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.881	rs2182169	MIMAT0005878	hsa-miR-1287-5p	5.89	7.54e-09	0.27	0.26	Metabolite levels;	chr10:98388247	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-5.89	7.63e-09	-0.18	-0.26	Migraine;	chr10:103278698	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.71	rs12905	MIMAT0019927	hsa-miR-4772-3p	5.88	7.65e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102343547	chr2:102432336~102432357:+
HNSC	cis	rs6841433	0.632	rs4585328	MIMAT0003242	hsa-miR-577	-5.88	7.66e-09	-0.3	-0.26	Hemoglobin concentration;	chr4:114613660	chr4:114656774~114656794:+
HNSC	cis	rs79387448	0.655	rs3771167	MIMAT0019926	hsa-miR-4772-5p	-5.88	7.78e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102369728	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.8	rs539014	MIMAT0014979	hsa-miR-3117-3p	5.88	7.79e-09	0.32	0.26	Presence of antiphospholipid antibodies;	chr1:66746204	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.592	rs6728945	MIMAT0019926	hsa-miR-4772-5p	-5.88	7.84e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102370011	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs11678975	MIMAT0019927	hsa-miR-4772-3p	5.88	7.91e-09	0.27	0.26	Serum protein levels (sST2);	chr2:102427279	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.881	rs7082192	MIMAT0005878	hsa-miR-1287-5p	5.88	7.97e-09	0.27	0.26	Metabolite levels;	chr10:98392087	chr10:98395271~98395292:-
HNSC	cis	rs79387448	0.592	rs76362690	MIMAT0019926	hsa-miR-4772-5p	-5.88	7.98e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102335017	chr2:102432300~102432321:+
HNSC	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-5.88	8.02e-09	-0.25	-0.26	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.655	rs79091585	MIMAT0019926	hsa-miR-4772-5p	-5.88	8.03e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102300783	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.655	rs17639215	MIMAT0019926	hsa-miR-4772-5p	-5.87	8.14e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102336984	chr2:102432300~102432321:+
HNSC	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	5.87	8.37e-09	0.4	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	5.87	8.37e-09	0.4	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
HNSC	cis	rs6681460	0.649	rs4655494	MIMAT0014979	hsa-miR-3117-3p	-5.87	8.38e-09	-0.32	-0.26	Presence of antiphospholipid antibodies;	chr1:66537193	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.576	rs11902044	MIMAT0019926	hsa-miR-4772-5p	-5.87	8.4e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102356074	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.677	rs4851585	MIMAT0019927	hsa-miR-4772-3p	5.87	8.41e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102446294	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-5.87	8.43e-09	-0.22	-0.26	Migraine;	chr10:103299082	chr10:103394341~103394361:-
HNSC	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	5.86	8.78e-09	0.23	0.26	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.701	rs10515921	MIMAT0019926	hsa-miR-4772-5p	-5.86	8.83e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102364558	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.701	rs11465584	MIMAT0019926	hsa-miR-4772-5p	-5.86	8.83e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102366169	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.671	rs628655	MIMAT0014979	hsa-miR-3117-3p	5.86	8.94e-09	0.32	0.26	Presence of antiphospholipid antibodies;	chr1:66747890	chr1:66628485~66628505:+
HNSC	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-5.85	9.06e-09	-0.25	-0.26	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
HNSC	cis	rs1014286	1	rs1829849	MIMAT0019926	hsa-miR-4772-5p	5.85	9.06e-09	0.3	0.26	Serum protein levels (sST2);	chr2:102533239	chr2:102432300~102432321:+
HNSC	cis	rs12712133	0.552	rs1115281	MIMAT0019927	hsa-miR-4772-3p	5.85	9.15e-09	0.24	0.26	Primary biliary cholangitis;	chr2:102274647	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.645	rs11679889	MIMAT0019927	hsa-miR-4772-3p	5.85	9.21e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102324549	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs11694360	MIMAT0019927	hsa-miR-4772-3p	5.85	9.25e-09	0.26	0.26	Serum protein levels (sST2);	chr2:102444687	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.614	rs6719130	MIMAT0019926	hsa-miR-4772-5p	-5.85	9.27e-09	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102341776	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.56	rs971764	MIMAT0019927	hsa-miR-4772-3p	5.85	9.32e-09	0.23	0.26	Serum protein levels (sST2);	chr2:102321875	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-5.85	9.42e-09	-0.21	-0.26	Migraine;	chr10:103262005	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.649	rs1856315	MIMAT0014979	hsa-miR-3117-3p	-5.85	9.54e-09	-0.32	-0.26	Presence of antiphospholipid antibodies;	chr1:66539546	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.56	rs12476925	MIMAT0019927	hsa-miR-4772-3p	5.84	9.61e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102308089	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs12476968	MIMAT0019927	hsa-miR-4772-3p	5.84	9.61e-09	0.24	0.26	Serum protein levels (sST2);	chr2:102308202	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.77	rs7909131	MIMAT0005878	hsa-miR-1287-5p	5.84	9.84e-09	0.27	0.26	Metabolite levels;	chr10:98411714	chr10:98395271~98395292:-
HNSC	cis	rs75358501	0.688	rs28365797	MIMAT0014994	hsa-miR-3130-3p	5.84	9.86e-09	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.688	rs28365797	MIMAT0014994_1	hsa-miR-3130-3p	5.84	9.86e-09	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783277~206783297:+
HNSC	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-5.84	9.91e-09	-0.18	-0.26	Migraine;	chr10:103299551	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	5.84	9.98e-09	0.23	0.26	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	5.84	1e-08	0.21	0.26	Migraine;	chr10:103240612	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	5.83	1.01e-08	0.21	0.26	Migraine;	chr10:103261506	chr10:103394341~103394361:-
HNSC	cis	rs79387448	0.655	rs77763678	MIMAT0019926	hsa-miR-4772-5p	-5.83	1.04e-08	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102300289	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.655	rs75579337	MIMAT0019926	hsa-miR-4772-5p	-5.83	1.04e-08	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102300842	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.655	rs76930359	MIMAT0019926	hsa-miR-4772-5p	-5.83	1.04e-08	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102308224	chr2:102432300~102432321:+
HNSC	cis	rs12712133	0.552	rs10469856	MIMAT0019927	hsa-miR-4772-3p	-5.83	1.04e-08	-0.24	-0.26	Primary biliary cholangitis;	chr2:102272369	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.881	rs10883084	MIMAT0005878	hsa-miR-1287-5p	5.83	1.06e-08	0.27	0.26	Metabolite levels;	chr10:98391432	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.71	rs7597017	MIMAT0019927	hsa-miR-4772-3p	5.82	1.07e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102445656	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-5.82	1.08e-08	-0.24	-0.26	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-5.82	1.08e-08	-0.24	-0.26	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-5.82	1.08e-08	-0.24	-0.26	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.624	rs2288673	MIMAT0019728	hsa-miR-4660	5.82	1.08e-08	0.31	0.26	Joint mobility (Beighton score);	chr8:9002766	chr8:9048453~9048475:+
HNSC	cis	rs79387448	0.745	rs7587856	MIMAT0019926	hsa-miR-4772-5p	-5.81	1.15e-08	-0.42	-0.26	Gut microbiota (bacterial taxa);	chr2:102527846	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.767	rs4851569	MIMAT0019927	hsa-miR-4772-3p	5.81	1.16e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102366787	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.767	rs1420098	MIMAT0019927	hsa-miR-4772-3p	5.81	1.16e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102367819	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.699	rs1882348	MIMAT0019927	hsa-miR-4772-3p	5.81	1.16e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102368211	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.686	rs1045527	MIMAT0019728	hsa-miR-4660	-5.81	1.17e-08	-0.3	-0.26	Joint mobility (Beighton score);	chr8:9032531	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.922	rs7097824	MIMAT0005878	hsa-miR-1287-5p	5.81	1.18e-08	0.27	0.26	Metabolite levels;	chr10:98392042	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.881	rs6584192	MIMAT0005878	hsa-miR-1287-5p	5.81	1.18e-08	0.27	0.26	Metabolite levels;	chr10:98392616	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.881	rs2274247	MIMAT0005878	hsa-miR-1287-5p	5.81	1.19e-08	0.27	0.26	Metabolite levels;	chr10:98390391	chr10:98395271~98395292:-
HNSC	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	5.8	1.2e-08	0.29	0.26	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
HNSC	cis	rs6681460	0.634	rs12143964	MIMAT0014979	hsa-miR-3117-3p	-5.8	1.2e-08	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66544583	chr1:66628485~66628505:+
HNSC	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-5.8	1.21e-08	-0.24	-0.26	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-5.8	1.21e-08	-0.24	-0.26	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-5.8	1.21e-08	-0.24	-0.26	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-5.8	1.21e-08	-0.21	-0.26	Migraine;	chr10:103386935	chr10:103394341~103394361:-
HNSC	cis	rs950880	0.71	rs17027179	MIMAT0019927	hsa-miR-4772-3p	5.8	1.22e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102440699	chr2:102432336~102432357:+
HNSC	cis	rs12712133	0.552	rs11123915	MIMAT0019927	hsa-miR-4772-3p	5.8	1.22e-08	0.24	0.26	Primary biliary cholangitis;	chr2:102264363	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-5.8	1.22e-08	-0.21	-0.26	Migraine;	chr10:103241568	chr10:103394341~103394361:-
HNSC	cis	rs79387448	0.745	rs17027442	MIMAT0019926	hsa-miR-4772-5p	5.8	1.23e-08	0.42	0.26	Gut microbiota (bacterial taxa);	chr2:102548489	chr2:102432300~102432321:+
HNSC	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-5.8	1.25e-08	-0.24	-0.26	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-5.8	1.25e-08	-0.24	-0.26	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
HNSC	cis	rs6841433	0.632	rs10034697	MIMAT0003242	hsa-miR-577	-5.8	1.25e-08	-0.3	-0.26	Hemoglobin concentration;	chr4:114614102	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.767	rs2287037	MIMAT0019927	hsa-miR-4772-3p	5.79	1.28e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102362568	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.584	rs11894165	MIMAT0014994	hsa-miR-3130-3p	5.79	1.33e-08	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.584	rs11894165	MIMAT0014994_1	hsa-miR-3130-3p	5.79	1.33e-08	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783277~206783297:+
HNSC	cis	rs75358501	0.688	rs1862087	MIMAT0014994	hsa-miR-3130-3p	5.79	1.33e-08	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.688	rs1862087	MIMAT0014994_1	hsa-miR-3130-3p	5.79	1.33e-08	0.41	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783277~206783297:+
HNSC	cis	rs950880	0.71	rs17026974	MIMAT0019927	hsa-miR-4772-3p	-5.79	1.33e-08	-0.26	-0.26	Serum protein levels (sST2);	chr2:102335900	chr2:102432336~102432357:+
HNSC	cis	rs12712133	0.552	rs10200945	MIMAT0019927	hsa-miR-4772-3p	5.79	1.33e-08	0.24	0.26	Primary biliary cholangitis;	chr2:102268297	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.649	rs1415974	MIMAT0014979	hsa-miR-3117-3p	5.78	1.35e-08	0.32	0.26	Presence of antiphospholipid antibodies;	chr1:66539820	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.745	rs72995658	MIMAT0019926	hsa-miR-4772-5p	-5.78	1.35e-08	-0.43	-0.26	Gut microbiota (bacterial taxa);	chr2:102560314	chr2:102432300~102432321:+
HNSC	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-5.78	1.35e-08	-0.4	-0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-5.78	1.35e-08	-0.4	-0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
HNSC	cis	rs950880	0.744	rs3771156	MIMAT0019927	hsa-miR-4772-3p	5.78	1.35e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102420217	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs55645612	MIMAT0019927	hsa-miR-4772-3p	5.78	1.36e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102439201	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs17027413	MIMAT0019926	hsa-miR-4772-5p	5.78	1.37e-08	0.42	0.26	Gut microbiota (bacterial taxa);	chr2:102537208	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	5.78	1.39e-08	0.21	0.26	Migraine;	chr10:103238157	chr10:103394341~103394361:-
HNSC	cis	rs79387448	0.701	rs11465596	MIMAT0019926	hsa-miR-4772-5p	-5.77	1.42e-08	-0.46	-0.26	Gut microbiota (bacterial taxa);	chr2:102370633	chr2:102432300~102432321:+
HNSC	cis	rs950880	0.71	rs11123927	MIMAT0019927	hsa-miR-4772-3p	5.77	1.42e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102442343	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs10490203	MIMAT0019927	hsa-miR-4772-3p	5.77	1.42e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102442777	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs4851583	MIMAT0019927	hsa-miR-4772-3p	5.77	1.42e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102443840	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
HNSC	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-5.77	1.45e-08	-0.24	-0.26	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.686	rs6987107	MIMAT0019728	hsa-miR-4660	-5.76	1.52e-08	-0.3	-0.26	Joint mobility (Beighton score);	chr8:9036071	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.649	rs10889625	MIMAT0014979	hsa-miR-3117-3p	-5.76	1.53e-08	-0.32	-0.26	Presence of antiphospholipid antibodies;	chr1:66541552	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.634	rs4142763	MIMAT0014979	hsa-miR-3117-3p	-5.76	1.53e-08	-0.33	-0.26	Presence of antiphospholipid antibodies;	chr1:66532353	chr1:66628485~66628505:+
HNSC	cis	rs453301	0.719	rs34004903	MIMAT0019728	hsa-miR-4660	-5.76	1.53e-08	-0.3	-0.26	Joint mobility (Beighton score);	chr8:9035094	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.77	rs7896828	MIMAT0005878	hsa-miR-1287-5p	5.76	1.54e-08	0.27	0.26	Metabolite levels;	chr10:98410750	chr10:98395271~98395292:-
HNSC	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-5.76	1.54e-08	-0.24	-0.26	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-5.76	1.54e-08	-0.24	-0.26	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
HNSC	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-5.76	1.54e-08	-0.24	-0.26	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-5.76	1.55e-08	-0.21	-0.26	Migraine;	chr10:103309363	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.686	rs10217044	MIMAT0019728	hsa-miR-4660	-5.76	1.55e-08	-0.3	-0.26	Joint mobility (Beighton score);	chr8:9037242	chr8:9048453~9048475:+
HNSC	cis	rs79387448	0.683	rs7571985	MIMAT0019926	hsa-miR-4772-5p	-5.76	1.56e-08	-0.42	-0.26	Gut microbiota (bacterial taxa);	chr2:102531102	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs9677607	MIMAT0019926	hsa-miR-4772-5p	-5.76	1.56e-08	-0.42	-0.26	Gut microbiota (bacterial taxa);	chr2:102533061	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs75644281	MIMAT0019926	hsa-miR-4772-5p	-5.76	1.56e-08	-0.42	-0.26	Gut microbiota (bacterial taxa);	chr2:102534857	chr2:102432300~102432321:+
HNSC	cis	rs79387448	0.745	rs72993760	MIMAT0019926	hsa-miR-4772-5p	-5.76	1.56e-08	-0.42	-0.26	Gut microbiota (bacterial taxa);	chr2:102535245	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.932	rs492109	MIMAT0014979	hsa-miR-3117-3p	5.76	1.57e-08	0.31	0.26	Presence of antiphospholipid antibodies;	chr1:66721450	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-5.75	1.58e-08	-0.22	-0.26	Migraine;	chr10:103292867	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-5.75	1.58e-08	-0.22	-0.26	Migraine;	chr10:103293183	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-5.75	1.58e-08	-0.22	-0.26	Migraine;	chr10:103293219	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-5.75	1.59e-08	-0.21	-0.26	Migraine;	chr10:103270083	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-5.75	1.61e-08	-0.21	-0.26	Migraine;	chr10:103317367	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-5.75	1.61e-08	-0.21	-0.26	Migraine;	chr10:103319682	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-5.75	1.62e-08	-0.22	-0.26	Migraine;	chr10:103289348	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-5.75	1.63e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.71	rs56166614	MIMAT0019927	hsa-miR-4772-3p	5.74	1.67e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102439636	chr2:102432336~102432357:+
HNSC	cis	rs12712133	0.514	rs10188022	MIMAT0019927	hsa-miR-4772-3p	5.74	1.68e-08	0.24	0.26	Primary biliary cholangitis;	chr2:102258406	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.932	rs523188	MIMAT0014979	hsa-miR-3117-3p	-5.74	1.71e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66708739	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.932	rs536410	MIMAT0014979	hsa-miR-3117-3p	-5.74	1.71e-08	-0.3	-0.26	Presence of antiphospholipid antibodies;	chr1:66725401	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.645	rs56044378	MIMAT0019927	hsa-miR-4772-3p	5.74	1.74e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102448907	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.934	rs4655635	MIMAT0014979	hsa-miR-3117-3p	-5.74	1.75e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66602557	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	5.73	1.77e-08	0.21	0.26	Migraine;	chr10:103241753	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-5.73	1.83e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.922	rs942813	MIMAT0005878	hsa-miR-1287-5p	5.73	1.83e-08	0.26	0.26	Metabolite levels;	chr10:98393851	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.71	rs11123928	MIMAT0019927	hsa-miR-4772-3p	5.71	1.99e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102444826	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.686	rs28482034	MIMAT0019728	hsa-miR-4660	-5.71	2.04e-08	-0.3	-0.26	Joint mobility (Beighton score);	chr8:9012154	chr8:9048453~9048475:+
HNSC	cis	rs950880	0.71	rs11123929	MIMAT0019927	hsa-miR-4772-3p	5.71	2.05e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102450683	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs6742433	MIMAT0019926	hsa-miR-4772-5p	-5.7	2.08e-08	-0.42	-0.26	Gut microbiota (bacterial taxa);	chr2:102558901	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.899	rs502690	MIMAT0014979	hsa-miR-3117-3p	-5.7	2.1e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66716720	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.71	rs17027255	MIMAT0019927	hsa-miR-4772-3p	5.7	2.13e-08	0.25	0.26	Serum protein levels (sST2);	chr2:102473668	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.932	rs602513	MIMAT0014979	hsa-miR-3117-3p	-5.7	2.14e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66711587	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.71	rs17027230	MIMAT0019927	hsa-miR-4772-3p	5.7	2.14e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102462870	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-5.7	2.17e-08	-0.21	-0.26	Migraine;	chr10:103384531	chr10:103394341~103394361:-
HNSC	cis	rs75358501	0.636	rs12478466	MIMAT0014994	hsa-miR-3130-3p	5.7	2.19e-08	0.4	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs12478466	MIMAT0014994_1	hsa-miR-3130-3p	5.7	2.19e-08	0.4	0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783277~206783297:+
HNSC	cis	rs453301	0.686	rs6748	MIMAT0019728	hsa-miR-4660	-5.69	2.2e-08	-0.29	-0.26	Joint mobility (Beighton score);	chr8:9033292	chr8:9048453~9048475:+
HNSC	cis	rs1045529	0.524	rs34251783	MIMAT0019728	hsa-miR-4660	-5.69	2.2e-08	-0.29	-0.26	Myopia (pathological);Myopia;	chr8:9033866	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.932	rs603750	MIMAT0014979	hsa-miR-3117-3p	-5.69	2.22e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66711805	chr1:66628485~66628505:+
HNSC	cis	rs453301	0.686	rs3895823	MIMAT0019728	hsa-miR-4660	-5.69	2.22e-08	-0.3	-0.26	Joint mobility (Beighton score);	chr8:9016136	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.899	rs499263	MIMAT0014979	hsa-miR-3117-3p	-5.69	2.22e-08	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66714254	chr1:66628485~66628505:+
HNSC	cis	rs1867631	0.565	rs10749764	MIMAT0014979	hsa-miR-3117-3p	-5.69	2.23e-08	-0.3	-0.26	Menopause (age at onset);	chr1:66684023	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.767	rs12999364	MIMAT0019927	hsa-miR-4772-3p	5.69	2.25e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102357669	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.767	rs12998521	MIMAT0019927	hsa-miR-4772-3p	5.69	2.25e-08	0.23	0.26	Serum protein levels (sST2);	chr2:102357957	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.56	rs974389	MIMAT0019927	hsa-miR-4772-3p	-5.69	2.26e-08	-0.23	-0.26	Serum protein levels (sST2);	chr2:102320521	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.745	rs723292	MIMAT0019926	hsa-miR-4772-5p	-5.69	2.31e-08	-0.41	-0.26	Gut microbiota (bacterial taxa);	chr2:102550345	chr2:102432300~102432321:+
HNSC	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-5.68	2.33e-08	-0.21	-0.26	Migraine;	chr10:103299551	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-5.68	2.36e-08	-0.39	-0.26	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-5.68	2.36e-08	-0.39	-0.26	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
HNSC	cis	rs6681460	0.576	rs2859914	MIMAT0014979	hsa-miR-3117-3p	-5.68	2.39e-08	-0.33	-0.25	Presence of antiphospholipid antibodies;	chr1:66524157	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-5.68	2.4e-08	-0.21	-0.25	Migraine;	chr10:103273871	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.686	rs7814328	MIMAT0019728	hsa-miR-4660	-5.68	2.42e-08	-0.3	-0.25	Joint mobility (Beighton score);	chr8:9018719	chr8:9048453~9048475:+
HNSC	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-5.67	2.45e-08	-0.24	-0.25	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-5.67	2.48e-08	-0.18	-0.25	Migraine;	chr10:103284400	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.71	rs56043441	MIMAT0019927	hsa-miR-4772-3p	5.67	2.48e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102470923	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-5.67	2.51e-08	-0.21	-0.25	Migraine;	chr10:103284207	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.853	rs6584194	MIMAT0005878	hsa-miR-1287-5p	5.67	2.55e-08	0.26	0.25	Metabolite levels;	chr10:98400642	chr10:98395271~98395292:-
HNSC	cis	rs453301	0.686	rs11785819	MIMAT0019728	hsa-miR-4660	-5.67	2.57e-08	-0.3	-0.25	Joint mobility (Beighton score);	chr8:9012868	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.966	rs2025595	MIMAT0014979	hsa-miR-3117-3p	-5.67	2.57e-08	-0.31	-0.25	Presence of antiphospholipid antibodies;	chr1:66686816	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-5.67	2.58e-08	-0.21	-0.25	Migraine;	chr10:103283532	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.658	rs6986044	MIMAT0019728	hsa-miR-4660	-5.66	2.59e-08	-0.3	-0.25	Joint mobility (Beighton score);	chr8:9017276	chr8:9048453~9048475:+
HNSC	cis	rs950880	0.593	rs887971	MIMAT0019927	hsa-miR-4772-3p	5.66	2.69e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102424707	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	5.65	2.74e-08	0.21	0.25	Migraine;	chr10:103244344	chr10:103394341~103394361:-
HNSC	cis	rs950880	0.767	rs11123923	MIMAT0019927	hsa-miR-4772-3p	5.65	2.74e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102351384	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.796	rs12987977	MIMAT0019927	hsa-miR-4772-3p	5.65	2.74e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102358876	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.686	rs7017868	MIMAT0019728	hsa-miR-4660	-5.65	2.77e-08	-0.3	-0.25	Joint mobility (Beighton score);	chr8:9015783	chr8:9048453~9048475:+
HNSC	cis	rs1964356	0.967	rs2953802	MIMAT0019728	hsa-miR-4660	5.65	2.8e-08	0.31	0.25	Mean corpuscular volume;	chr8:8994371	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.686	rs11785634	MIMAT0019728	hsa-miR-4660	-5.65	2.81e-08	-0.29	-0.25	Joint mobility (Beighton score);	chr8:9035087	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.77	rs1061115	MIMAT0005878	hsa-miR-1287-5p	5.64	2.92e-08	0.27	0.25	Metabolite levels;	chr10:98417292	chr10:98395271~98395292:-
HNSC	cis	rs6681460	0.932	rs523132	MIMAT0014979	hsa-miR-3117-3p	5.64	2.94e-08	0.3	0.25	Presence of antiphospholipid antibodies;	chr1:66708757	chr1:66628485~66628505:+
HNSC	cis	rs74233809	1	rs11191515	MIMAT0022727	hsa-miR-1307-5p	-5.63	3.06e-08	-0.36	-0.25	Birth weight;	chr10:103016770	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.653	rs1045529	MIMAT0019728	hsa-miR-4660	-5.63	3.09e-08	-0.3	-0.25	Joint mobility (Beighton score);	chr8:9032588	chr8:9048453~9048475:+
HNSC	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-5.63	3.13e-08	-0.18	-0.25	Migraine;	chr10:103273258	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	5.63	3.15e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.576	rs7354983	MIMAT0014979	hsa-miR-3117-3p	-5.63	3.21e-08	-0.33	-0.25	Presence of antiphospholipid antibodies;	chr1:66522466	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.836	rs11191649	MIMAT0005951	hsa-miR-1307-3p	-5.62	3.21e-08	-0.18	-0.25	Migraine;	chr10:103307280	chr10:103394301~103394322:-
HNSC	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-5.62	3.23e-08	-0.39	-0.25	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
HNSC	cis	rs75358501	0.636	rs10932164	MIMAT0014994	hsa-miR-3130-3p	5.62	3.31e-08	0.41	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs10932164	MIMAT0014994_1	hsa-miR-3130-3p	5.62	3.31e-08	0.41	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783277~206783297:+
HNSC	cis	rs6681460	0.834	rs544258	MIMAT0014979	hsa-miR-3117-3p	5.62	3.35e-08	0.31	0.25	Presence of antiphospholipid antibodies;	chr1:66753526	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.767	rs6710885	MIMAT0019927	hsa-miR-4772-3p	-5.62	3.38e-08	-0.23	-0.25	Serum protein levels (sST2);	chr2:102361077	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs17027166	MIMAT0019927	hsa-miR-4772-3p	5.61	3.43e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102438960	chr2:102432336~102432357:+
HNSC	cis	rs74233809	1	rs75970938	MIMAT0022727	hsa-miR-1307-5p	-5.61	3.45e-08	-0.36	-0.25	Birth weight;	chr10:103033891	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs79668541	MIMAT0022727	hsa-miR-1307-5p	-5.61	3.47e-08	-0.36	-0.25	Birth weight;	chr10:103034147	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs3781285	MIMAT0022727	hsa-miR-1307-5p	-5.61	3.47e-08	-0.36	-0.25	Birth weight;	chr10:103065908	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.576	rs7355221	MIMAT0014979	hsa-miR-3117-3p	-5.61	3.51e-08	-0.33	-0.25	Presence of antiphospholipid antibodies;	chr1:66520618	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.576	rs7354930	MIMAT0014979	hsa-miR-3117-3p	-5.61	3.56e-08	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66520694	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.576	rs1338200	MIMAT0014979	hsa-miR-3117-3p	-5.61	3.56e-08	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66526514	chr1:66628485~66628505:+
HNSC	cis	rs75358501	0.748	rs12470963	MIMAT0014994	hsa-miR-3130-3p	5.6	3.67e-08	0.44	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.748	rs12470963	MIMAT0014994_1	hsa-miR-3130-3p	5.6	3.67e-08	0.44	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783277~206783297:+
HNSC	cis	rs950880	0.542	rs7568913	MIMAT0019927	hsa-miR-4772-3p	5.6	3.77e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102303577	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.542	rs10179654	MIMAT0019927	hsa-miR-4772-3p	5.6	3.77e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102305323	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.71	rs17027258	MIMAT0019927	hsa-miR-4772-3p	5.59	3.83e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102475081	chr2:102432336~102432357:+
HNSC	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-5.59	3.85e-08	-0.18	-0.25	Migraine;	chr10:103279291	chr10:103394301~103394322:-
HNSC	cis	rs453301	0.624	rs2979256	MIMAT0019728	hsa-miR-4660	5.59	3.86e-08	0.3	0.25	Joint mobility (Beighton score);	chr8:9014200	chr8:9048453~9048475:+
HNSC	cis	rs950880	0.56	rs2110660	MIMAT0019927	hsa-miR-4772-3p	5.59	3.96e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102302141	chr2:102432336~102432357:+
HNSC	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-5.59	3.96e-08	-0.38	-0.25	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-5.59	3.96e-08	-0.38	-0.25	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-5.58	4e-08	-0.18	-0.25	Migraine;	chr10:103305652	chr10:103394301~103394322:-
HNSC	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	5.58	4.02e-08	0.39	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	5.58	4.02e-08	0.39	0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
HNSC	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-5.58	4.03e-08	-0.23	-0.25	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
HNSC	cis	rs6681460	0.966	rs4655506	MIMAT0014979	hsa-miR-3117-3p	-5.58	4.04e-08	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66685128	chr1:66628485~66628505:+
HNSC	cis	rs950880	1	rs13019081	MIMAT0019927	hsa-miR-4772-3p	-5.58	4.13e-08	-0.23	-0.25	Serum protein levels (sST2);	chr2:102334362	chr2:102432336~102432357:+
HNSC	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-5.58	4.2e-08	-0.18	-0.25	Migraine;	chr10:103273985	chr10:103394301~103394322:-
HNSC	cis	rs1964356	0.967	rs17701675	MIMAT0019728	hsa-miR-4660	-5.57	4.26e-08	-0.3	-0.25	Mean corpuscular volume;	chr8:8993123	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	5.57	4.33e-08	0.3	0.25	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-5.57	4.34e-08	-0.21	-0.25	Migraine;	chr10:103279822	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.691	rs10786419	MIMAT0005878	hsa-miR-1287-5p	5.57	4.37e-08	0.27	0.25	Metabolite levels;	chr10:98421183	chr10:98395271~98395292:-
HNSC	cis	rs6681460	0.576	rs1338194	MIMAT0014979	hsa-miR-3117-3p	-5.57	4.39e-08	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66520793	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.745	rs72993754	MIMAT0019926	hsa-miR-4772-5p	-5.57	4.4e-08	-0.39	-0.25	Gut microbiota (bacterial taxa);	chr2:102534677	chr2:102432300~102432321:+
HNSC	cis	rs453301	0.686	rs28665409	MIMAT0019728	hsa-miR-4660	-5.57	4.42e-08	-0.29	-0.25	Joint mobility (Beighton score);	chr8:9011767	chr8:9048453~9048475:+
HNSC	cis	rs950880	0.614	rs60038017	MIMAT0019927	hsa-miR-4772-3p	5.56	4.54e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102459541	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.624	rs6987558	MIMAT0019728	hsa-miR-4660	5.56	4.59e-08	0.29	0.25	Joint mobility (Beighton score);	chr8:9005011	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.522	rs1964356	MIMAT0019728	hsa-miR-4660	5.56	4.63e-08	0.3	0.25	Joint mobility (Beighton score);	chr8:8995760	chr8:9048453~9048475:+
HNSC	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-5.55	4.8e-08	-0.21	-0.25	Migraine;	chr10:103297804	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.658	rs9650616	MIMAT0019728	hsa-miR-4660	-5.55	4.84e-08	-0.29	-0.25	Joint mobility (Beighton score);	chr8:9011689	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.649	rs1415984	MIMAT0014979	hsa-miR-3117-3p	-5.53	5.25e-08	-0.32	-0.25	Presence of antiphospholipid antibodies;	chr1:66536434	chr1:66628485~66628505:+
HNSC	cis	rs6841433	0.632	rs7699896	MIMAT0003242	hsa-miR-577	5.53	5.37e-08	0.29	0.25	Hemoglobin concentration;	chr4:114617357	chr4:114656774~114656794:+
HNSC	cis	rs6681460	0.535	rs6588204	MIMAT0014979	hsa-miR-3117-3p	-5.53	5.43e-08	-0.31	-0.25	Presence of antiphospholipid antibodies;	chr1:66525325	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-5.52	5.69e-08	-0.18	-0.25	Migraine;	chr10:103297804	chr10:103394301~103394322:-
HNSC	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-5.52	5.7e-08	-0.2	-0.25	Migraine;	chr10:103284400	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.624	rs4841083	MIMAT0019728	hsa-miR-4660	5.52	5.74e-08	0.29	0.25	Joint mobility (Beighton score);	chr8:9012918	chr8:9048453~9048475:+
HNSC	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	5.51	5.84e-08	0.2	0.25	Migraine;	chr10:103248169	chr10:103394341~103394361:-
HNSC	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	5.51	5.84e-08	0.2	0.25	Migraine;	chr10:103249329	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.658	rs13271797	MIMAT0019728	hsa-miR-4660	-5.51	5.85e-08	-0.29	-0.25	Joint mobility (Beighton score);	chr8:9028444	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.686	rs4840389	MIMAT0019728	hsa-miR-4660	-5.51	5.94e-08	-0.29	-0.25	Joint mobility (Beighton score);	chr8:9026993	chr8:9048453~9048475:+
HNSC	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	5.51	6.05e-08	0.38	0.25	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	5.51	6.06e-08	0.2	0.25	Migraine;	chr10:103237257	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.576	rs6588203	MIMAT0014979	hsa-miR-3117-3p	-5.51	6.12e-08	-0.31	-0.25	Presence of antiphospholipid antibodies;	chr1:66525168	chr1:66628485~66628505:+
HNSC	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-5.5	6.16e-08	-0.2	-0.25	Migraine;	chr10:103278698	chr10:103394341~103394361:-
HNSC	cis	rs6993244	1	rs6993244	MIMAT0019728	hsa-miR-4660	5.5	6.31e-08	0.29	0.25	Mean corpuscular hemoglobin;	chr8:9005549	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	5.49	6.54e-08	0.3	0.25	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
HNSC	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	5.48	6.86e-08	0.47	0.25	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
HNSC	cis	rs453301	0.653	rs7853	MIMAT0019728	hsa-miR-4660	5.48	6.96e-08	0.29	0.25	Joint mobility (Beighton score);	chr8:9033304	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.652	rs11189600	MIMAT0005878	hsa-miR-1287-5p	-5.47	7.23e-08	-0.26	-0.25	Metabolite levels;	chr10:98419517	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-5.47	7.25e-08	-0.2	-0.25	Migraine;	chr10:103389790	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.932	rs2483705	MIMAT0014979	hsa-miR-3117-3p	5.47	7.31e-08	0.29	0.25	Presence of antiphospholipid antibodies;	chr1:66725497	chr1:66628485~66628505:+
HNSC	cis	rs950880	1	rs13001325	MIMAT0019927	hsa-miR-4772-3p	5.47	7.35e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102322576	chr2:102432336~102432357:+
HNSC	cis	rs950880	1	rs12479210	MIMAT0019927	hsa-miR-4772-3p	5.47	7.35e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102332701	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.686	rs2409120	MIMAT0019728	hsa-miR-4660	-5.47	7.35e-08	-0.28	-0.25	Joint mobility (Beighton score);	chr8:9025061	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.606	rs7462373	MIMAT0019728	hsa-miR-4660	-5.47	7.44e-08	-0.29	-0.25	Joint mobility (Beighton score);	chr8:9041808	chr8:9048453~9048475:+
HNSC	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	5.47	7.5e-08	0.38	0.25	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
HNSC	cis	rs950880	1	rs950880	MIMAT0019927	hsa-miR-4772-3p	5.47	7.54e-08	0.23	0.25	Serum protein levels (sST2);	chr2:102316102	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.621	rs3750604	MIMAT0005878	hsa-miR-1287-5p	5.46	7.7e-08	0.29	0.25	Metabolite levels;	chr10:98415824	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-5.46	7.72e-08	-0.2	-0.25	Migraine;	chr10:103375562	chr10:103394341~103394361:-
HNSC	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	5.46	7.77e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.638	rs13405222	MIMAT0019926	hsa-miR-4772-5p	-5.46	7.79e-08	-0.43	-0.25	Gut microbiota (bacterial taxa);	chr2:102365431	chr2:102432300~102432321:+
HNSC	cis	rs6681460	0.966	rs10749765	MIMAT0014979	hsa-miR-3117-3p	-5.45	8.09e-08	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66684597	chr1:66628485~66628505:+
HNSC	cis	rs453301	0.598	rs2921383	MIMAT0019728	hsa-miR-4660	5.45	8.24e-08	0.29	0.25	Joint mobility (Beighton score);	chr8:9034711	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.932	rs659291	MIMAT0014979	hsa-miR-3117-3p	-5.45	8.3e-08	-0.29	-0.25	Presence of antiphospholipid antibodies;	chr1:66715063	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.77	rs1061123	MIMAT0005878	hsa-miR-1287-5p	5.45	8.34e-08	0.26	0.25	Metabolite levels;	chr10:98417240	chr10:98395271~98395292:-
HNSC	cis	rs453301	0.653	rs7016139	MIMAT0019728	hsa-miR-4660	-5.44	8.7e-08	-0.29	-0.24	Joint mobility (Beighton score);	chr8:9037960	chr8:9048453~9048475:+
HNSC	cis	rs74233809	1	rs11191531	MIMAT0022727	hsa-miR-1307-5p	-5.44	8.72e-08	-0.34	-0.24	Birth weight;	chr10:103047141	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.932	rs665319	MIMAT0014979	hsa-miR-3117-3p	-5.43	9.09e-08	-0.29	-0.24	Presence of antiphospholipid antibodies;	chr1:66709805	chr1:66628485~66628505:+
HNSC	cis	rs453301	0.652	rs2043129	MIMAT0019728	hsa-miR-4660	5.43	9.15e-08	0.28	0.24	Joint mobility (Beighton score);	chr8:8967994	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.508	rs1594437	MIMAT0019728	hsa-miR-4660	5.43	9.15e-08	0.28	0.24	Mood instability;	chr8:8968365	chr8:9048453~9048475:+
HNSC	cis	rs74233809	1	rs76752100	MIMAT0022727	hsa-miR-1307-5p	-5.43	9.33e-08	-0.34	-0.24	Birth weight;	chr10:103034329	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191514	MIMAT0022727	hsa-miR-1307-5p	-5.42	9.36e-08	-0.33	-0.24	Birth weight;	chr10:103013607	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.866	rs485521	MIMAT0014979	hsa-miR-3117-3p	5.42	9.57e-08	0.29	0.24	Presence of antiphospholipid antibodies;	chr1:66743879	chr1:66628485~66628505:+
HNSC	cis	rs79387448	0.745	rs17027496	MIMAT0019926	hsa-miR-4772-5p	-5.42	9.6e-08	-0.4	-0.24	Gut microbiota (bacterial taxa);	chr2:102561764	chr2:102432300~102432321:+
HNSC	cis	rs74233809	1	rs77787671	MIMAT0022727	hsa-miR-1307-5p	-5.42	9.64e-08	-0.34	-0.24	Birth weight;	chr10:103016448	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191519	MIMAT0022727	hsa-miR-1307-5p	-5.42	9.64e-08	-0.34	-0.24	Birth weight;	chr10:103025161	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.658	rs3855900	MIMAT0019728	hsa-miR-4660	-5.42	9.78e-08	-0.28	-0.24	Joint mobility (Beighton score);	chr8:9044411	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.624	rs7014430	MIMAT0019728	hsa-miR-4660	5.41	1.01e-07	0.28	0.24	Joint mobility (Beighton score);	chr8:8970227	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.77	rs1739	MIMAT0005878	hsa-miR-1287-5p	5.41	1.02e-07	0.26	0.24	Metabolite levels;	chr10:98416582	chr10:98395271~98395292:-
HNSC	cis	rs453301	0.686	rs6601281	MIMAT0019728	hsa-miR-4660	-5.41	1.02e-07	-0.28	-0.24	Joint mobility (Beighton score);	chr8:9053494	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.899	rs1280280	MIMAT0014979	hsa-miR-3117-3p	-5.4	1.06e-07	-0.29	-0.24	Presence of antiphospholipid antibodies;	chr1:66708220	chr1:66628485~66628505:+
HNSC	cis	rs950880	0.961	rs13020553	MIMAT0019927	hsa-miR-4772-3p	5.4	1.09e-07	0.22	0.24	Serum protein levels (sST2);	chr2:102315366	chr2:102432336~102432357:+
HNSC	cis	rs74233809	1	rs12219027	MIMAT0022727	hsa-miR-1307-5p	-5.4	1.09e-07	-0.34	-0.24	Birth weight;	chr10:103051446	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	5.39	1.1e-07	0.37	0.24	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
HNSC	cis	rs17027258	0.697	rs1468789	MIMAT0019927	hsa-miR-4772-3p	5.39	1.1e-07	0.26	0.24	White blood cell types;	chr2:102476044	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.636	rs1862089	MIMAT0014994	hsa-miR-3130-3p	5.39	1.1e-07	0.38	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs1862089	MIMAT0014994_1	hsa-miR-3130-3p	5.39	1.1e-07	0.38	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783277~206783297:+
HNSC	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	5.39	1.12e-07	0.28	0.24	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
HNSC	cis	rs950880	0.593	rs887972	MIMAT0019927	hsa-miR-4772-3p	5.38	1.16e-07	0.24	0.24	Serum protein levels (sST2);	chr2:102424485	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.624	rs2979265	MIMAT0019728	hsa-miR-4660	5.38	1.17e-07	0.28	0.24	Joint mobility (Beighton score);	chr8:9001207	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.653	rs2956244	MIMAT0019728	hsa-miR-4660	5.38	1.2e-07	0.29	0.24	Joint mobility (Beighton score);	chr8:9027656	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	5.38	1.2e-07	0.28	0.24	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
HNSC	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	5.38	1.2e-07	0.2	0.24	Migraine;	chr10:103402122	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.555	rs2296433	MIMAT0005878	hsa-miR-1287-5p	5.37	1.24e-07	0.29	0.24	Metabolite levels;	chr10:98424305	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.555	rs2296432	MIMAT0005878	hsa-miR-1287-5p	5.37	1.24e-07	0.29	0.24	Metabolite levels;	chr10:98424306	chr10:98395271~98395292:-
HNSC	cis	rs74233809	1	rs11191543	MIMAT0022727	hsa-miR-1307-5p	-5.37	1.25e-07	-0.34	-0.24	Birth weight;	chr10:103064630	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.592	rs4841084	MIMAT0019728	hsa-miR-4660	5.36	1.31e-07	0.29	0.24	Joint mobility (Beighton score);	chr8:9026395	chr8:9048453~9048475:+
HNSC	cis	rs74233809	1	rs11191505	MIMAT0022727	hsa-miR-1307-5p	-5.35	1.36e-07	-0.34	-0.24	Birth weight;	chr10:103007134	chr10:103394341~103394361:-
HNSC	cis	rs74233809	0.901	rs17115100	MIMAT0022727	hsa-miR-1307-5p	-5.34	1.43e-07	-0.35	-0.24	Birth weight;	chr10:102831636	chr10:103394341~103394361:-
HNSC	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-5.34	1.44e-07	-0.33	-0.24	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
HNSC	cis	rs453301	0.606	rs6601279	MIMAT0019728	hsa-miR-4660	-5.34	1.44e-07	-0.28	-0.24	Joint mobility (Beighton score);	chr8:9050721	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.658	rs6983877	MIMAT0019728	hsa-miR-4660	-5.34	1.46e-07	-0.28	-0.24	Joint mobility (Beighton score);	chr8:9047129	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.658	rs12114954	MIMAT0019728	hsa-miR-4660	-5.34	1.48e-07	-0.28	-0.24	Joint mobility (Beighton score);	chr8:9047352	chr8:9048453~9048475:+
HNSC	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	5.34	1.49e-07	0.36	0.24	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	5.34	1.49e-07	0.36	0.24	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
HNSC	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	5.33	1.51e-07	0.2	0.24	Migraine;	chr10:103242040	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	5.33	1.52e-07	0.37	0.24	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs11191454	MIMAT0022727	hsa-miR-1307-5p	-5.33	1.53e-07	-0.33	-0.24	Birth weight;	chr10:102900247	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.606	rs6981060	MIMAT0019728	hsa-miR-4660	-5.33	1.53e-07	-0.28	-0.24	Joint mobility (Beighton score);	chr8:9050725	chr8:9048453~9048475:+
HNSC	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	5.31	1.66e-07	0.29	0.24	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
HNSC	cis	rs7477	0.557	rs3785626	MIMAT0005942	hsa-miR-1288-3p	-5.31	1.68e-07	-0.28	-0.24	Amyotrophic lateral sclerosis;	chr17:16281934	chr17:16282058~16282078:+
HNSC	cis	rs74233809	1	rs943037	MIMAT0022727	hsa-miR-1307-5p	-5.31	1.69e-07	-0.35	-0.24	Birth weight;	chr10:103076162	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.77	rs3830020	MIMAT0005878	hsa-miR-1287-5p	-5.31	1.72e-07	-0.25	-0.24	Metabolite levels;	chr10:98416858	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.881	rs11189591	MIMAT0005878	hsa-miR-1287-5p	5.3	1.81e-07	0.25	0.24	Metabolite levels;	chr10:98395539	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.77	rs1737	MIMAT0005878	hsa-miR-1287-5p	5.29	1.88e-07	0.25	0.24	Metabolite levels;	chr10:98416609	chr10:98395271~98395292:-
HNSC	cis	rs74233809	1	rs74444347	MIMAT0022727	hsa-miR-1307-5p	-5.29	1.9e-07	-0.33	-0.24	Birth weight;	chr10:103009518	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs12221335	MIMAT0022727	hsa-miR-1307-5p	-5.29	1.9e-07	-0.33	-0.24	Birth weight;	chr10:103009635	chr10:103394341~103394361:-
HNSC	cis	rs7477	0.557	rs9914734	MIMAT0005942	hsa-miR-1288-3p	5.28	1.97e-07	0.27	0.24	Amyotrophic lateral sclerosis;	chr17:16278700	chr17:16282058~16282078:+
HNSC	cis	rs74233809	1	rs11191502	MIMAT0022727	hsa-miR-1307-5p	-5.28	2.01e-07	-0.33	-0.24	Birth weight;	chr10:103005737	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.77	rs7897357	MIMAT0005878	hsa-miR-1287-5p	5.28	2.01e-07	0.25	0.24	Metabolite levels;	chr10:98403840	chr10:98395271~98395292:-
HNSC	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	5.27	2.05e-07	0.37	0.24	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	5.27	2.09e-07	0.37	0.24	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	5.27	2.1e-07	0.37	0.24	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	5.27	2.1e-07	0.37	0.24	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	5.27	2.1e-07	0.37	0.24	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	5.27	2.1e-07	0.37	0.24	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	5.27	2.14e-07	0.23	0.24	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	5.26	2.23e-07	0.24	0.24	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	5.26	2.23e-07	0.24	0.24	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
HNSC	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	5.25	2.3e-07	0.2	0.24	Migraine;	chr10:103347713	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	5.25	2.32e-07	0.24	0.24	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	5.25	2.32e-07	0.24	0.24	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	5.25	2.32e-07	0.24	0.24	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	5.25	2.32e-07	0.24	0.24	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	5.25	2.32e-07	0.24	0.24	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	5.25	2.32e-07	0.24	0.24	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	5.25	2.32e-07	0.24	0.24	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
HNSC	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	5.25	2.32e-07	0.37	0.24	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	5.25	2.32e-07	0.37	0.24	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
HNSC	cis	rs453301	0.686	rs3989373	MIMAT0019728	hsa-miR-4660	-5.25	2.33e-07	-0.27	-0.24	Joint mobility (Beighton score);	chr8:9053798	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	5.25	2.33e-07	0.24	0.24	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
HNSC	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	5.24	2.4e-07	0.36	0.24	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	5.24	2.5e-07	0.24	0.24	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	5.23	2.52e-07	0.24	0.24	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs12219901	MIMAT0022727	hsa-miR-1307-5p	-5.23	2.52e-07	-0.33	-0.24	Birth weight;	chr10:103081210	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs10458729	MIMAT0022727	hsa-miR-1307-5p	-5.23	2.52e-07	-0.33	-0.24	Birth weight;	chr10:103081722	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-5.23	2.58e-07	-0.24	-0.24	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
HNSC	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	5.23	2.63e-07	0.37	0.24	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	5.22	2.64e-07	0.36	0.24	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
HNSC	cis	rs950880	1	rs12470864	MIMAT0019927	hsa-miR-4772-3p	5.22	2.68e-07	0.22	0.24	Serum protein levels (sST2);	chr2:102309902	chr2:102432336~102432357:+
HNSC	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	5.22	2.69e-07	0.36	0.24	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	5.22	2.73e-07	0.36	0.24	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	5.22	2.74e-07	0.36	0.24	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	5.22	2.77e-07	0.24	0.24	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	5.22	2.77e-07	0.24	0.24	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	5.22	2.77e-07	0.24	0.24	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	5.22	2.77e-07	0.24	0.24	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	5.22	2.77e-07	0.24	0.24	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	5.21	2.83e-07	0.24	0.24	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	5.21	2.83e-07	0.24	0.24	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	5.21	2.83e-07	0.24	0.24	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	5.21	2.83e-07	0.24	0.24	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
HNSC	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	5.21	2.84e-07	0.36	0.24	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs12217501	MIMAT0022727	hsa-miR-1307-5p	-5.21	2.9e-07	-0.34	-0.23	Birth weight;	chr10:103092132	chr10:103394341~103394361:-
HNSC	cis	rs7477	0.557	rs2109262	MIMAT0005942	hsa-miR-1288-3p	5.21	2.92e-07	0.27	0.23	Amyotrophic lateral sclerosis;	chr17:16281315	chr17:16282058~16282078:+
HNSC	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	5.2	2.98e-07	0.24	0.23	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs10883815	MIMAT0022727	hsa-miR-1307-5p	-5.2	3e-07	-0.33	-0.23	Birth weight;	chr10:102979422	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs112390216	MIMAT0022727	hsa-miR-1307-5p	-5.2	3e-07	-0.33	-0.23	Birth weight;	chr10:102981274	chr10:103394341~103394361:-
HNSC	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-5.19	3.14e-07	-0.19	-0.23	Migraine;	chr10:103273985	chr10:103394341~103394361:-
HNSC	cis	rs7477	0.557	rs6502498	MIMAT0005942	hsa-miR-1288-3p	5.19	3.16e-07	0.27	0.23	Amyotrophic lateral sclerosis;	chr17:16295661	chr17:16282058~16282078:+
HNSC	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-5.18	3.35e-07	-0.23	-0.23	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
HNSC	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-5.17	3.46e-07	-0.19	-0.23	Migraine;	chr10:103305652	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.686	rs13252797	MIMAT0019728	hsa-miR-4660	5.17	3.52e-07	0.27	0.23	Joint mobility (Beighton score);	chr8:9003920	chr8:9048453~9048475:+
HNSC	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	5.17	3.57e-07	0.35	0.23	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	5.17	3.57e-07	0.35	0.23	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
HNSC	cis	rs7477	0.557	rs4792728	MIMAT0005942	hsa-miR-1288-3p	5.16	3.64e-07	0.27	0.23	Amyotrophic lateral sclerosis;	chr17:16283501	chr17:16282058~16282078:+
HNSC	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	5.16	3.67e-07	0.34	0.23	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs34747231	MIMAT0022727	hsa-miR-1307-5p	-5.16	3.7e-07	-0.34	-0.23	Birth weight;	chr10:103182487	chr10:103394341~103394361:-
HNSC	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-5.16	3.72e-07	-0.33	-0.23	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
HNSC	cis	rs7894407	0.504	rs7089271	MIMAT0022727	hsa-miR-1307-5p	-5.15	3.83e-07	-0.2	-0.23	White matter hyperintensity burden;	chr10:103417157	chr10:103394341~103394361:-
HNSC	cis	rs6681460	0.898	rs1032634	MIMAT0014979	hsa-miR-3117-3p	5.15	3.91e-07	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66729509	chr1:66628485~66628505:+
HNSC	cis	rs74233809	1	rs11191580	MIMAT0022727	hsa-miR-1307-5p	5.15	3.92e-07	0.33	0.23	Birth weight;	chr10:103146454	chr10:103394341~103394361:-
HNSC	cis	rs7649443	0.842	rs6797085	MIMAT0019973	hsa-miR-4797-3p	5.14	3.96e-07	0.28	0.23	Nonsyndromic cleft lip with cleft palate;	chr3:197221457	chr3:197293888~197293908:-
HNSC	cis	rs74233809	0.901	rs1004467	MIMAT0022727	hsa-miR-1307-5p	-5.14	3.97e-07	-0.31	-0.23	Birth weight;	chr10:102834750	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	5.14	3.99e-07	0.24	0.23	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	5.13	4.19e-07	0.24	0.23	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	5.13	4.19e-07	0.24	0.23	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
HNSC	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-5.13	4.25e-07	-0.19	-0.23	Migraine;	chr10:103279291	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191551	MIMAT0022727	hsa-miR-1307-5p	-5.13	4.26e-07	-0.33	-0.23	Birth weight;	chr10:103091078	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs17094683	MIMAT0022727	hsa-miR-1307-5p	-5.13	4.26e-07	-0.33	-0.23	Birth weight;	chr10:103091544	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs12220743	MIMAT0022727	hsa-miR-1307-5p	-5.13	4.26e-07	-0.33	-0.23	Birth weight;	chr10:103092155	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs77860422	MIMAT0022727	hsa-miR-1307-5p	-5.13	4.28e-07	-0.32	-0.23	Birth weight;	chr10:102988252	chr10:103394341~103394361:-
HNSC	cis	rs13088645	0.683	rs9790169	MIMAT0019958	hsa-miR-4788	5.13	4.3e-07	0.26	0.23	Coronary artery disease;	chr3:134433117	chr3:134437836~134437857:+
HNSC	cis	rs6681460	0.898	rs2483704	MIMAT0014979	hsa-miR-3117-3p	5.13	4.32e-07	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66729670	chr1:66628485~66628505:+
HNSC	cis	rs74233809	1	rs12221193	MIMAT0022727	hsa-miR-1307-5p	-5.13	4.32e-07	-0.33	-0.23	Birth weight;	chr10:102905510	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs77180047	MIMAT0022727	hsa-miR-1307-5p	-5.13	4.32e-07	-0.33	-0.23	Birth weight;	chr10:102907000	chr10:103394341~103394361:-
HNSC	cis	rs950880	0.767	rs13001714	MIMAT0019927	hsa-miR-4772-3p	5.12	4.38e-07	0.21	0.23	Serum protein levels (sST2);	chr2:102344025	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.621	rs11189595	MIMAT0005878	hsa-miR-1287-5p	5.12	4.41e-07	0.27	0.23	Metabolite levels;	chr10:98407565	chr10:98395271~98395292:-
HNSC	cis	rs7477	0.557	rs4792731	MIMAT0005942	hsa-miR-1288-3p	5.12	4.43e-07	0.27	0.23	Amyotrophic lateral sclerosis;	chr17:16298627	chr17:16282058~16282078:+
HNSC	cis	rs74233809	1	rs11191453	MIMAT0022727	hsa-miR-1307-5p	-5.12	4.49e-07	-0.32	-0.23	Birth weight;	chr10:102900095	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	5.12	4.59e-07	0.35	0.23	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	5.12	4.59e-07	0.35	0.23	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	5.12	4.59e-07	0.35	0.23	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs12411886	MIMAT0022727	hsa-miR-1307-5p	-5.11	4.75e-07	-0.33	-0.23	Birth weight;	chr10:102925542	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	5.11	4.78e-07	0.24	0.23	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
HNSC	cis	rs7594645	0.59	rs879472	MIMAT0014995	hsa-miR-3130-5p	-5.11	4.8e-07	-0.34	-0.23	Episodic memory;	chr2:206787058	chr2:206783276~206783296:-
HNSC	cis	rs7594645	0.59	rs879472	MIMAT0014995_1	hsa-miR-3130-5p	-5.11	4.8e-07	-0.34	-0.23	Episodic memory;	chr2:206787058	chr2:206783246~206783266:+
HNSC	cis	rs6681460	0.932	rs524114	MIMAT0014979	hsa-miR-3117-3p	5.11	4.81e-07	0.27	0.23	Presence of antiphospholipid antibodies;	chr1:66722652	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.8	rs485543	MIMAT0014979	hsa-miR-3117-3p	5.1	5.06e-07	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66728689	chr1:66628485~66628505:+
HNSC	cis	rs6681460	0.898	rs1032635	MIMAT0014979	hsa-miR-3117-3p	5.09	5.11e-07	0.27	0.23	Presence of antiphospholipid antibodies;	chr1:66729501	chr1:66628485~66628505:+
HNSC	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-5.09	5.22e-07	-0.31	-0.23	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
HNSC	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-5.09	5.22e-07	-0.31	-0.23	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
HNSC	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-5.08	5.51e-07	-0.19	-0.23	Migraine;	chr10:103307280	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	5.08	5.55e-07	0.36	0.23	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
HNSC	cis	rs1163656	0.605	rs7487519	MIMAT0003287	hsa-miR-618	-5.07	5.82e-07	-0.31	-0.23	Dental caries;	chr12:80921469	chr12:80935796~80935818:-
HNSC	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-5.07	5.82e-07	-0.31	-0.23	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
HNSC	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	5.07	5.86e-07	0.35	0.23	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs11191499	MIMAT0022727	hsa-miR-1307-5p	-5.06	6.12e-07	-0.3	-0.23	Birth weight;	chr10:103004514	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.686	rs11787026	MIMAT0019728	hsa-miR-4660	5.06	6.16e-07	0.26	0.23	Joint mobility (Beighton score);	chr8:9044861	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	5.04	6.58e-07	0.24	0.23	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
HNSC	cis	rs453301	0.653	rs7005133	MIMAT0019728	hsa-miR-4660	5.04	6.58e-07	0.27	0.23	Joint mobility (Beighton score);	chr8:9043712	chr8:9048453~9048475:+
HNSC	cis	rs7477	0.557	rs9944524	MIMAT0005942	hsa-miR-1288-3p	5.04	6.83e-07	0.26	0.23	Amyotrophic lateral sclerosis;	chr17:16309336	chr17:16282058~16282078:+
HNSC	cis	rs74233809	1	rs79237883	MIMAT0022727	hsa-miR-1307-5p	-5.03	7.1e-07	-0.33	-0.23	Birth weight;	chr10:103181189	chr10:103394341~103394361:-
HNSC	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-5.02	7.46e-07	-0.19	-0.23	Migraine;	chr10:103273258	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs12220375	MIMAT0022727	hsa-miR-1307-5p	-5.02	7.52e-07	-0.32	-0.23	Birth weight;	chr10:103141734	chr10:103394341~103394361:-
HNSC	cis	rs74233809	0.901	rs12416331	MIMAT0022727	hsa-miR-1307-5p	-5.02	7.52e-07	-0.32	-0.23	Birth weight;	chr10:103169157	chr10:103394341~103394361:-
HNSC	cis	rs7477	0.56	rs11651578	MIMAT0005942	hsa-miR-1288-3p	5.02	7.52e-07	0.26	0.23	Amyotrophic lateral sclerosis;	chr17:16284278	chr17:16282058~16282078:+
HNSC	cis	rs7477	0.557	rs4792729	MIMAT0005942	hsa-miR-1288-3p	5.02	7.52e-07	0.26	0.23	Amyotrophic lateral sclerosis;	chr17:16285105	chr17:16282058~16282078:+
HNSC	cis	rs7477	0.557	rs3785625	MIMAT0005942	hsa-miR-1288-3p	5.02	7.52e-07	0.26	0.23	Amyotrophic lateral sclerosis;	chr17:16287104	chr17:16282058~16282078:+
HNSC	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	5.01	7.68e-07	0.35	0.23	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	5.01	7.68e-07	0.35	0.23	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	5.01	7.7e-07	0.35	0.23	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
HNSC	cis	rs17109512	1	rs942812	MIMAT0005878	hsa-miR-1287-5p	5.01	7.89e-07	0.49	0.23	Aspartate aminotransferase levels;	chr10:98393907	chr10:98395271~98395292:-
HNSC	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	5.01	7.91e-07	0.35	0.23	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs11191582	MIMAT0022727	hsa-miR-1307-5p	-5.01	7.92e-07	-0.33	-0.23	Birth weight;	chr10:103153896	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs79082900	MIMAT0022727	hsa-miR-1307-5p	-5	7.99e-07	-0.33	-0.23	Birth weight;	chr10:103117545	chr10:103394341~103394361:-
HNSC	cis	rs7649443	0.704	rs34381158	MIMAT0019973	hsa-miR-4797-3p	5	8.21e-07	0.27	0.23	Nonsyndromic cleft lip with cleft palate;	chr3:197219776	chr3:197293888~197293908:-
HNSC	cis	rs7072216	0.763	rs7914401	MIMAT0026738	hsa-miR-1287-3p	5	8.25e-07	0.23	0.23	Metabolite levels;	chr10:98404171	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs12413046	MIMAT0022727	hsa-miR-1307-5p	-5	8.32e-07	-0.32	-0.23	Birth weight;	chr10:103111447	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs10883832	MIMAT0022727	hsa-miR-1307-5p	-5	8.32e-07	-0.32	-0.23	Birth weight;	chr10:103111522	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	4.99	8.35e-07	0.23	0.23	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
HNSC	cis	rs17109512	1	rs7073497	MIMAT0005878	hsa-miR-1287-5p	4.99	8.37e-07	0.49	0.23	Aspartate aminotransferase levels;	chr10:98393931	chr10:98395271~98395292:-
HNSC	cis	rs74233809	1	rs35125602	MIMAT0022727	hsa-miR-1307-5p	-4.99	8.41e-07	-0.31	-0.23	Birth weight;	chr10:102896282	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	4.99	8.46e-07	0.23	0.23	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	4.99	8.54e-07	0.24	0.23	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	4.99	8.54e-07	0.24	0.23	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.77	rs942810	MIMAT0005878	hsa-miR-1287-5p	4.99	8.6e-07	0.23	0.23	Metabolite levels;	chr10:98408103	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	4.99	8.64e-07	0.23	0.23	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	4.99	8.64e-07	0.23	0.23	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
HNSC	cis	rs7649443	0.759	rs3903682	MIMAT0019973	hsa-miR-4797-3p	-4.98	8.92e-07	-0.27	-0.23	Nonsyndromic cleft lip with cleft palate;	chr3:197280675	chr3:197293888~197293908:-
HNSC	cis	rs74233809	1	rs11191472	MIMAT0022727	hsa-miR-1307-5p	-4.98	9.01e-07	-0.32	-0.23	Birth weight;	chr10:102947259	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	4.97	9.3e-07	0.23	0.22	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
HNSC	cis	rs74233809	0.901	rs3824754	MIMAT0022727	hsa-miR-1307-5p	-4.97	9.6e-07	-0.33	-0.22	Birth weight;	chr10:102854593	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	4.96	9.71e-07	0.23	0.22	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs12413409	MIMAT0022727	hsa-miR-1307-5p	-4.96	9.74e-07	-0.32	-0.22	Birth weight;	chr10:102959339	chr10:103394341~103394361:-
HNSC	cis	rs1018697	0.966	rs1953930	MIMAT0005951	hsa-miR-1307-3p	4.96	9.74e-07	0.16	0.22	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs11191593	MIMAT0022727	hsa-miR-1307-5p	-4.96	1.01e-06	-0.32	-0.22	Birth weight;	chr10:103179458	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs17115213	MIMAT0022727	hsa-miR-1307-5p	-4.96	1.01e-06	-0.32	-0.22	Birth weight;	chr10:102921386	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs10509759	MIMAT0022727	hsa-miR-1307-5p	-4.96	1.01e-06	-0.32	-0.22	Birth weight;	chr10:102929908	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs10883806	MIMAT0022727	hsa-miR-1307-5p	-4.96	1.01e-06	-0.32	-0.22	Birth weight;	chr10:102953319	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.655	rs3830025	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.24	0.22	Metabolite levels;	chr10:98416347	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.655	rs3830024	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.24	0.22	Metabolite levels;	chr10:98416349	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs78260931	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.05e-06	-0.32	-0.22	Birth weight;	chr10:102962205	chr10:103394341~103394361:-
HNSC	cis	rs7477	0.557	rs12938878	MIMAT0005942	hsa-miR-1288-3p	4.95	1.05e-06	0.26	0.22	Amyotrophic lateral sclerosis;	chr17:16313291	chr17:16282058~16282078:+
HNSC	cis	rs74233809	1	rs11191575	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.06e-06	-0.31	-0.22	Birth weight;	chr10:103138580	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs79993475	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.06e-06	-0.31	-0.22	Birth weight;	chr10:103141274	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191587	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.06e-06	-0.31	-0.22	Birth weight;	chr10:103169959	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	4.94	1.08e-06	0.23	0.22	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	4.94	1.08e-06	0.23	0.22	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	4.94	1.08e-06	0.23	0.22	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	4.94	1.08e-06	0.23	0.22	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	4.94	1.08e-06	0.23	0.22	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	4.94	1.08e-06	0.23	0.22	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
HNSC	cis	rs13088645	0.532	rs12695612	MIMAT0019958	hsa-miR-4788	-4.94	1.11e-06	-0.27	-0.22	Coronary artery disease;	chr3:134442982	chr3:134437836~134437857:+
HNSC	cis	rs74233809	0.892	rs11191447	MIMAT0022727	hsa-miR-1307-5p	-4.93	1.13e-06	-0.31	-0.22	Birth weight;	chr10:102892566	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs74233296	MIMAT0022727	hsa-miR-1307-5p	-4.93	1.13e-06	-0.31	-0.22	Birth weight;	chr10:102895593	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.598	rs1025395	MIMAT0019728	hsa-miR-4660	4.93	1.13e-06	0.26	0.22	Joint mobility (Beighton score);	chr8:8979093	chr8:9048453~9048475:+
HNSC	cis	rs74233809	1	rs9633712	MIMAT0022727	hsa-miR-1307-5p	-4.93	1.14e-06	-0.32	-0.22	Birth weight;	chr10:103114004	chr10:103394341~103394361:-
HNSC	cis	rs74233809	0.786	rs11191564	MIMAT0022727	hsa-miR-1307-5p	-4.93	1.14e-06	-0.32	-0.22	Birth weight;	chr10:103118786	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs1060240	MIMAT0022727	hsa-miR-1307-5p	-4.93	1.14e-06	-0.32	-0.22	Birth weight;	chr10:103123580	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs10883835	MIMAT0022727	hsa-miR-1307-5p	-4.93	1.14e-06	-0.32	-0.22	Birth weight;	chr10:103124451	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	4.92	1.18e-06	0.23	0.22	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
HNSC	cis	rs950880	0.553	rs2241116	MIMAT0019927	hsa-miR-4772-3p	4.92	1.18e-06	0.26	0.22	Serum protein levels (sST2);	chr2:102386805	chr2:102432336~102432357:+
HNSC	cis	rs950880	0.767	rs6543119	MIMAT0019927	hsa-miR-4772-3p	4.92	1.2e-06	0.2	0.22	Serum protein levels (sST2);	chr2:102346612	chr2:102432336~102432357:+
HNSC	cis	rs12712133	0.545	rs60304550	MIMAT0019926	hsa-miR-4772-5p	-4.92	1.2e-06	-0.29	-0.22	Primary biliary cholangitis;	chr2:102251178	chr2:102432300~102432321:+
HNSC	cis	rs74233809	1	rs12221064	MIMAT0022727	hsa-miR-1307-5p	-4.92	1.21e-06	-0.31	-0.22	Birth weight;	chr10:102917369	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs77602510	MIMAT0022727	hsa-miR-1307-5p	-4.92	1.21e-06	-0.31	-0.22	Birth weight;	chr10:102922845	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs78821730	MIMAT0022727	hsa-miR-1307-5p	-4.92	1.21e-06	-0.31	-0.22	Birth weight;	chr10:102924787	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs5011520	MIMAT0022727	hsa-miR-1307-5p	-4.92	1.21e-06	-0.31	-0.22	Birth weight;	chr10:102937759	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	4.92	1.22e-06	0.23	0.22	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
HNSC	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	4.91	1.24e-06	0.33	0.22	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	4.91	1.24e-06	0.33	0.22	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	4.91	1.24e-06	0.33	0.22	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	4.91	1.24e-06	0.33	0.22	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	4.91	1.24e-06	0.33	0.22	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
HNSC	cis	rs74233809	0.901	rs11191416	MIMAT0022727	hsa-miR-1307-5p	4.91	1.25e-06	0.31	0.22	Birth weight;	chr10:102845159	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	4.91	1.25e-06	0.23	0.22	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs10883808	MIMAT0022727	hsa-miR-1307-5p	-4.91	1.26e-06	-0.31	-0.22	Birth weight;	chr10:102961369	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.598	rs10104303	MIMAT0019728	hsa-miR-4660	4.91	1.27e-06	0.25	0.22	Joint mobility (Beighton score);	chr8:8977018	chr8:9048453~9048475:+
HNSC	cis	rs75358501	0.901	rs79499040	MIMAT0014994	hsa-miR-3130-3p	4.91	1.28e-06	0.47	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.901	rs79499040	MIMAT0014994_1	hsa-miR-3130-3p	4.91	1.28e-06	0.47	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783277~206783297:+
HNSC	cis	rs1018697	1	rs10748830	MIMAT0005951	hsa-miR-1307-3p	4.91	1.29e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394301~103394322:-
HNSC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-4.9	1.31e-06	-0.35	-0.22	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
HNSC	cis	rs453301	0.653	rs1562211	MIMAT0019728	hsa-miR-4660	-4.9	1.33e-06	-0.26	-0.22	Joint mobility (Beighton score);	chr8:9044914	chr8:9048453~9048475:+
HNSC	cis	rs74233809	1	rs732998	MIMAT0022727	hsa-miR-1307-5p	4.89	1.37e-06	0.31	0.22	Birth weight;	chr10:103138144	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs4919685	MIMAT0022727	hsa-miR-1307-5p	4.89	1.41e-06	0.21	0.22	Arsenic metabolism;	chr10:102827605	chr10:103394341~103394361:-
HNSC	cis	rs7649443	0.959	rs7616531	MIMAT0019973	hsa-miR-4797-3p	4.89	1.41e-06	0.29	0.22	Nonsyndromic cleft lip with cleft palate;	chr3:197213012	chr3:197293888~197293908:-
HNSC	cis	rs453301	0.653	rs11784393	MIMAT0019728	hsa-miR-4660	4.89	1.42e-06	0.26	0.22	Joint mobility (Beighton score);	chr8:9045624	chr8:9048453~9048475:+
HNSC	cis	rs1018697	0.966	rs10748832	MIMAT0005951	hsa-miR-1307-3p	4.89	1.42e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394301~103394322:-
HNSC	cis	rs7594645	1	rs73070048	MIMAT0014995	hsa-miR-3130-5p	4.88	1.45e-06	0.32	0.22	Episodic memory;	chr2:206776670	chr2:206783276~206783296:-
HNSC	cis	rs7594645	1	rs73070048	MIMAT0014995_1	hsa-miR-3130-5p	4.88	1.45e-06	0.32	0.22	Episodic memory;	chr2:206776670	chr2:206783246~206783266:+
HNSC	cis	rs7649443	0.759	rs6805920	MIMAT0019973	hsa-miR-4797-3p	4.88	1.45e-06	0.27	0.22	Nonsyndromic cleft lip with cleft palate;	chr3:197235458	chr3:197293888~197293908:-
HNSC	cis	rs74233809	1	rs11191548	MIMAT0022727	hsa-miR-1307-5p	4.88	1.49e-06	0.31	0.22	Birth weight;	chr10:103086421	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.662	rs4919686	MIMAT0022727	hsa-miR-1307-5p	4.88	1.49e-06	0.21	0.22	Arsenic metabolism;	chr10:102832492	chr10:103394341~103394361:-
HNSC	cis	rs950880	0.767	rs13017455	MIMAT0019927	hsa-miR-4772-3p	4.88	1.49e-06	0.2	0.22	Serum protein levels (sST2);	chr2:102348282	chr2:102432336~102432357:+
HNSC	cis	rs17639215	0.55	rs4851003	MIMAT0019927	hsa-miR-4772-3p	-4.87	1.5e-06	-0.22	-0.22	Serum protein levels (sST2);	chr2:102292817	chr2:102432336~102432357:+
HNSC	cis	rs1018697	0.897	rs2150929	MIMAT0005951	hsa-miR-1307-3p	4.87	1.52e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394301~103394322:-
HNSC	cis	rs6681460	0.8	rs481681	MIMAT0014979	hsa-miR-3117-3p	4.86	1.58e-06	0.26	0.22	Presence of antiphospholipid antibodies;	chr1:66728695	chr1:66628485~66628505:+
HNSC	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	4.86	1.62e-06	0.23	0.22	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs12412038	MIMAT0022727	hsa-miR-1307-5p	-4.86	1.62e-06	-0.32	-0.22	Birth weight;	chr10:103096405	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191555	MIMAT0022727	hsa-miR-1307-5p	-4.86	1.62e-06	-0.32	-0.22	Birth weight;	chr10:103097766	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191557	MIMAT0022727	hsa-miR-1307-5p	-4.86	1.62e-06	-0.32	-0.22	Birth weight;	chr10:103104857	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191558	MIMAT0022727	hsa-miR-1307-5p	-4.86	1.62e-06	-0.32	-0.22	Birth weight;	chr10:103104921	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.624	rs2288671	MIMAT0019728	hsa-miR-4660	4.86	1.65e-06	0.25	0.22	Joint mobility (Beighton score);	chr8:9003384	chr8:9048453~9048475:+
HNSC	cis	rs1018697	1	rs1018696	MIMAT0005951	hsa-miR-1307-3p	4.85	1.73e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394301~103394322:-
HNSC	cis	rs9527	0.641	rs4919684	MIMAT0022727	hsa-miR-1307-5p	4.84	1.75e-06	0.2	0.22	Arsenic metabolism;	chr10:102827267	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191479	MIMAT0022727	hsa-miR-1307-5p	-4.84	1.76e-06	-0.31	-0.22	Birth weight;	chr10:102963863	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.662	rs10883783	MIMAT0022727	hsa-miR-1307-5p	4.84	1.81e-06	0.2	0.22	Arsenic metabolism;	chr10:102831395	chr10:103394341~103394361:-
HNSC	cis	rs13088645	0.532	rs9857134	MIMAT0019958	hsa-miR-4788	-4.84	1.81e-06	-0.27	-0.22	Coronary artery disease;	chr3:134442765	chr3:134437836~134437857:+
HNSC	cis	rs7649443	0.759	rs12632536	MIMAT0019973	hsa-miR-4797-3p	4.83	1.87e-06	0.27	0.22	Nonsyndromic cleft lip with cleft palate;	chr3:197106779	chr3:197293888~197293908:-
HNSC	cis	rs74233809	1	rs11191607	MIMAT0022727	hsa-miR-1307-5p	-4.83	1.88e-06	-0.32	-0.22	Birth weight;	chr10:103199431	chr10:103394341~103394361:-
HNSC	cis	rs1018697	1	rs7092051	MIMAT0005951	hsa-miR-1307-3p	4.83	1.9e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394301~103394322:-
HNSC	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	4.82	1.95e-06	0.22	0.22	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
HNSC	cis	rs7851726	0.932	rs10821415	MIMAT0019208	hsa-miR-3074-5p	4.81	2.03e-06	0.22	0.22	Urinary albumin-to-creatinine ratio;	chr9:94951177	chr9:95086063~95086083:-
HNSC	cis	rs6681460	0.898	rs536527	MIMAT0014979	hsa-miR-3117-3p	-4.81	2.03e-06	-0.26	-0.22	Presence of antiphospholipid antibodies;	chr1:66728110	chr1:66628485~66628505:+
HNSC	cis	rs1018697	0.966	rs11191396	MIMAT0005951	hsa-miR-1307-3p	4.81	2.07e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394301~103394322:-
HNSC	cis	rs1018697	1	rs4919677	MIMAT0005951	hsa-miR-1307-3p	4.81	2.07e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394301~103394322:-
HNSC	cis	rs1018697	1	rs4919678	MIMAT0005951	hsa-miR-1307-3p	4.81	2.07e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394301~103394322:-
HNSC	cis	rs1018697	1	rs10786710	MIMAT0005951	hsa-miR-1307-3p	4.81	2.07e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394301~103394322:-
HNSC	cis	rs13088645	0.532	rs12695613	MIMAT0019958	hsa-miR-4788	-4.8	2.1e-06	-0.26	-0.22	Coronary artery disease;	chr3:134447730	chr3:134437836~134437857:+
HNSC	cis	rs74233809	0.901	rs3824755	MIMAT0022727	hsa-miR-1307-5p	-4.8	2.11e-06	-0.29	-0.22	Birth weight;	chr10:102836092	chr10:103394341~103394361:-
HNSC	cis	rs1018697	1	rs7092346	MIMAT0005951	hsa-miR-1307-3p	4.8	2.13e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394301~103394322:-
HNSC	cis	rs1018697	1	rs7086400	MIMAT0005951	hsa-miR-1307-3p	4.8	2.13e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394301~103394322:-
HNSC	cis	rs1014286	1	rs4851617	MIMAT0019926	hsa-miR-4772-5p	4.79	2.21e-06	0.26	0.22	Serum protein levels (sST2);	chr2:102535601	chr2:102432300~102432321:+
HNSC	cis	rs1018697	1	rs7073114	MIMAT0005951	hsa-miR-1307-3p	4.79	2.28e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394301~103394322:-
HNSC	cis	rs75358501	0.636	rs7580138	MIMAT0014994	hsa-miR-3130-3p	4.79	2.29e-06	0.34	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.636	rs7580138	MIMAT0014994_1	hsa-miR-3130-3p	4.79	2.29e-06	0.34	0.22	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783277~206783297:+
HNSC	cis	rs13088645	0.532	rs9835166	MIMAT0019958	hsa-miR-4788	-4.78	2.3e-06	-0.26	-0.22	Coronary artery disease;	chr3:134447382	chr3:134437836~134437857:+
HNSC	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	4.78	2.32e-06	0.22	0.22	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
HNSC	cis	rs1018697	1	rs2150928	MIMAT0005951	hsa-miR-1307-3p	4.77	2.42e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394301~103394322:-
HNSC	cis	rs1018697	1	rs7911528	MIMAT0005951	hsa-miR-1307-3p	4.77	2.42e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394301~103394322:-
HNSC	cis	rs1018697	1	rs11191397	MIMAT0005951	hsa-miR-1307-3p	4.77	2.49e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs12219304	MIMAT0022727	hsa-miR-1307-5p	-4.77	2.5e-06	-0.31	-0.22	Birth weight;	chr10:103171827	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs77420391	MIMAT0022727	hsa-miR-1307-5p	-4.77	2.5e-06	-0.31	-0.22	Birth weight;	chr10:103186066	chr10:103394341~103394361:-
HNSC	cis	rs7851726	1	rs356131	MIMAT0019208	hsa-miR-3074-5p	-4.77	2.51e-06	-0.21	-0.22	Urinary albumin-to-creatinine ratio;	chr9:94805045	chr9:95086063~95086083:-
HNSC	cis	rs11693697	1	rs11693697	MIMAT0019927	hsa-miR-4772-3p	4.77	2.51e-06	0.26	0.22	Serum protein levels (sST2);	chr2:102299202	chr2:102432336~102432357:+
HNSC	cis	rs13088645	0.532	rs7623580	MIMAT0019958	hsa-miR-4788	-4.76	2.57e-06	-0.25	-0.22	Coronary artery disease;	chr3:134445503	chr3:134437836~134437857:+
HNSC	cis	rs1018697	1	rs6584525	MIMAT0005951	hsa-miR-1307-3p	4.76	2.6e-06	0.15	0.22	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394301~103394322:-
HNSC	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	4.76	2.61e-06	0.32	0.22	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	4.75	2.72e-06	0.22	0.22	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
HNSC	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-4.74	2.79e-06	-0.31	-0.22	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
HNSC	cis	rs950880	0.553	rs3755272	MIMAT0019927	hsa-miR-4772-3p	4.71	3.25e-06	0.24	0.21	Serum protein levels (sST2);	chr2:102417365	chr2:102432336~102432357:+
HNSC	cis	rs74233809	1	rs3740390	MIMAT0022727	hsa-miR-1307-5p	-4.71	3.34e-06	-0.29	-0.21	Birth weight;	chr10:102878723	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.662	rs4919687	MIMAT0022727	hsa-miR-1307-5p	4.7	3.36e-06	0.2	0.21	Arsenic metabolism;	chr10:102835491	chr10:103394341~103394361:-
HNSC	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	4.7	3.38e-06	0.31	0.21	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	4.7	3.38e-06	0.31	0.21	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs74233809	MIMAT0022727	hsa-miR-1307-5p	-4.7	3.42e-06	-0.3	-0.21	Birth weight;	chr10:103154183	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-4.7	3.49e-06	-0.22	-0.21	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
HNSC	cis	rs1018697	0.966	rs1475643	MIMAT0005951	hsa-miR-1307-3p	4.69	3.54e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394301~103394322:-
HNSC	cis	rs9527	0.545	rs35756290	MIMAT0022727	hsa-miR-1307-5p	4.68	3.79e-06	0.2	0.21	Arsenic metabolism;	chr10:102825815	chr10:103394341~103394361:-
HNSC	cis	rs7851726	0.966	rs391784	MIMAT0019208	hsa-miR-3074-5p	-4.67	3.87e-06	-0.21	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94813345	chr9:95086063~95086083:-
HNSC	cis	rs7649443	0.759	rs36035383	MIMAT0019973	hsa-miR-4797-3p	4.67	3.89e-06	0.26	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197243260	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.759	rs7624684	MIMAT0019973	hsa-miR-4797-3p	4.67	3.89e-06	0.26	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197244290	chr3:197293888~197293908:-
HNSC	cis	rs7851726	0.932	rs7853195	MIMAT0019208	hsa-miR-3074-5p	4.67	3.91e-06	0.21	0.21	Urinary albumin-to-creatinine ratio;	chr9:94923016	chr9:95086063~95086083:-
HNSC	cis	rs7477	0.647	rs3785623	MIMAT0005942	hsa-miR-1288-3p	4.67	3.91e-06	0.24	0.21	Amyotrophic lateral sclerosis;	chr17:16297846	chr17:16282058~16282078:+
HNSC	cis	rs7477	0.557	rs11868284	MIMAT0005942	hsa-miR-1288-3p	4.67	3.92e-06	0.25	0.21	Amyotrophic lateral sclerosis;	chr17:16292961	chr17:16282058~16282078:+
HNSC	cis	rs7851726	0.934	rs7019720	MIMAT0019208	hsa-miR-3074-5p	-4.67	3.93e-06	-0.21	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94777206	chr9:95086063~95086083:-
HNSC	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-4.67	3.99e-06	-0.22	-0.21	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
HNSC	cis	rs7649443	0.959	rs6782349	MIMAT0019973	hsa-miR-4797-3p	4.67	4.03e-06	0.27	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197221936	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs2044861	MIMAT0019973	hsa-miR-4797-3p	4.67	4.03e-06	0.27	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197222693	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs2044860	MIMAT0019973	hsa-miR-4797-3p	4.67	4.03e-06	0.27	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197222999	chr3:197293888~197293908:-
HNSC	cis	rs7851726	0.932	rs1123534	MIMAT0019208	hsa-miR-3074-5p	4.66	4.14e-06	0.21	0.21	Urinary albumin-to-creatinine ratio;	chr9:94947443	chr9:95086063~95086083:-
HNSC	cis	rs7477	0.708	rs4792730	MIMAT0005942	hsa-miR-1288-3p	4.66	4.15e-06	0.24	0.21	Amyotrophic lateral sclerosis;	chr17:16285262	chr17:16282058~16282078:+
HNSC	cis	rs950880	1	rs1420101	MIMAT0019927	hsa-miR-4772-3p	4.66	4.23e-06	0.2	0.21	Serum protein levels (sST2);	chr2:102341256	chr2:102432336~102432357:+
HNSC	cis	rs1018697	1	rs7080587	MIMAT0005951	hsa-miR-1307-3p	4.65	4.28e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394301~103394322:-
HNSC	cis	rs7851726	0.585	rs7870160	MIMAT0019208	hsa-miR-3074-5p	-4.65	4.35e-06	-0.21	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94950249	chr9:95086063~95086083:-
HNSC	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	4.64	4.54e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
HNSC	cis	rs1018697	1	rs7088711	MIMAT0005951	hsa-miR-1307-3p	-4.63	4.73e-06	-0.15	-0.21	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394301~103394322:-
HNSC	cis	rs9663711	1	rs9663711	MIMAT0005951	hsa-miR-1307-3p	4.62	4.87e-06	0.15	0.21	Carotid plaque burden;	chr10:102787871	chr10:103394301~103394322:-
HNSC	cis	rs4921799	0.711	rs34646323	MIMAT0015020	hsa-miR-548v	-4.62	4.89e-06	-0.24	-0.21	Lung cancer;Adenocarcinoma;	chr8:17673776	chr8:17681588~17681609:-
HNSC	cis	rs7477	0.587	rs7225920	MIMAT0005942	hsa-miR-1288-3p	4.62	4.98e-06	0.24	0.21	Amyotrophic lateral sclerosis;	chr17:16275432	chr17:16282058~16282078:+
HNSC	cis	rs950880	0.767	rs12712142	MIMAT0019927	hsa-miR-4772-3p	-4.62	5.07e-06	-0.19	-0.21	Serum protein levels (sST2);	chr2:102344124	chr2:102432336~102432357:+
HNSC	cis	rs7851726	0.932	rs4744411	MIMAT0019208	hsa-miR-3074-5p	4.61	5.1e-06	0.21	0.21	Urinary albumin-to-creatinine ratio;	chr9:94926763	chr9:95086063~95086083:-
HNSC	cis	rs8064299	0.655	rs12797	MIMAT0017994	hsa-miR-3615	-4.61	5.18e-06	-0.24	-0.21	Monocyte count;	chr17:74770854	chr17:74748663~74748683:+
HNSC	cis	rs7851726	0.966	rs4744378	MIMAT0019208	hsa-miR-3074-5p	-4.61	5.22e-06	-0.21	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94816864	chr9:95086063~95086083:-
HNSC	cis	rs453301	0.624	rs2915251	MIMAT0019728	hsa-miR-4660	4.61	5.26e-06	0.25	0.21	Joint mobility (Beighton score);	chr8:9009901	chr8:9048453~9048475:+
HNSC	cis	rs7477	0.528	rs12948244	MIMAT0005942	hsa-miR-1288-3p	4.61	5.28e-06	0.24	0.21	Amyotrophic lateral sclerosis;	chr17:16274786	chr17:16282058~16282078:+
HNSC	cis	rs1014286	0.589	rs2192669	MIMAT0019926	hsa-miR-4772-5p	-4.59	5.6e-06	-0.26	-0.21	Serum protein levels (sST2);	chr2:102635095	chr2:102432300~102432321:+
HNSC	cis	rs4921799	0.662	rs17690083	MIMAT0015020	hsa-miR-548v	-4.59	5.8e-06	-0.24	-0.21	Lung cancer;Adenocarcinoma;	chr8:17680756	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.618	rs35985354	MIMAT0015020	hsa-miR-548v	-4.59	5.8e-06	-0.24	-0.21	Lung cancer;Adenocarcinoma;	chr8:17680894	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.662	rs57661227	MIMAT0015020	hsa-miR-548v	-4.59	5.8e-06	-0.24	-0.21	Lung cancer;Adenocarcinoma;	chr8:17680912	chr8:17681588~17681609:-
HNSC	cis	rs9527	0.662	rs10786714	MIMAT0022727	hsa-miR-1307-5p	4.59	5.81e-06	0.19	0.21	Arsenic metabolism;	chr10:102838849	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.662	rs743575	MIMAT0022727	hsa-miR-1307-5p	4.59	5.84e-06	0.19	0.21	Arsenic metabolism;	chr10:102835149	chr10:103394341~103394361:-
HNSC	cis	rs75358501	0.901	rs76270461	MIMAT0014994	hsa-miR-3130-3p	4.58	5.89e-06	0.43	0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.901	rs76270461	MIMAT0014994_1	hsa-miR-3130-3p	4.58	5.89e-06	0.43	0.21	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783277~206783297:+
HNSC	cis	rs7477	0.557	rs11654658	MIMAT0005942	hsa-miR-1288-3p	-4.58	5.9e-06	-0.24	-0.21	Amyotrophic lateral sclerosis;	chr17:16304141	chr17:16282058~16282078:+
HNSC	cis	rs74233809	1	rs11191560	MIMAT0022727	hsa-miR-1307-5p	-4.58	5.99e-06	-0.29	-0.21	Birth weight;	chr10:103109281	chr10:103394341~103394361:-
HNSC	cis	rs7851726	0.966	rs10993398	MIMAT0019208	hsa-miR-3074-5p	4.58	6.01e-06	0.21	0.21	Urinary albumin-to-creatinine ratio;	chr9:94919793	chr9:95086063~95086083:-
HNSC	cis	rs7851726	1	rs1751434	MIMAT0019208	hsa-miR-3074-5p	-4.58	6.1e-06	-0.2	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94775700	chr9:95086063~95086083:-
HNSC	cis	rs4921799	0.64	rs28716839	MIMAT0015020	hsa-miR-548v	-4.57	6.24e-06	-0.24	-0.21	Lung cancer;Adenocarcinoma;	chr8:17680463	chr8:17681588~17681609:-
HNSC	cis	rs1014286	0.553	rs7602160	MIMAT0019926	hsa-miR-4772-5p	4.57	6.24e-06	0.26	0.21	Serum protein levels (sST2);	chr2:102632384	chr2:102432300~102432321:+
HNSC	cis	rs7072216	0.666	rs2274248	MIMAT0005878	hsa-miR-1287-5p	4.57	6.33e-06	0.22	0.21	Metabolite levels;	chr10:98388785	chr10:98395271~98395292:-
HNSC	cis	rs1018697	0.761	rs7904281	MIMAT0005951	hsa-miR-1307-3p	4.57	6.36e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102785079	chr10:103394301~103394322:-
HNSC	cis	rs7649443	0.959	rs12152266	MIMAT0019973	hsa-miR-4797-3p	4.56	6.44e-06	0.28	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197184490	chr3:197293888~197293908:-
HNSC	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	4.56	6.54e-06	0.31	0.21	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
HNSC	cis	rs7851726	1	rs35487382	MIMAT0019208	hsa-miR-3074-5p	4.56	6.56e-06	0.2	0.21	Urinary albumin-to-creatinine ratio;	chr9:94823506	chr9:95086063~95086083:-
HNSC	cis	rs1018697	0.966	rs10748831	MIMAT0005951	hsa-miR-1307-3p	4.56	6.56e-06	0.14	0.21	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394301~103394322:-
HNSC	cis	rs7649443	0.959	rs3796263	MIMAT0019973	hsa-miR-4797-3p	-4.56	6.67e-06	-0.26	-0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197079929	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.759	rs13066853	MIMAT0019973	hsa-miR-4797-3p	4.54	7.06e-06	0.25	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197180445	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs10489880	MIMAT0019973	hsa-miR-4797-3p	4.54	7.07e-06	0.25	0.21	Nonsyndromic cleft lip with cleft palate;	chr3:197234315	chr3:197293888~197293908:-
HNSC	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	4.54	7.18e-06	0.31	0.21	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
HNSC	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	4.54	7.21e-06	0.31	0.21	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
HNSC	cis	rs8064299	0.655	rs895691	MIMAT0017994	hsa-miR-3615	-4.54	7.24e-06	-0.24	-0.21	Monocyte count;	chr17:74770161	chr17:74748663~74748683:+
HNSC	cis	rs1018697	1	rs7909612	MIMAT0005951	hsa-miR-1307-3p	4.54	7.29e-06	0.14	0.21	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394301~103394322:-
HNSC	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	4.53	7.61e-06	0.21	0.21	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
HNSC	cis	rs7477	0.647	rs4791665	MIMAT0005942	hsa-miR-1288-3p	4.51	8.07e-06	0.24	0.21	Amyotrophic lateral sclerosis;	chr17:16292742	chr17:16282058~16282078:+
HNSC	cis	rs7072216	0.843	rs4400721	MIMAT0026738	hsa-miR-1287-3p	4.51	8.13e-06	0.2	0.21	Metabolite levels;	chr10:98387340	chr10:98395232~98395253:-
HNSC	cis	rs4921799	0.662	rs11203898	MIMAT0015020	hsa-miR-548v	-4.51	8.17e-06	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679823	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.662	rs11987569	MIMAT0015020	hsa-miR-548v	-4.51	8.17e-06	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17680140	chr8:17681588~17681609:-
HNSC	cis	rs10492002	0.853	rs61936383	MIMAT0003287	hsa-miR-618	4.51	8.27e-06	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81176367	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.888	rs35166008	MIMAT0003287	hsa-miR-618	4.51	8.27e-06	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81177469	chr12:80935796~80935818:-
HNSC	cis	rs4921799	0.662	rs10888142	MIMAT0015020	hsa-miR-548v	-4.5	8.43e-06	-0.24	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679605	chr8:17681588~17681609:-
HNSC	cis	rs7072216	0.616	rs701801	MIMAT0005878	hsa-miR-1287-5p	4.5	8.45e-06	0.22	0.2	Metabolite levels;	chr10:98417112	chr10:98395271~98395292:-
HNSC	cis	rs7649443	0.959	rs4491876	MIMAT0019973	hsa-miR-4797-3p	4.5	8.58e-06	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197190701	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs3821714	MIMAT0019973	hsa-miR-4797-3p	4.5	8.58e-06	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197191199	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.876	rs12630261	MIMAT0019973	hsa-miR-4797-3p	4.5	8.58e-06	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197198405	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs2341184	MIMAT0019973	hsa-miR-4797-3p	4.5	8.58e-06	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197203910	chr3:197293888~197293908:-
HNSC	cis	rs7649443	1	rs7649443	MIMAT0019973	hsa-miR-4797-3p	4.5	8.58e-06	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197204950	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs12632727	MIMAT0019973	hsa-miR-4797-3p	4.5	8.58e-06	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197205191	chr3:197293888~197293908:-
HNSC	cis	rs7594645	0.59	rs61258471	MIMAT0014995	hsa-miR-3130-5p	4.49	8.81e-06	0.3	0.2	Episodic memory;	chr2:206751133	chr2:206783276~206783296:-
HNSC	cis	rs7594645	0.59	rs61258471	MIMAT0014995_1	hsa-miR-3130-5p	4.49	8.81e-06	0.3	0.2	Episodic memory;	chr2:206751133	chr2:206783246~206783266:+
HNSC	cis	rs7851726	1	rs446540	MIMAT0019208	hsa-miR-3074-5p	-4.49	8.85e-06	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94746917	chr9:95086063~95086083:-
HNSC	cis	rs1957429	0.731	rs1951495	MIMAT0004808	hsa-miR-625-3p	4.49	8.93e-06	0.33	0.2	Pediatric areal bone mineral density (radius);	chr14:64869972	chr14:65471153~65471174:+
HNSC	cis	rs10492002	0.853	rs34605308	MIMAT0003287	hsa-miR-618	4.49	9.01e-06	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81165368	chr12:80935796~80935818:-
HNSC	cis	rs17730929	0.722	rs35827885	MIMAT0005923	hsa-miR-1269a	-4.48	9.29e-06	-0.54	-0.2	Colorectal cancer (SNP x SNP interaction);	chr4:66263658	chr4:66276890~66276911:+
HNSC	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	4.48	9.38e-06	0.31	0.2	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
HNSC	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	4.47	9.68e-06	0.21	0.2	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
HNSC	cis	rs7851726	1	rs10993377	MIMAT0019208	hsa-miR-3074-5p	4.47	9.68e-06	0.2	0.2	Urinary albumin-to-creatinine ratio;	chr9:94868545	chr9:95086063~95086083:-
HNSC	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	4.47	9.72e-06	0.14	0.2	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
HNSC	cis	rs7649443	0.959	rs10461050	MIMAT0019973	hsa-miR-4797-3p	4.47	9.77e-06	0.27	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197225300	chr3:197293888~197293908:-
HNSC	cis	rs7851726	0.966	rs12235316	MIMAT0019208	hsa-miR-3074-5p	4.46	1.02e-05	0.2	0.2	Urinary albumin-to-creatinine ratio;	chr9:94915274	chr9:95086063~95086083:-
HNSC	cis	rs13088645	0.652	rs13074557	MIMAT0019958	hsa-miR-4788	-4.46	1.02e-05	-0.23	-0.2	Coronary artery disease;	chr3:134434684	chr3:134437836~134437857:+
HNSC	cis	rs7649443	0.917	rs6782876	MIMAT0019973	hsa-miR-4797-3p	4.46	1.02e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197294275	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs3915512	MIMAT0019973	hsa-miR-4797-3p	4.46	1.02e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197295369	chr3:197293888~197293908:-
HNSC	cis	rs7851726	0.899	rs10993397	MIMAT0019208	hsa-miR-3074-5p	4.46	1.03e-05	0.2	0.2	Urinary albumin-to-creatinine ratio;	chr9:94917489	chr9:95086063~95086083:-
HNSC	cis	rs10492002	1	rs12815742	MIMAT0003287	hsa-miR-618	4.46	1.05e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81150100	chr12:80935796~80935818:-
HNSC	cis	rs7851726	0.966	rs7019822	MIMAT0019208	hsa-miR-3074-5p	-4.45	1.09e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94720609	chr9:95086063~95086083:-
HNSC	cis	rs7851726	1	rs4744403	MIMAT0019208	hsa-miR-3074-5p	4.45	1.09e-05	0.2	0.2	Urinary albumin-to-creatinine ratio;	chr9:94908276	chr9:95086063~95086083:-
HNSC	cis	rs7477	0.529	rs11656811	MIMAT0005942	hsa-miR-1288-3p	4.45	1.09e-05	0.23	0.2	Amyotrophic lateral sclerosis;	chr17:16310940	chr17:16282058~16282078:+
HNSC	cis	rs7851726	0.628	rs4744412	MIMAT0019208	hsa-miR-3074-5p	4.45	1.1e-05	0.2	0.2	Urinary albumin-to-creatinine ratio;	chr9:94928219	chr9:95086063~95086083:-
HNSC	cis	rs9527	0.662	rs4919686	MIMAT0005951	hsa-miR-1307-3p	4.44	1.11e-05	0.16	0.2	Arsenic metabolism;	chr10:102832492	chr10:103394301~103394322:-
HNSC	cis	rs74233809	0.71	rs4147157	MIMAT0022727	hsa-miR-1307-5p	-4.44	1.11e-05	-0.3	-0.2	Birth weight;	chr10:102776603	chr10:103394341~103394361:-
HNSC	cis	rs10993397	0.507	rs10993366	MIMAT0019208	hsa-miR-3074-5p	-4.44	1.12e-05	-0.2	-0.2	Polycystic ovary syndrome;	chr9:94844308	chr9:95086063~95086083:-
HNSC	cis	rs7649443	0.918	rs7619429	MIMAT0019973	hsa-miR-4797-3p	4.44	1.12e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197272219	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs1073726	MIMAT0019973	hsa-miR-4797-3p	4.44	1.12e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197274137	chr3:197293888~197293908:-
HNSC	cis	rs79387448	0.81	rs75218113	MIMAT0019926	hsa-miR-4772-5p	-4.44	1.13e-05	-0.34	-0.2	Gut microbiota (bacterial taxa);	chr2:102622897	chr2:102432300~102432321:+
HNSC	cis	rs10492002	1	rs10492002	MIMAT0003287	hsa-miR-618	4.44	1.13e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81150757	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.959	rs34207201	MIMAT0019973	hsa-miR-4797-3p	4.44	1.15e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197195220	chr3:197293888~197293908:-
HNSC	cis	rs10492002	0.597	rs7306808	MIMAT0003287	hsa-miR-618	4.43	1.15e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81107695	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.506	rs7297387	MIMAT0003287	hsa-miR-618	4.43	1.15e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81108854	chr12:80935796~80935818:-
HNSC	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	4.43	1.16e-05	0.21	0.2	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.666	rs11598689	MIMAT0005878	hsa-miR-1287-5p	4.43	1.18e-05	0.22	0.2	Metabolite levels;	chr10:98396270	chr10:98395271~98395292:-
HNSC	cis	rs7851726	1	rs4385527	MIMAT0019208	hsa-miR-3074-5p	-4.43	1.18e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94886305	chr9:95086063~95086083:-
HNSC	cis	rs7649443	0.959	rs34121928	MIMAT0019973	hsa-miR-4797-3p	4.43	1.19e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197275998	chr3:197293888~197293908:-
HNSC	cis	rs7851726	0.933	rs2183958	MIMAT0019208	hsa-miR-3074-5p	4.43	1.2e-05	0.2	0.2	Urinary albumin-to-creatinine ratio;	chr9:94907391	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.628	rs12344211	MIMAT0019208	hsa-miR-3074-5p	4.43	1.2e-05	0.2	0.2	Urinary albumin-to-creatinine ratio;	chr9:94928822	chr9:95086063~95086083:-
HNSC	cis	rs17001239	0.85	rs79935572	MIMAT0004658	hsa-miR-155-3p	4.42	1.21e-05	0.37	0.2	Cognitive performance;	chr21:25618030	chr21:25574022~25574043:+
HNSC	cis	rs7649443	0.959	rs6782621	MIMAT0019973	hsa-miR-4797-3p	4.42	1.22e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197112157	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.921	rs12631361	MIMAT0019973	hsa-miR-4797-3p	4.42	1.22e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197114703	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.921	rs35624335	MIMAT0019973	hsa-miR-4797-3p	4.42	1.22e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197156210	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.878	rs7642604	MIMAT0019973	hsa-miR-4797-3p	4.42	1.22e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197165115	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.878	rs7634994	MIMAT0019973	hsa-miR-4797-3p	4.42	1.22e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197165142	chr3:197293888~197293908:-
HNSC	cis	rs10492002	1	rs12831934	MIMAT0003287	hsa-miR-618	4.41	1.26e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81155195	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.797	rs35665404	MIMAT0019973	hsa-miR-4797-3p	4.41	1.27e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197254900	chr3:197293888~197293908:-
HNSC	cis	rs74233809	0.901	rs17878846	MIMAT0022727	hsa-miR-1307-5p	-4.41	1.3e-05	-0.3	-0.2	Birth weight;	chr10:102870655	chr10:103394341~103394361:-
HNSC	cis	rs7649443	0.959	rs6779689	MIMAT0019973	hsa-miR-4797-3p	4.4	1.32e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197287302	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.758	rs34305944	MIMAT0019973	hsa-miR-4797-3p	4.4	1.32e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197288547	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs10461048	MIMAT0019973	hsa-miR-4797-3p	4.4	1.33e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197226420	chr3:197293888~197293908:-
HNSC	cis	rs7851726	1	rs943393	MIMAT0019208	hsa-miR-3074-5p	-4.4	1.36e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94737144	chr9:95086063~95086083:-
HNSC	cis	rs4921799	0.662	rs17125108	MIMAT0015020	hsa-miR-548v	-4.4	1.36e-05	-0.23	-0.2	Lung cancer;Adenocarcinoma;	chr8:17680832	chr8:17681588~17681609:-
HNSC	cis	rs9814567	0.731	rs34797591	MIMAT0019958	hsa-miR-4788	-4.39	1.38e-05	-0.26	-0.2	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134473674	chr3:134437836~134437857:+
HNSC	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	4.39	1.39e-05	0.29	0.2	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
HNSC	cis	rs7851726	0.668	rs10821390	MIMAT0019208	hsa-miR-3074-5p	-4.39	1.4e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94743305	chr9:95086063~95086083:-
HNSC	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	4.39	1.4e-05	0.2	0.2	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
HNSC	cis	rs10492002	0.636	rs1435968	MIMAT0003287	hsa-miR-618	4.39	1.41e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81136877	chr12:80935796~80935818:-
HNSC	cis	rs950880	0.553	rs2293225	MIMAT0019927	hsa-miR-4772-3p	4.39	1.41e-05	0.23	0.2	Serum protein levels (sST2);	chr2:102419429	chr2:102432336~102432357:+
HNSC	cis	rs10492002	0.558	rs11613491	MIMAT0003287	hsa-miR-618	4.39	1.42e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81145901	chr12:80935796~80935818:-
HNSC	cis	rs7477	0.619	rs12938397	MIMAT0005942	hsa-miR-1288-3p	-4.39	1.42e-05	-0.23	-0.2	Amyotrophic lateral sclerosis;	chr17:16282786	chr17:16282058~16282078:+
HNSC	cis	rs7851726	0.69	rs10821404	MIMAT0019208	hsa-miR-3074-5p	-4.39	1.43e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94834583	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.69	rs4743969	MIMAT0019208	hsa-miR-3074-5p	-4.39	1.43e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94836684	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.646	rs2031698	MIMAT0019208	hsa-miR-3074-5p	-4.38	1.45e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94779050	chr9:95086063~95086083:-
HNSC	cis	rs7594645	0.59	rs73068058	MIMAT0014995	hsa-miR-3130-5p	4.38	1.46e-05	0.29	0.2	Episodic memory;	chr2:206752613	chr2:206783276~206783296:-
HNSC	cis	rs7594645	0.59	rs73068058	MIMAT0014995_1	hsa-miR-3130-5p	4.38	1.46e-05	0.29	0.2	Episodic memory;	chr2:206752613	chr2:206783246~206783266:+
HNSC	cis	rs7072216	0.666	rs11189592	MIMAT0005878	hsa-miR-1287-5p	4.38	1.48e-05	0.21	0.2	Metabolite levels;	chr10:98395885	chr10:98395271~98395292:-
HNSC	cis	rs10492002	0.782	rs61934663	MIMAT0003287	hsa-miR-618	4.38	1.49e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81212462	chr12:80935796~80935818:-
HNSC	cis	rs7477	0.557	rs12939078	MIMAT0005942	hsa-miR-1288-3p	4.38	1.49e-05	0.23	0.2	Amyotrophic lateral sclerosis;	chr17:16313152	chr17:16282058~16282078:+
HNSC	cis	rs7851726	1	rs7851726	MIMAT0019208	hsa-miR-3074-5p	-4.37	1.53e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94741703	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.865	rs2584806	MIMAT0019208	hsa-miR-3074-5p	-4.37	1.54e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94766996	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.624	rs10993344	MIMAT0019208	hsa-miR-3074-5p	-4.37	1.55e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94785653	chr9:95086063~95086083:-
HNSC	cis	rs9814567	0.722	rs13083717	MIMAT0019958	hsa-miR-4788	-4.37	1.56e-05	-0.26	-0.2	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134629954	chr3:134437836~134437857:+
HNSC	cis	rs10492002	0.522	rs1882258	MIMAT0003287	hsa-miR-618	4.36	1.58e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81104925	chr12:80935796~80935818:-
HNSC	cis	rs9527	0.615	rs11191401	MIMAT0022727	hsa-miR-1307-5p	4.36	1.59e-05	0.19	0.2	Arsenic metabolism;	chr10:102813646	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.587	rs2296435	MIMAT0005878	hsa-miR-1287-5p	-4.36	1.59e-05	-0.21	-0.2	Metabolite levels;	chr10:98422528	chr10:98395271~98395292:-
HNSC	cis	rs10492002	0.596	rs7305347	MIMAT0003287	hsa-miR-618	4.36	1.59e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81119115	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.557	rs7973522	MIMAT0003287	hsa-miR-618	4.36	1.63e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81095362	chr12:80935796~80935818:-
HNSC	cis	rs7851726	0.934	rs368138	MIMAT0019208	hsa-miR-3074-5p	-4.35	1.69e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94761301	chr9:95086063~95086083:-
HNSC	cis	rs7851726	1	rs183066	MIMAT0019208	hsa-miR-3074-5p	-4.34	1.72e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94755150	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.69	rs10739982	MIMAT0019208	hsa-miR-3074-5p	-4.34	1.73e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94763966	chr9:95086063~95086083:-
HNSC	cis	rs1957429	0.808	rs4899150	MIMAT0004808	hsa-miR-625-3p	4.34	1.74e-05	0.3	0.2	Pediatric areal bone mineral density (radius);	chr14:64877682	chr14:65471153~65471174:+
HNSC	cis	rs7649443	0.959	rs12632559	MIMAT0019973	hsa-miR-4797-3p	4.34	1.74e-05	0.27	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197076776	chr3:197293888~197293908:-
HNSC	cis	rs10492002	0.636	rs17736448	MIMAT0003287	hsa-miR-618	4.34	1.77e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81116390	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs61934932	MIMAT0003287	hsa-miR-618	4.34	1.77e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81117248	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.782	rs1882180	MIMAT0003287	hsa-miR-618	4.34	1.77e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81209134	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs11614641	MIMAT0003287	hsa-miR-618	4.34	1.78e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81119546	chr12:80935796~80935818:-
HNSC	cis	rs453301	0.658	rs9329175	MIMAT0019728	hsa-miR-4660	-4.33	1.81e-05	-0.23	-0.2	Joint mobility (Beighton score);	chr8:9009151	chr8:9048453~9048475:+
HNSC	cis	rs7649443	0.959	rs13081715	MIMAT0019973	hsa-miR-4797-3p	4.33	1.84e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197180419	chr3:197293888~197293908:-
HNSC	cis	rs1014286	0.52	rs4851624	MIMAT0019926	hsa-miR-4772-5p	4.32	1.87e-05	0.25	0.2	Serum protein levels (sST2);	chr2:102644864	chr2:102432300~102432321:+
HNSC	cis	rs7851726	0.69	rs10821392	MIMAT0019208	hsa-miR-3074-5p	-4.32	1.88e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94746625	chr9:95086063~95086083:-
HNSC	cis	rs7649443	0.959	rs1868891	MIMAT0019973	hsa-miR-4797-3p	4.32	1.88e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197174821	chr3:197293888~197293908:-
HNSC	cis	rs10492002	0.522	rs12315512	MIMAT0003287	hsa-miR-618	4.32	1.89e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81100600	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.522	rs12315517	MIMAT0003287	hsa-miR-618	4.32	1.89e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81100625	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.545	rs12299448	MIMAT0003287	hsa-miR-618	4.32	1.89e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81102693	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.522	rs10862241	MIMAT0003287	hsa-miR-618	4.32	1.89e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81102979	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.522	rs12809234	MIMAT0003287	hsa-miR-618	4.32	1.89e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81103740	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.522	rs10862240	MIMAT0003287	hsa-miR-618	4.32	1.89e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81101847	chr12:80935796~80935818:-
HNSC	cis	rs250677	0.687	rs1422581	MIMAT0003249	hsa-miR-584-5p	-4.32	1.92e-05	-0.2	-0.2	Breast cancer;	chr5:149057823	chr5:149062373~149062394:-
HNSC	cis	rs7649443	0.917	rs13099700	MIMAT0019973	hsa-miR-4797-3p	4.32	1.92e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197091982	chr3:197293888~197293908:-
HNSC	cis	rs4921799	0.597	rs35034557	MIMAT0015020	hsa-miR-548v	-4.32	1.93e-05	-0.22	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679136	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.686	rs10112397	MIMAT0015020	hsa-miR-548v	-4.32	1.93e-05	-0.22	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679195	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.513	rs10112412	MIMAT0015020	hsa-miR-548v	-4.32	1.93e-05	-0.22	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679236	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.577	rs10112413	MIMAT0015020	hsa-miR-548v	-4.32	1.93e-05	-0.22	-0.2	Lung cancer;Adenocarcinoma;	chr8:17679238	chr8:17681588~17681609:-
HNSC	cis	rs7649443	0.876	rs11185466	MIMAT0019973	hsa-miR-4797-3p	4.32	1.94e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197142056	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.876	rs6804327	MIMAT0019973	hsa-miR-4797-3p	4.32	1.94e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197143866	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.876	rs6771091	MIMAT0019973	hsa-miR-4797-3p	4.32	1.94e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197144124	chr3:197293888~197293908:-
HNSC	cis	rs7851726	0.628	rs12338409	MIMAT0019208	hsa-miR-3074-5p	4.32	1.94e-05	0.19	0.2	Urinary albumin-to-creatinine ratio;	chr9:94928807	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.69	rs7027708	MIMAT0019208	hsa-miR-3074-5p	-4.32	1.95e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94748390	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.646	rs10821393	MIMAT0019208	hsa-miR-3074-5p	-4.32	1.95e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94754478	chr9:95086063~95086083:-
HNSC	cis	rs7851726	0.646	rs10739983	MIMAT0019208	hsa-miR-3074-5p	-4.32	1.95e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94764002	chr9:95086063~95086083:-
HNSC	cis	rs17730929	0.858	rs72902549	MIMAT0005923	hsa-miR-1269a	-4.31	2e-05	-0.5	-0.2	Colorectal cancer (SNP x SNP interaction);	chr4:66467002	chr4:66276890~66276911:+
HNSC	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-4.31	2.01e-05	-0.21	-0.2	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
HNSC	cis	rs9527	0.59	rs1475642	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.06e-05	-0.19	-0.2	Arsenic metabolism;	chr10:102786426	chr10:103394341~103394361:-
HNSC	cis	rs10492002	0.596	rs61934930	MIMAT0003287	hsa-miR-618	4.3	2.07e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81107027	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs11614891	MIMAT0003287	hsa-miR-618	4.3	2.07e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81107185	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs12817088	MIMAT0003287	hsa-miR-618	4.3	2.07e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81107848	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs35423806	MIMAT0003287	hsa-miR-618	4.3	2.07e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81110064	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.558	rs11613490	MIMAT0003287	hsa-miR-618	4.3	2.07e-05	0.22	0.2	Response to antidepressant treatment (citalopram);	chr12:81145895	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.878	rs3906480	MIMAT0019973	hsa-miR-4797-3p	4.3	2.07e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197106424	chr3:197293888~197293908:-
HNSC	cis	rs74233809	0.636	rs284851	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.08e-05	-0.24	-0.2	Birth weight;	chr10:102818774	chr10:103394341~103394361:-
HNSC	cis	rs4921799	0.711	rs3862091	MIMAT0015020	hsa-miR-548v	4.3	2.09e-05	0.22	0.2	Lung cancer;Adenocarcinoma;	chr8:17673680	chr8:17681588~17681609:-
HNSC	cis	rs9527	1	rs12416687	MIMAT0022727	hsa-miR-1307-5p	4.3	2.1e-05	0.2	0.2	Arsenic metabolism;	chr10:102869254	chr10:103394341~103394361:-
HNSC	cis	rs7594645	0.59	rs2359724	MIMAT0014995	hsa-miR-3130-5p	-4.29	2.16e-05	-0.28	-0.2	Episodic memory;	chr2:206750798	chr2:206783276~206783296:-
HNSC	cis	rs7594645	0.59	rs2359724	MIMAT0014995_1	hsa-miR-3130-5p	-4.29	2.16e-05	-0.28	-0.2	Episodic memory;	chr2:206750798	chr2:206783246~206783266:+
HNSC	cis	rs7649443	0.959	rs62282105	MIMAT0019973	hsa-miR-4797-3p	4.29	2.17e-05	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197251848	chr3:197293888~197293908:-
HNSC	cis	rs4851551	0.619	rs34722443	MIMAT0019926	hsa-miR-4772-5p	4.29	2.17e-05	0.49	0.2	Blood protein levels;	chr2:102223859	chr2:102432300~102432321:+
HNSC	cis	rs7851726	0.676	rs10821398	MIMAT0019208	hsa-miR-3074-5p	-4.29	2.18e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94815277	chr9:95086063~95086083:-
HNSC	cis	rs10492002	0.691	rs1921035	MIMAT0003287	hsa-miR-618	4.29	2.21e-05	0.23	0.2	Response to antidepressant treatment (citalopram);	chr12:81208670	chr12:80935796~80935818:-
HNSC	cis	rs7851726	0.69	rs7848139	MIMAT0019208	hsa-miR-3074-5p	-4.29	2.22e-05	-0.19	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94733185	chr9:95086063~95086083:-
HNSC	cis	rs7851726	1	rs414253	MIMAT0019208	hsa-miR-3074-5p	-4.28	2.25e-05	-0.19	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94724740	chr9:95086063~95086083:-
HNSC	cis	rs4921799	0.64	rs10503600	MIMAT0015020	hsa-miR-548v	-4.28	2.27e-05	-0.2	-0.19	Lung cancer;Adenocarcinoma;	chr8:17667655	chr8:17681588~17681609:-
HNSC	cis	rs7649443	0.959	rs35112822	MIMAT0019973	hsa-miR-4797-3p	4.28	2.32e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197249598	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.796	rs2340433	MIMAT0019973	hsa-miR-4797-3p	4.28	2.32e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197250008	chr3:197293888~197293908:-
HNSC	cis	rs10492002	0.596	rs10862238	MIMAT0003287	hsa-miR-618	4.27	2.36e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81100151	chr12:80935796~80935818:-
HNSC	cis	rs7851726	0.69	rs11788697	MIMAT0019208	hsa-miR-3074-5p	-4.27	2.37e-05	-0.19	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94823083	chr9:95086063~95086083:-
HNSC	cis	rs4921799	0.711	rs11203891	MIMAT0015020	hsa-miR-548v	-4.27	2.38e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17676783	chr8:17681588~17681609:-
HNSC	cis	rs2980439	0.783	rs2955587	MIMAT0019728	hsa-miR-4660	4.26	2.42e-05	0.23	0.19	Neuroticism;	chr8:8240557	chr8:9048453~9048475:+
HNSC	cis	rs10492002	1	rs7132119	MIMAT0003287	hsa-miR-618	-4.26	2.43e-05	-0.22	-0.19	Response to antidepressant treatment (citalopram);	chr12:81155896	chr12:80935796~80935818:-
HNSC	cis	rs13088645	0.621	rs7611834	MIMAT0019958	hsa-miR-4788	-4.26	2.43e-05	-0.22	-0.19	Coronary artery disease;	chr3:134427246	chr3:134437836~134437857:+
HNSC	cis	rs7477	0.647	rs2014604	MIMAT0005942	hsa-miR-1288-3p	-4.26	2.44e-05	-0.22	-0.19	Amyotrophic lateral sclerosis;	chr17:16273569	chr17:16282058~16282078:+
HNSC	cis	rs7894407	1	rs7894407	MIMAT0005951	hsa-miR-1307-3p	4.26	2.44e-05	0.15	0.19	White matter hyperintensity burden;	chr10:103416422	chr10:103394301~103394322:-
HNSC	cis	rs4921799	0.711	rs11203890	MIMAT0015020	hsa-miR-548v	-4.26	2.44e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17676717	chr8:17681588~17681609:-
HNSC	cis	rs7072216	0.555	rs2296433	MIMAT0026738	hsa-miR-1287-3p	4.26	2.47e-05	0.21	0.19	Metabolite levels;	chr10:98424305	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.555	rs2296432	MIMAT0026738	hsa-miR-1287-3p	4.26	2.47e-05	0.21	0.19	Metabolite levels;	chr10:98424306	chr10:98395232~98395253:-
HNSC	cis	rs10492002	0.596	rs55924813	MIMAT0003287	hsa-miR-618	4.26	2.48e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81133017	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.959	rs56309312	MIMAT0019973	hsa-miR-4797-3p	4.26	2.5e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197103636	chr3:197293888~197293908:-
HNSC	cis	rs4851551	0.543	rs62156407	MIMAT0019926	hsa-miR-4772-5p	4.25	2.54e-05	0.49	0.19	Blood protein levels;	chr2:102208162	chr2:102432300~102432321:+
HNSC	cis	rs9527	1	rs4919690	MIMAT0022727	hsa-miR-1307-5p	-4.25	2.55e-05	-0.19	-0.19	Arsenic metabolism;	chr10:102856743	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	4.25	2.58e-05	0.2	0.19	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
HNSC	cis	rs9527	0.615	rs4919682	MIMAT0022727	hsa-miR-1307-5p	4.25	2.62e-05	0.19	0.19	Arsenic metabolism;	chr10:102824573	chr10:103394341~103394361:-
HNSC	cis	rs4921799	0.662	rs35211928	MIMAT0015020	hsa-miR-548v	-4.25	2.62e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17677494	chr8:17681588~17681609:-
HNSC	cis	rs74233809	0.901	rs4409766	MIMAT0022727	hsa-miR-1307-5p	-4.25	2.62e-05	-0.25	-0.19	Birth weight;	chr10:102856906	chr10:103394341~103394361:-
HNSC	cis	rs4921799	0.64	rs10112153	MIMAT0015020	hsa-miR-548v	-4.25	2.63e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679023	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.64	rs10109250	MIMAT0015020	hsa-miR-548v	-4.25	2.63e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679026	chr8:17681588~17681609:-
HNSC	cis	rs7851726	0.966	rs10993372	MIMAT0019208	hsa-miR-3074-5p	4.24	2.66e-05	0.19	0.19	Urinary albumin-to-creatinine ratio;	chr9:94856808	chr9:95086063~95086083:-
HNSC	cis	rs17730929	0.722	rs35980427	MIMAT0005923	hsa-miR-1269a	-4.24	2.68e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66262645	chr4:66276890~66276911:+
HNSC	cis	rs7649443	0.959	rs13072590	MIMAT0019973	hsa-miR-4797-3p	4.24	2.69e-05	0.26	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197284809	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.876	rs3773855	MIMAT0019973	hsa-miR-4797-3p	-4.24	2.69e-05	-0.26	-0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197141000	chr3:197293888~197293908:-
HNSC	cis	rs10492002	0.636	rs4306334	MIMAT0003287	hsa-miR-618	4.24	2.7e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81111304	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs4584646	MIMAT0003287	hsa-miR-618	4.24	2.7e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81111382	chr12:80935796~80935818:-
HNSC	cis	rs74233809	0.901	rs11191425	MIMAT0022727	hsa-miR-1307-5p	-4.24	2.71e-05	-0.29	-0.19	Birth weight;	chr10:102866213	chr10:103394341~103394361:-
HNSC	cis	rs17730929	0.722	rs13141975	MIMAT0005923	hsa-miR-1269a	-4.24	2.72e-05	-0.54	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266997	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs17714933	MIMAT0005923	hsa-miR-1269a	-4.24	2.72e-05	-0.54	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66273140	chr4:66276890~66276911:+
HNSC	cis	rs10492002	0.636	rs1545083	MIMAT0003287	hsa-miR-618	4.24	2.72e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81133424	chr12:80935796~80935818:-
HNSC	cis	rs7035284	1	rs7028950	MIMAT0004504	hsa-miR-31-3p	-4.23	2.83e-05	-0.2	-0.19	Pediatric bone mineral content (radius);	chr9:21682261	chr9:21512121~21512142:-
HNSC	cis	rs6584202	0.589	rs10883094	MIMAT0026738	hsa-miR-1287-3p	4.23	2.84e-05	0.2	0.19	Obesity-related traits;	chr10:98428349	chr10:98395232~98395253:-
HNSC	cis	rs10492002	0.547	rs7980266	MIMAT0003287	hsa-miR-618	4.22	2.9e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81137967	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs2107416	MIMAT0003287	hsa-miR-618	4.22	2.9e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81138503	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.876	rs62282106	MIMAT0019973	hsa-miR-4797-3p	4.22	2.96e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197270277	chr3:197293888~197293908:-
HNSC	cis	rs9807989	0.839	rs6749114	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.96e-05	-0.17	-0.19	Asthma;	chr2:102351127	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.773	rs72823661	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102352256	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.801	rs72823663	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102352278	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.811	rs67088699	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102352291	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.773	rs5010059	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102352366	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs11695627	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102353645	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.801	rs7558339	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102353783	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.811	rs7608638	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102353829	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.811	rs4485584	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102354290	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.811	rs4485585	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102354299	chr2:102432336~102432357:+
HNSC	cis	rs9807989	1	rs9807989	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102354740	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs9808453	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102354846	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs4851565	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102355021	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.765	rs9807962	MIMAT0019927	hsa-miR-4772-3p	-4.22	2.97e-05	-0.17	-0.19	Asthma;	chr2:102355204	chr2:102432336~102432357:+
HNSC	cis	rs7851726	0.624	rs12338859	MIMAT0019208	hsa-miR-3074-5p	4.22	2.98e-05	0.19	0.19	Urinary albumin-to-creatinine ratio;	chr9:94901338	chr9:95086063~95086083:-
HNSC	cis	rs2980439	0.818	rs2945249	MIMAT0019728	hsa-miR-4660	4.22	2.99e-05	0.22	0.19	Neuroticism;	chr8:8237204	chr8:9048453~9048475:+
HNSC	cis	rs9527	0.615	rs4919685	MIMAT0005951	hsa-miR-1307-3p	4.22	2.99e-05	0.15	0.19	Arsenic metabolism;	chr10:102827605	chr10:103394301~103394322:-
HNSC	cis	rs9807989	0.571	rs10208293	MIMAT0019926	hsa-miR-4772-5p	-4.21	3.05e-05	-0.24	-0.19	Asthma;	chr2:102349850	chr2:102432300~102432321:+
HNSC	cis	rs4921799	0.662	rs7462063	MIMAT0015020	hsa-miR-548v	-4.21	3.06e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17678838	chr8:17681588~17681609:-
HNSC	cis	rs9807989	0.765	rs13424006	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102350776	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.765	rs6751967	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102350953	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.765	rs6751977	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102350970	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.801	rs6734742	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351397	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.801	rs6752482	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351398	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs4988956	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351547	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs10192036	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351751	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs10204137	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351752	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs4988958	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351825	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs10192157	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351896	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs10206753	MIMAT0019927	hsa-miR-4772-3p	-4.21	3.12e-05	-0.17	-0.19	Asthma;	chr2:102351902	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs4988957	MIMAT0019927	hsa-miR-4772-3p	4.21	3.12e-05	0.17	0.19	Asthma;	chr2:102351615	chr2:102432336~102432357:+
HNSC	cis	rs7649443	0.959	rs61394945	MIMAT0019973	hsa-miR-4797-3p	4.21	3.13e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197247731	chr3:197293888~197293908:-
HNSC	cis	rs4921799	0.711	rs2301541	MIMAT0015020	hsa-miR-548v	-4.21	3.13e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17676059	chr8:17681588~17681609:-
HNSC	cis	rs4921799	0.711	rs17125083	MIMAT0015020	hsa-miR-548v	-4.2	3.15e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17675959	chr8:17681588~17681609:-
HNSC	cis	rs1163656	1	rs1163656	MIMAT0003287	hsa-miR-618	-4.2	3.15e-05	-0.26	-0.19	Dental caries;	chr12:80943679	chr12:80935796~80935818:-
HNSC	cis	rs9807989	0.801	rs4851566	MIMAT0019927	hsa-miR-4772-3p	-4.2	3.22e-05	-0.17	-0.19	Asthma;	chr2:102356339	chr2:102432336~102432357:+
HNSC	cis	rs7649443	0.876	rs12638001	MIMAT0019973	hsa-miR-4797-3p	4.2	3.23e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197090304	chr3:197293888~197293908:-
HNSC	cis	rs10492002	0.596	rs17736095	MIMAT0003287	hsa-miR-618	4.19	3.28e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81101115	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.596	rs12811480	MIMAT0003287	hsa-miR-618	4.19	3.28e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81101405	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.596	rs11608692	MIMAT0003287	hsa-miR-618	4.19	3.28e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81101897	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.596	rs11608718	MIMAT0003287	hsa-miR-618	4.19	3.28e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81102007	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.557	rs34246226	MIMAT0003287	hsa-miR-618	4.19	3.28e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81102245	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.917	rs13077565	MIMAT0019973	hsa-miR-4797-3p	4.19	3.31e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197239949	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs7624764	MIMAT0019973	hsa-miR-4797-3p	4.19	3.31e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197244326	chr3:197293888~197293908:-
HNSC	cis	rs10492002	0.596	rs34429601	MIMAT0003287	hsa-miR-618	4.19	3.31e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81105117	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.596	rs1574365	MIMAT0003287	hsa-miR-618	4.19	3.31e-05	0.22	0.19	Response to antidepressant treatment (citalopram);	chr12:81105515	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.959	rs12374173	MIMAT0019973	hsa-miR-4797-3p	4.19	3.37e-05	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197089418	chr3:197293888~197293908:-
HNSC	cis	rs9527	0.615	rs10883781	MIMAT0022727	hsa-miR-1307-5p	4.18	3.44e-05	0.18	0.19	Arsenic metabolism;	chr10:102821373	chr10:103394341~103394361:-
HNSC	cis	rs953492	0.831	rs2783965	MIMAT0019761	hsa-miR-4677-3p	-4.18	3.49e-05	-0.19	-0.19	Diastolic blood pressure;	chr1:243337095	chr1:243346225~243346246:+
HNSC	cis	rs9527	0.662	rs4919687	MIMAT0005951	hsa-miR-1307-3p	4.18	3.52e-05	0.15	0.19	Arsenic metabolism;	chr10:102835491	chr10:103394301~103394322:-
HNSC	cis	rs10492002	0.613	rs11114762	MIMAT0003287	hsa-miR-618	4.18	3.52e-05	0.21	0.19	Response to antidepressant treatment (citalopram);	chr12:81099128	chr12:80935796~80935818:-
HNSC	cis	rs7072216	0.881	rs2147895	MIMAT0026738	hsa-miR-1287-3p	4.18	3.53e-05	0.18	0.19	Metabolite levels;	chr10:98388551	chr10:98395232~98395253:-
HNSC	cis	rs4921799	0.686	rs7459632	MIMAT0015020	hsa-miR-548v	4.18	3.54e-05	0.22	0.19	Lung cancer;Adenocarcinoma;	chr8:17678579	chr8:17681588~17681609:-
HNSC	cis	rs17730929	0.722	rs35028404	MIMAT0005923	hsa-miR-1269a	-4.18	3.54e-05	-0.53	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263128	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs35749355	MIMAT0005923	hsa-miR-1269a	-4.18	3.54e-05	-0.53	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263160	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs34908018	MIMAT0005923	hsa-miR-1269a	-4.18	3.54e-05	-0.53	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263222	chr4:66276890~66276911:+
HNSC	cis	rs7035284	1	rs7028950	MIMAT0000089	hsa-miR-31-5p	-4.17	3.57e-05	-0.21	-0.19	Pediatric bone mineral content (radius);	chr9:21682261	chr9:21512158~21512178:-
HNSC	cis	rs2980436	1	rs2980436	MIMAT0019728	hsa-miR-4660	-4.17	3.62e-05	-0.23	-0.19	Schizophrenia;	chr8:8234503	chr8:9048453~9048475:+
HNSC	cis	rs4921799	0.662	rs12680944	MIMAT0015020	hsa-miR-548v	-4.17	3.66e-05	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17677530	chr8:17681588~17681609:-
HNSC	cis	rs9299	0.502	rs4793944	MIMAT0004555	hsa-miR-10a-3p	4.17	3.66e-05	0.23	0.19	Obesity;	chr17:48589942	chr17:48579864~48579885:-
HNSC	cis	rs7026071	1	rs7026071	MIMAT0019208	hsa-miR-3074-5p	-4.17	3.67e-05	-0.19	-0.19	Atrial fibrillation;	chr9:94730238	chr9:95086063~95086083:-
HNSC	cis	rs10832417	1	rs10832430	MIMAT0004761	hsa-miR-483-5p	4.17	3.69e-05	0.26	0.19	Blood pressure measurement (high sodium intervention);	chr11:2633443	chr11:2134181~2134202:-
HNSC	cis	rs9807989	0.765	rs6704565	MIMAT0019927	hsa-miR-4772-3p	-4.16	3.77e-05	-0.17	-0.19	Asthma;	chr2:102350971	chr2:102432336~102432357:+
HNSC	cis	rs6519955	0.796	rs4072455	MIMAT0019911	hsa-miR-4762-3p	4.16	3.84e-05	0.22	0.19	Dupuytren's disease;	chr22:46027058	chr22:45760572~45760593:+
HNSC	cis	rs4819852	1	rs1034565	MIMAT0000455	hsa-miR-185-5p	4.16	3.85e-05	0.2	0.19	Pulse pressure;	chr22:19996688	chr22:20033153~20033174:+
HNSC	cis	rs6519955	0.765	rs7292527	MIMAT0019911	hsa-miR-4762-3p	-4.16	3.86e-05	-0.22	-0.19	Dupuytren's disease;	chr22:46027245	chr22:45760572~45760593:+
HNSC	cis	rs250677	0.687	rs250674	MIMAT0003249	hsa-miR-584-5p	-4.16	3.86e-05	-0.2	-0.19	Breast cancer;	chr5:149059034	chr5:149062373~149062394:-
HNSC	cis	rs4921799	0.711	rs2269696	MIMAT0015020	hsa-miR-548v	-4.16	3.86e-05	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17674805	chr8:17681588~17681609:-
HNSC	cis	rs17730929	0.656	rs61224431	MIMAT0005923	hsa-miR-1269a	-4.15	3.89e-05	-0.48	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66290047	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs67668930	MIMAT0005923	hsa-miR-1269a	-4.15	3.89e-05	-0.48	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66290585	chr4:66276890~66276911:+
HNSC	cis	rs7851726	0.69	rs4744386	MIMAT0019208	hsa-miR-3074-5p	-4.15	3.93e-05	-0.19	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94852359	chr9:95086063~95086083:-
HNSC	cis	rs9807989	0.811	rs11688559	MIMAT0019927	hsa-miR-4772-3p	-4.15	3.94e-05	-0.17	-0.19	Asthma;	chr2:102353453	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.811	rs11688568	MIMAT0019927	hsa-miR-4772-3p	-4.15	3.94e-05	-0.17	-0.19	Asthma;	chr2:102353489	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.811	rs11688573	MIMAT0019927	hsa-miR-4772-3p	-4.15	3.94e-05	-0.17	-0.19	Asthma;	chr2:102353511	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.811	rs11689730	MIMAT0019927	hsa-miR-4772-3p	-4.15	3.94e-05	-0.17	-0.19	Asthma;	chr2:102353524	chr2:102432336~102432357:+
HNSC	cis	rs11892454	0.712	rs66524787	MIMAT0026639	hsa-miR-1301-5p	4.15	3.96e-05	0.25	0.19	Heschl's gyrus morphology;	chr2:25725008	chr2:25328689~25328707:-
HNSC	cis	rs7792596	0.565	rs10487252	MIMAT0003328	hsa-miR-653-5p	4.15	3.97e-05	0.25	0.19	Intelligence;	chr7:94351777	chr7:93482823~93482843:-
HNSC	cis	rs7072216	0.621	rs11189595	MIMAT0026738	hsa-miR-1287-3p	4.15	4e-05	0.21	0.19	Metabolite levels;	chr10:98407565	chr10:98395232~98395253:-
HNSC	cis	rs8064299	0.655	rs2305214	MIMAT0017994	hsa-miR-3615	-4.15	4.01e-05	-0.22	-0.19	Monocyte count;	chr17:74772831	chr17:74748663~74748683:+
HNSC	cis	rs10492002	0.522	rs11114765	MIMAT0003287	hsa-miR-618	-4.14	4.13e-05	-0.21	-0.19	Response to antidepressant treatment (citalopram);	chr12:81100495	chr12:80935796~80935818:-
HNSC	cis	rs9527	0.662	rs10883783	MIMAT0005951	hsa-miR-1307-3p	4.14	4.17e-05	0.15	0.19	Arsenic metabolism;	chr10:102831395	chr10:103394301~103394322:-
HNSC	cis	rs17730929	0.722	rs13101728	MIMAT0005923	hsa-miR-1269a	-4.14	4.19e-05	-0.48	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66289547	chr4:66276890~66276911:+
HNSC	cis	rs4921799	0.711	rs35627095	MIMAT0015020	hsa-miR-548v	-4.14	4.19e-05	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17674109	chr8:17681588~17681609:-
HNSC	cis	rs11892454	0.712	rs10181262	MIMAT0026639	hsa-miR-1301-5p	4.13	4.23e-05	0.24	0.19	Heschl's gyrus morphology;	chr2:25726790	chr2:25328689~25328707:-
HNSC	cis	rs7829975	0.714	rs6994038	MIMAT0019728	hsa-miR-4660	4.13	4.25e-05	0.22	0.19	Mood instability;	chr8:8803028	chr8:9048453~9048475:+
HNSC	cis	rs17730929	0.656	rs72641630	MIMAT0005923	hsa-miR-1269a	-4.13	4.29e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66270256	chr4:66276890~66276911:+
HNSC	cis	rs7072216	0.621	rs3750604	MIMAT0026738	hsa-miR-1287-3p	4.13	4.32e-05	0.2	0.19	Metabolite levels;	chr10:98415824	chr10:98395232~98395253:-
HNSC	cis	rs4921799	0.662	rs34105101	MIMAT0015020	hsa-miR-548v	-4.13	4.33e-05	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17675909	chr8:17681588~17681609:-
HNSC	cis	rs17730929	0.722	rs13141988	MIMAT0005923	hsa-miR-1269a	-4.13	4.35e-05	-0.53	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263266	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13122552	MIMAT0005923	hsa-miR-1269a	-4.13	4.35e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267818	chr4:66276890~66276911:+
HNSC	cis	rs2980439	0.846	rs2980437	MIMAT0019728	hsa-miR-4660	-4.12	4.44e-05	-0.21	-0.19	Neuroticism;	chr8:8237241	chr8:9048453~9048475:+
HNSC	cis	rs10492002	0.597	rs12815528	MIMAT0003287	hsa-miR-618	4.12	4.46e-05	0.21	0.19	Response to antidepressant treatment (citalopram);	chr12:81126418	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs10492006	MIMAT0003287	hsa-miR-618	4.12	4.46e-05	0.21	0.19	Response to antidepressant treatment (citalopram);	chr12:81126959	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.596	rs73149275	MIMAT0003287	hsa-miR-618	4.12	4.46e-05	0.21	0.19	Response to antidepressant treatment (citalopram);	chr12:81128275	chr12:80935796~80935818:-
HNSC	cis	rs7829975	0.536	rs2980439	MIMAT0019728	hsa-miR-4660	4.12	4.47e-05	0.22	0.19	Mood instability;	chr8:8237348	chr8:9048453~9048475:+
HNSC	cis	rs10492002	0.636	rs34334790	MIMAT0003287	hsa-miR-618	4.12	4.47e-05	0.21	0.19	Response to antidepressant treatment (citalopram);	chr12:81122814	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs35713634	MIMAT0003287	hsa-miR-618	4.12	4.47e-05	0.21	0.19	Response to antidepressant treatment (citalopram);	chr12:81122818	chr12:80935796~80935818:-
HNSC	cis	rs17730929	0.722	rs10517974	MIMAT0005923	hsa-miR-1269a	4.12	4.5e-05	0.52	0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263513	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs10517970	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263813	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.591	rs72641615	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263912	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.591	rs72641616	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263923	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs17838961	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66264579	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13107500	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66265657	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13139833	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66265742	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13107954	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66265877	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13113516	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266094	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13111921	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266095	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13145575	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266161	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13113894	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266216	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13112620	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266350	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.656	rs13115053	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266794	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13113717	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266893	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13147393	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266945	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13147401	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266956	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13113927	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266990	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13119186	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267060	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13119418	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267145	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs35943387	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267443	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs35358552	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267628	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs34134312	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267647	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs36044013	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267679	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13148783	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267739	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13148985	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66267827	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs114518531	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66269990	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs74482402	MIMAT0005923	hsa-miR-1269a	-4.12	4.5e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66270874	chr4:66276890~66276911:+
HNSC	cis	rs17109512	1	rs7073497	MIMAT0026738	hsa-miR-1287-3p	4.12	4.53e-05	0.38	0.19	Aspartate aminotransferase levels;	chr10:98393931	chr10:98395232~98395253:-
HNSC	cis	rs17109512	1	rs942812	MIMAT0026738	hsa-miR-1287-3p	4.11	4.62e-05	0.38	0.19	Aspartate aminotransferase levels;	chr10:98393907	chr10:98395232~98395253:-
HNSC	cis	rs7594645	0.59	rs10164949	MIMAT0014995	hsa-miR-3130-5p	4.11	4.63e-05	0.28	0.19	Episodic memory;	chr2:206816281	chr2:206783276~206783296:-
HNSC	cis	rs7594645	0.59	rs10164949	MIMAT0014995_1	hsa-miR-3130-5p	4.11	4.63e-05	0.28	0.19	Episodic memory;	chr2:206816281	chr2:206783246~206783266:+
HNSC	cis	rs17730929	0.722	rs72641620	MIMAT0005923	hsa-miR-1269a	-4.11	4.65e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66265652	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs13140283	MIMAT0005923	hsa-miR-1269a	-4.11	4.74e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66265990	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.656	rs13111848	MIMAT0005923	hsa-miR-1269a	-4.11	4.74e-05	-0.52	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66266020	chr4:66276890~66276911:+
HNSC	cis	rs74233809	0.901	rs77335224	MIMAT0022727	hsa-miR-1307-5p	-4.11	4.77e-05	-0.26	-0.19	Birth weight;	chr10:102876519	chr10:103394341~103394361:-
HNSC	cis	rs7649443	0.959	rs12631126	MIMAT0019973	hsa-miR-4797-3p	4.1	4.9e-05	0.24	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197061567	chr3:197293888~197293908:-
HNSC	cis	rs9527	0.662	rs743575	MIMAT0005951	hsa-miR-1307-3p	4.1	4.96e-05	0.15	0.19	Arsenic metabolism;	chr10:102835149	chr10:103394301~103394322:-
HNSC	cis	rs17730929	0.722	rs10517969	MIMAT0005923	hsa-miR-1269a	-4.09	5.05e-05	-0.51	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263852	chr4:66276890~66276911:+
HNSC	cis	rs992157	0.764	rs2015863	MIMAT0000083	hsa-miR-26b-5p	4.09	5.08e-05	0.12	0.19	Colorectal cancer;	chr2:218320438	chr2:218402657~218402677:+
HNSC	cis	rs2980439	0.783	rs2948305	MIMAT0019728	hsa-miR-4660	4.09	5.1e-05	0.22	0.19	Neuroticism;	chr8:8241055	chr8:9048453~9048475:+
HNSC	cis	rs4921799	0.64	rs11203887	MIMAT0015020	hsa-miR-548v	-4.09	5.16e-05	-0.2	-0.19	Lung cancer;Adenocarcinoma;	chr8:17668143	chr8:17681588~17681609:-
HNSC	cis	rs7477	0.647	rs7219687	MIMAT0005942	hsa-miR-1288-3p	-4.09	5.16e-05	-0.21	-0.19	Amyotrophic lateral sclerosis;	chr17:16274073	chr17:16282058~16282078:+
HNSC	cis	rs7649443	0.959	rs59171696	MIMAT0019973	hsa-miR-4797-3p	4.08	5.21e-05	0.24	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197072503	chr3:197293888~197293908:-
HNSC	cis	rs7792596	0.565	rs58784836	MIMAT0003328	hsa-miR-653-5p	-4.08	5.22e-05	-0.25	-0.19	Intelligence;	chr7:94356288	chr7:93482823~93482843:-
HNSC	cis	rs11743006	0.626	rs6859738	MIMAT0004911	hsa-miR-874-3p	4.08	5.23e-05	0.28	0.19	Mathematical ability;	chr5:137164459	chr5:137647582~137647603:-
HNSC	cis	rs7851726	0.668	rs10217143	MIMAT0019208	hsa-miR-3074-5p	-4.08	5.24e-05	-0.18	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94876351	chr9:95086063~95086083:-
HNSC	cis	rs4819852	0.752	rs2012714	MIMAT0000455	hsa-miR-185-5p	-4.08	5.25e-05	-0.19	-0.19	Pulse pressure;	chr22:19990124	chr22:20033153~20033174:+
HNSC	cis	rs74233809	0.605	rs999867	MIMAT0022727	hsa-miR-1307-5p	-4.07	5.46e-05	-0.27	-0.19	Birth weight;	chr10:102744807	chr10:103394341~103394361:-
HNSC	cis	rs4921799	0.64	rs11203895	MIMAT0015020	hsa-miR-548v	-4.07	5.52e-05	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17678085	chr8:17681588~17681609:-
HNSC	cis	rs9527	0.641	rs4919684	MIMAT0005951	hsa-miR-1307-3p	4.07	5.55e-05	0.15	0.19	Arsenic metabolism;	chr10:102827267	chr10:103394301~103394322:-
HNSC	cis	rs9814567	0.762	rs13075332	MIMAT0019958	hsa-miR-4788	-4.07	5.55e-05	-0.24	-0.19	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134610994	chr3:134437836~134437857:+
HNSC	cis	rs9814567	0.762	rs13070654	MIMAT0019958	hsa-miR-4788	-4.07	5.63e-05	-0.24	-0.19	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134500506	chr3:134437836~134437857:+
HNSC	cis	rs9814567	0.762	rs13071852	MIMAT0019958	hsa-miR-4788	-4.07	5.63e-05	-0.24	-0.19	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134504375	chr3:134437836~134437857:+
HNSC	cis	rs17730929	0.722	rs10517975	MIMAT0005923	hsa-miR-1269a	-4.06	5.65e-05	-0.5	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66263472	chr4:66276890~66276911:+
HNSC	cis	rs9527	0.545	rs35756290	MIMAT0005951	hsa-miR-1307-3p	4.06	5.66e-05	0.15	0.19	Arsenic metabolism;	chr10:102825815	chr10:103394301~103394322:-
HNSC	cis	rs1133906	0.808	rs6956577	MIMAT0003328	hsa-miR-653-5p	4.06	5.68e-05	0.27	0.19	Systemic lupus erythematosus and Systemic sclerosis;	chr7:93196638	chr7:93482823~93482843:-
HNSC	cis	rs10021731	0.597	rs11098263	MIMAT0003242	hsa-miR-577	-4.06	5.73e-05	-0.19	-0.19	Optic disc area;	chr4:114686481	chr4:114656774~114656794:+
HNSC	cis	rs74233809	1	rs11191499	MIMAT0005951	hsa-miR-1307-3p	-4.06	5.78e-05	-0.21	-0.19	Birth weight;	chr10:103004514	chr10:103394301~103394322:-
HNSC	cis	rs9527	0.59	rs7894959	MIMAT0022727	hsa-miR-1307-5p	4.06	5.82e-05	0.16	0.19	Arsenic metabolism;	chr10:102996425	chr10:103394341~103394361:-
HNSC	cis	rs7829975	0.56	rs56094035	MIMAT0019728	hsa-miR-4660	-4.06	5.82e-05	-0.23	-0.19	Mood instability;	chr8:8694112	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.539	rs4841012	MIMAT0019728	hsa-miR-4660	-4.06	5.82e-05	-0.23	-0.19	Mood instability;	chr8:8694200	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.56	rs4841013	MIMAT0019728	hsa-miR-4660	-4.06	5.82e-05	-0.23	-0.19	Mood instability;	chr8:8694503	chr8:9048453~9048475:+
HNSC	cis	rs17730929	0.656	rs13106117	MIMAT0005923	hsa-miR-1269a	4.06	5.83e-05	0.51	0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66295169	chr4:66276890~66276911:+
HNSC	cis	rs7072216	0.691	rs10786419	MIMAT0026738	hsa-miR-1287-3p	4.06	5.86e-05	0.18	0.19	Metabolite levels;	chr10:98421183	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.922	rs942813	MIMAT0026738	hsa-miR-1287-3p	4.05	5.91e-05	0.17	0.18	Metabolite levels;	chr10:98393851	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.881	rs7082192	MIMAT0026738	hsa-miR-1287-3p	4.05	5.94e-05	0.17	0.18	Metabolite levels;	chr10:98392087	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.881	rs2147897	MIMAT0026738	hsa-miR-1287-3p	-4.05	5.96e-05	-0.17	-0.18	Metabolite levels;	chr10:98388056	chr10:98395232~98395253:-
HNSC	cis	rs9807989	0.729	rs10170583	MIMAT0019927	hsa-miR-4772-3p	-4.05	6.01e-05	-0.17	-0.18	Asthma;	chr2:102358304	chr2:102432336~102432357:+
HNSC	cis	rs1345301	1	rs10200410	MIMAT0019927	hsa-miR-4772-3p	4.05	6.06e-05	0.17	0.18	Waist circumference;	chr2:102254411	chr2:102432336~102432357:+
HNSC	cis	rs4919687	0.679	rs12762176	MIMAT0022727	hsa-miR-1307-5p	4.05	6.11e-05	0.17	0.18	Colorectal cancer;	chr10:102739475	chr10:103394341~103394361:-
HNSC	cis	rs7851726	0.714	rs1867102	MIMAT0019208	hsa-miR-3074-5p	-4.05	6.12e-05	-0.19	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94865485	chr9:95086063~95086083:-
HNSC	cis	rs10492002	0.678	rs6539561	MIMAT0003287	hsa-miR-618	4.04	6.13e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81182231	chr12:80935796~80935818:-
HNSC	cis	rs9807989	0.839	rs7603730	MIMAT0019927	hsa-miR-4772-3p	-4.04	6.13e-05	-0.17	-0.18	Asthma;	chr2:102357911	chr2:102432336~102432357:+
HNSC	cis	rs7649443	0.917	rs3843374	MIMAT0019973	hsa-miR-4797-3p	4.04	6.15e-05	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197070329	chr3:197293888~197293908:-
HNSC	cis	rs7649443	0.959	rs35260201	MIMAT0019973	hsa-miR-4797-3p	4.04	6.15e-05	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197071830	chr3:197293888~197293908:-
HNSC	cis	rs4819852	0.752	rs2238781	MIMAT0000455	hsa-miR-185-5p	-4.04	6.15e-05	-0.19	-0.18	Pulse pressure;	chr22:19983024	chr22:20033153~20033174:+
HNSC	cis	rs7594645	0.661	rs12463410	MIMAT0014995	hsa-miR-3130-5p	4.04	6.18e-05	0.36	0.18	Episodic memory;	chr2:206850884	chr2:206783276~206783296:-
HNSC	cis	rs7594645	0.661	rs12463410	MIMAT0014995_1	hsa-miR-3130-5p	4.04	6.18e-05	0.36	0.18	Episodic memory;	chr2:206850884	chr2:206783246~206783266:+
HNSC	cis	rs7829975	0.545	rs13261926	MIMAT0019728	hsa-miR-4660	-4.04	6.19e-05	-0.23	-0.18	Mood instability;	chr8:8694100	chr8:9048453~9048475:+
HNSC	cis	rs11743006	0.626	rs1072158	MIMAT0004911	hsa-miR-874-3p	4.04	6.21e-05	0.27	0.18	Mathematical ability;	chr5:137168977	chr5:137647582~137647603:-
HNSC	cis	rs4819852	0.662	rs2073748	MIMAT0000455	hsa-miR-185-5p	-4.04	6.24e-05	-0.19	-0.18	Pulse pressure;	chr22:19981448	chr22:20033153~20033174:+
HNSC	cis	rs10492002	0.678	rs61934661	MIMAT0003287	hsa-miR-618	4.04	6.25e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81197688	chr12:80935796~80935818:-
HNSC	cis	rs17730929	0.656	rs66532564	MIMAT0005923	hsa-miR-1269a	-4.04	6.27e-05	-0.51	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66290392	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs34456439	MIMAT0005923	hsa-miR-1269a	-4.04	6.27e-05	-0.51	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66290938	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs72641646	MIMAT0005923	hsa-miR-1269a	-4.04	6.27e-05	-0.51	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66291437	chr4:66276890~66276911:+
HNSC	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	4.03	6.42e-05	0.26	0.18	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
HNSC	cis	rs17730929	0.722	rs36104639	MIMAT0005923	hsa-miR-1269a	-4.03	6.46e-05	-0.51	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66285403	chr4:66276890~66276911:+
HNSC	cis	rs74233809	0.901	rs7098825	MIMAT0022727	hsa-miR-1307-5p	-4.03	6.5e-05	-0.27	-0.18	Birth weight;	chr10:102868477	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.621	rs3750605	MIMAT0026738	hsa-miR-1287-3p	4.03	6.52e-05	0.2	0.18	Metabolite levels;	chr10:98415897	chr10:98395232~98395253:-
HNSC	cis	rs7792596	0.565	rs10464587	MIMAT0003328	hsa-miR-653-5p	-4.03	6.55e-05	-0.24	-0.18	Intelligence;	chr7:94352727	chr7:93482823~93482843:-
HNSC	cis	rs7072216	0.881	rs2182168	MIMAT0026738	hsa-miR-1287-3p	4.03	6.61e-05	0.17	0.18	Metabolite levels;	chr10:98388596	chr10:98395232~98395253:-
HNSC	cis	rs4919687	0.55	rs12259058	MIMAT0022727	hsa-miR-1307-5p	4.02	6.7e-05	0.16	0.18	Colorectal cancer;	chr10:102725042	chr10:103394341~103394361:-
HNSC	cis	rs4919687	0.55	rs12775883	MIMAT0022727	hsa-miR-1307-5p	4.02	6.7e-05	0.16	0.18	Colorectal cancer;	chr10:102725544	chr10:103394341~103394361:-
HNSC	cis	rs4921799	0.64	rs11203894	MIMAT0015020	hsa-miR-548v	-4.02	6.72e-05	-0.21	-0.18	Lung cancer;Adenocarcinoma;	chr8:17677953	chr8:17681588~17681609:-
HNSC	cis	rs7851726	0.652	rs7847277	MIMAT0019208	hsa-miR-3074-5p	-4.02	6.74e-05	-0.18	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94851146	chr9:95086063~95086083:-
HNSC	cis	rs10492002	0.678	rs7135822	MIMAT0003287	hsa-miR-618	-4.02	6.76e-05	-0.21	-0.18	Response to antidepressant treatment (citalopram);	chr12:81174094	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs7960221	MIMAT0003287	hsa-miR-618	4.02	6.76e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81142041	chr12:80935796~80935818:-
HNSC	cis	rs953492	0.831	rs2783966	MIMAT0019761	hsa-miR-4677-3p	-4.02	6.77e-05	-0.18	-0.18	Diastolic blood pressure;	chr1:243336645	chr1:243346225~243346246:+
HNSC	cis	rs4921799	0.711	rs34097123	MIMAT0015020	hsa-miR-548v	-4.02	6.81e-05	-0.21	-0.18	Lung cancer;Adenocarcinoma;	chr8:17673786	chr8:17681588~17681609:-
HNSC	cis	rs9527	0.615	rs9733635	MIMAT0022727	hsa-miR-1307-5p	4.01	6.94e-05	0.16	0.18	Arsenic metabolism;	chr10:102952183	chr10:103394341~103394361:-
HNSC	cis	rs9814567	0.762	rs13067564	MIMAT0019958	hsa-miR-4788	-4.01	6.95e-05	-0.24	-0.18	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134491114	chr3:134437836~134437857:+
HNSC	cis	rs10492002	0.636	rs11612380	MIMAT0003287	hsa-miR-618	4.01	7.01e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81141526	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.636	rs35069036	MIMAT0003287	hsa-miR-618	4.01	7.01e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81141696	chr12:80935796~80935818:-
HNSC	cis	rs7649443	0.959	rs13070996	MIMAT0019973	hsa-miR-4797-3p	4.01	7.02e-05	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197179203	chr3:197293888~197293908:-
HNSC	cis	rs9527	0.545	rs7894588	MIMAT0022727	hsa-miR-1307-5p	4.01	7.04e-05	0.16	0.18	Arsenic metabolism;	chr10:102996273	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	4.01	7.09e-05	0.18	0.18	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.652	rs11189600	MIMAT0026738	hsa-miR-1287-3p	-4.01	7.17e-05	-0.18	-0.18	Metabolite levels;	chr10:98419517	chr10:98395232~98395253:-
HNSC	cis	rs250677	1	rs40525	MIMAT0003249	hsa-miR-584-5p	-4.01	7.18e-05	-0.18	-0.18	Breast cancer;	chr5:149053369	chr5:149062373~149062394:-
HNSC	cis	rs11892454	0.565	rs6758088	MIMAT0026639	hsa-miR-1301-5p	-4.01	7.22e-05	-0.23	-0.18	Heschl's gyrus morphology;	chr2:25813167	chr2:25328689~25328707:-
HNSC	cis	rs992157	0.73	rs2382828	MIMAT0000083	hsa-miR-26b-5p	-4	7.22e-05	-0.12	-0.18	Colorectal cancer;	chr2:218319769	chr2:218402657~218402677:+
HNSC	cis	rs992157	0.672	rs2382829	MIMAT0000083	hsa-miR-26b-5p	-4	7.22e-05	-0.12	-0.18	Colorectal cancer;	chr2:218319894	chr2:218402657~218402677:+
HNSC	cis	rs992157	0.764	rs2891079	MIMAT0000083	hsa-miR-26b-5p	-4	7.22e-05	-0.12	-0.18	Colorectal cancer;	chr2:218319968	chr2:218402657~218402677:+
HNSC	cis	rs992157	0.73	rs4280446	MIMAT0000083	hsa-miR-26b-5p	-4	7.22e-05	-0.12	-0.18	Colorectal cancer;	chr2:218319998	chr2:218402657~218402677:+
HNSC	cis	rs992157	0.764	rs4552182	MIMAT0000083	hsa-miR-26b-5p	-4	7.22e-05	-0.12	-0.18	Colorectal cancer;	chr2:218320149	chr2:218402657~218402677:+
HNSC	cis	rs992157	0.764	rs4423579	MIMAT0000083	hsa-miR-26b-5p	-4	7.27e-05	-0.12	-0.18	Colorectal cancer;	chr2:218320310	chr2:218402657~218402677:+
HNSC	cis	rs7072216	0.881	rs1079179	MIMAT0026738	hsa-miR-1287-3p	4	7.31e-05	0.17	0.18	Metabolite levels;	chr10:98389589	chr10:98395232~98395253:-
HNSC	cis	rs7829975	0.714	rs60315134	MIMAT0019728	hsa-miR-4660	4	7.37e-05	0.21	0.18	Mood instability;	chr8:8813089	chr8:9048453~9048475:+
HNSC	cis	rs10492002	0.563	rs4240725	MIMAT0003287	hsa-miR-618	-4	7.39e-05	-0.21	-0.18	Response to antidepressant treatment (citalopram);	chr12:81121267	chr12:80935796~80935818:-
HNSC	cis	rs74233809	1	rs3740390	MIMAT0005951	hsa-miR-1307-3p	-4	7.49e-05	-0.21	-0.18	Birth weight;	chr10:102878723	chr10:103394301~103394322:-
HNSC	cis	rs1345301	0.905	rs2310243	MIMAT0019927	hsa-miR-4772-3p	3.99	7.53e-05	0.17	0.18	Waist circumference;	chr2:102261100	chr2:102432336~102432357:+
HNSC	cis	rs1588265	0.536	rs11739760	MIMAT0003247	hsa-miR-582-5p	-3.99	7.53e-05	-0.22	-0.18	Asthma;	chr5:60257915	chr5:59703666~59703688:-
HNSC	cis	rs7072216	0.881	rs7916469	MIMAT0026738	hsa-miR-1287-3p	3.99	7.57e-05	0.17	0.18	Metabolite levels;	chr10:98388896	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.881	rs755126	MIMAT0026738	hsa-miR-1287-3p	3.99	7.57e-05	0.17	0.18	Metabolite levels;	chr10:98389194	chr10:98395232~98395253:-
HNSC	cis	rs7477	0.647	rs3112511	MIMAT0005942	hsa-miR-1288-3p	-3.99	7.63e-05	-0.21	-0.18	Amyotrophic lateral sclerosis;	chr17:16304212	chr17:16282058~16282078:+
HNSC	cis	rs17001239	0.85	rs73158419	MIMAT0004658	hsa-miR-155-3p	3.99	7.64e-05	0.33	0.18	Cognitive performance;	chr21:25591882	chr21:25574022~25574043:+
HNSC	cis	rs1957429	0.808	rs4902327	MIMAT0004808	hsa-miR-625-3p	3.99	7.67e-05	0.29	0.18	Pediatric areal bone mineral density (radius);	chr14:64878085	chr14:65471153~65471174:+
HNSC	cis	rs7829975	0.714	rs4840362	MIMAT0019728	hsa-miR-4660	-3.99	7.69e-05	-0.21	-0.18	Mood instability;	chr8:8812572	chr8:9048453~9048475:+
HNSC	cis	rs7851726	0.565	rs10821413	MIMAT0019208	hsa-miR-3074-5p	-3.99	7.69e-05	-0.18	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94907034	chr9:95086063~95086083:-
HNSC	cis	rs4553443	1	rs7303230	MIMAT0000226	hsa-miR-196a-5p	3.99	7.77e-05	0.24	0.18	Cancer;	chr12:54934046	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs7303230	MIMAT0000226_1	hsa-miR-196a-5p	3.99	7.77e-05	0.24	0.18	Cancer;	chr12:54934046	chr17:48632532~48632553:-
HNSC	cis	rs4851551	0.543	rs35918372	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.8e-05	-0.33	-0.18	Blood protein levels;	chr2:102202803	chr2:102432336~102432357:+
HNSC	cis	rs17001239	0.85	rs12482056	MIMAT0004658	hsa-miR-155-3p	3.99	7.8e-05	0.33	0.18	Cognitive performance;	chr21:25585437	chr21:25574022~25574043:+
HNSC	cis	rs1345301	1	rs1420093	MIMAT0019927	hsa-miR-4772-3p	3.98	7.86e-05	0.17	0.18	Waist circumference;	chr2:102253998	chr2:102432336~102432357:+
HNSC	cis	rs8064299	0.655	rs734232	MIMAT0017994	hsa-miR-3615	-3.98	7.9e-05	-0.21	-0.18	Monocyte count;	chr17:74769592	chr17:74748663~74748683:+
HNSC	cis	rs17730929	0.722	rs72641644	MIMAT0005923	hsa-miR-1269a	-3.98	7.9e-05	-0.51	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66291307	chr4:66276890~66276911:+
HNSC	cis	rs10492002	0.636	rs2107415	MIMAT0003287	hsa-miR-618	3.98	7.92e-05	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81139299	chr12:80935796~80935818:-
HNSC	cis	rs8074700	0.501	rs56670520	MIMAT0004555	hsa-miR-10a-3p	3.98	7.92e-05	0.22	0.18	Body mass index in non-asthmatics;	chr17:48668416	chr17:48579864~48579885:-
HNSC	cis	rs2277912	0.865	rs111954117	MIMAT0014995	hsa-miR-3130-5p	3.98	8.01e-05	0.21	0.18	Height;	chr2:206793017	chr2:206783276~206783296:-
HNSC	cis	rs2277912	0.865	rs111954117	MIMAT0014995_1	hsa-miR-3130-5p	3.98	8.01e-05	0.21	0.18	Height;	chr2:206793017	chr2:206783246~206783266:+
HNSC	cis	rs9527	1	rs9527	MIMAT0022727	hsa-miR-1307-5p	3.97	8.16e-05	0.18	0.18	Arsenic metabolism;	chr10:102863821	chr10:103394341~103394361:-
HNSC	cis	rs79387448	0.655	rs3771167	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.25e-05	-0.25	-0.18	Gut microbiota (bacterial taxa);	chr2:102369728	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.881	rs10883084	MIMAT0026738	hsa-miR-1287-3p	3.97	8.32e-05	0.17	0.18	Metabolite levels;	chr10:98391432	chr10:98395232~98395253:-
HNSC	cis	rs17730929	0.722	rs35630788	MIMAT0005923	hsa-miR-1269a	-3.97	8.35e-05	-0.51	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66298031	chr4:66276890~66276911:+
HNSC	cis	rs4819852	0.958	rs2238787	MIMAT0000455	hsa-miR-185-5p	-3.97	8.37e-05	-0.19	-0.18	Pulse pressure;	chr22:19988883	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.958	rs9606204	MIMAT0000455	hsa-miR-185-5p	-3.97	8.37e-05	-0.19	-0.18	Pulse pressure;	chr22:19988987	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.958	rs756653	MIMAT0000455	hsa-miR-185-5p	-3.97	8.37e-05	-0.19	-0.18	Pulse pressure;	chr22:19989322	chr22:20033153~20033174:+
HNSC	cis	rs9814567	0.762	rs13079012	MIMAT0019958	hsa-miR-4788	-3.97	8.38e-05	-0.23	-0.18	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134528864	chr3:134437836~134437857:+
HNSC	cis	rs7072216	0.922	rs10786415	MIMAT0026738	hsa-miR-1287-3p	3.97	8.47e-05	0.17	0.18	Metabolite levels;	chr10:98391509	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.922	rs942814	MIMAT0026738	hsa-miR-1287-3p	3.97	8.47e-05	0.17	0.18	Metabolite levels;	chr10:98391548	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.922	rs6584191	MIMAT0026738	hsa-miR-1287-3p	3.97	8.47e-05	0.17	0.18	Metabolite levels;	chr10:98392298	chr10:98395232~98395253:-
HNSC	cis	rs953492	0.831	rs2783964	MIMAT0019761	hsa-miR-4677-3p	-3.96	8.51e-05	-0.18	-0.18	Diastolic blood pressure;	chr1:243337362	chr1:243346225~243346246:+
HNSC	cis	rs9527	0.569	rs10883801	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102918130	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs2152915	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102931975	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs3897401	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102936622	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs36045108	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102938172	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.568	rs12772775	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102943242	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs10883804	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102946763	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.64	rs7089061	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102963258	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs7089065	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102963265	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.569	rs10786730	MIMAT0022727	hsa-miR-1307-5p	3.96	8.52e-05	0.16	0.18	Arsenic metabolism;	chr10:102964443	chr10:103394341~103394361:-
HNSC	cis	rs9824310	1	rs7617202	MIMAT0000417	hsa-miR-15b-5p	3.96	8.52e-05	0.13	0.18	Iron status biomarkers (total iron binding capacity);	chr3:159480827	chr3:160404607~160404628:+
HNSC	cis	rs4921799	0.711	rs28660237	MIMAT0015020	hsa-miR-548v	-3.96	8.55e-05	-0.2	-0.18	Lung cancer;Adenocarcinoma;	chr8:17674217	chr8:17681588~17681609:-
HNSC	cis	rs7072216	0.922	rs7097824	MIMAT0026738	hsa-miR-1287-3p	3.96	8.59e-05	0.17	0.18	Metabolite levels;	chr10:98392042	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.881	rs6584192	MIMAT0026738	hsa-miR-1287-3p	3.96	8.59e-05	0.17	0.18	Metabolite levels;	chr10:98392616	chr10:98395232~98395253:-
HNSC	cis	rs8064299	0.597	rs3785539	MIMAT0017994	hsa-miR-3615	-3.96	8.66e-05	-0.21	-0.18	Monocyte count;	chr17:74778960	chr17:74748663~74748683:+
HNSC	cis	rs1345301	1	rs12470560	MIMAT0019927	hsa-miR-4772-3p	3.96	8.68e-05	0.17	0.18	Waist circumference;	chr2:102252380	chr2:102432336~102432357:+
HNSC	cis	rs1345301	1	rs12474199	MIMAT0019927	hsa-miR-4772-3p	3.96	8.68e-05	0.17	0.18	Waist circumference;	chr2:102252520	chr2:102432336~102432357:+
HNSC	cis	rs74233809	0.636	rs284861	MIMAT0022727	hsa-miR-1307-5p	3.96	8.68e-05	0.23	0.18	Birth weight;	chr10:102812519	chr10:103394341~103394361:-
HNSC	cis	rs10492002	0.522	rs12311688	MIMAT0003287	hsa-miR-618	3.96	8.73e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81239725	chr12:80935796~80935818:-
HNSC	cis	rs7829975	0.714	rs59046059	MIMAT0019728	hsa-miR-4660	3.96	8.73e-05	0.21	0.18	Mood instability;	chr8:8813226	chr8:9048453~9048475:+
HNSC	cis	rs9527	0.615	rs10883800	MIMAT0022727	hsa-miR-1307-5p	3.96	8.77e-05	0.16	0.18	Arsenic metabolism;	chr10:102911455	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs7073295	MIMAT0022727	hsa-miR-1307-5p	3.96	8.77e-05	0.16	0.18	Arsenic metabolism;	chr10:102912476	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.881	rs2274247	MIMAT0026738	hsa-miR-1287-3p	3.96	8.77e-05	0.17	0.18	Metabolite levels;	chr10:98390391	chr10:98395232~98395253:-
HNSC	cis	rs1345301	1	rs1345301	MIMAT0019927	hsa-miR-4772-3p	3.96	8.78e-05	0.17	0.18	Waist circumference;	chr2:102259127	chr2:102432336~102432357:+
HNSC	cis	rs7851726	1	rs7866848	MIMAT0019208	hsa-miR-3074-5p	-3.96	8.78e-05	-0.18	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94743326	chr9:95086063~95086083:-
HNSC	cis	rs1345301	1	rs11686567	MIMAT0019927	hsa-miR-4772-3p	3.95	8.85e-05	0.17	0.18	Waist circumference;	chr2:102260149	chr2:102432336~102432357:+
HNSC	cis	rs1345301	0.935	rs11691721	MIMAT0019927	hsa-miR-4772-3p	3.95	8.85e-05	0.17	0.18	Waist circumference;	chr2:102260219	chr2:102432336~102432357:+
HNSC	cis	rs7829975	0.714	rs12544992	MIMAT0019728	hsa-miR-4660	3.95	8.91e-05	0.21	0.18	Mood instability;	chr8:8804171	chr8:9048453~9048475:+
HNSC	cis	rs1345301	1	rs1345302	MIMAT0019927	hsa-miR-4772-3p	3.95	8.96e-05	0.17	0.18	Waist circumference;	chr2:102256909	chr2:102432336~102432357:+
HNSC	cis	rs1345301	1	rs13431601	MIMAT0019927	hsa-miR-4772-3p	3.95	8.96e-05	0.17	0.18	Waist circumference;	chr2:102257253	chr2:102432336~102432357:+
HNSC	cis	rs7649443	0.959	rs2341225	MIMAT0019973	hsa-miR-4797-3p	3.95	8.96e-05	0.23	0.18	Nonsyndromic cleft lip with cleft palate;	chr3:197098527	chr3:197293888~197293908:-
HNSC	cis	rs11892454	0.565	rs10182811	MIMAT0026639	hsa-miR-1301-5p	3.95	8.98e-05	0.23	0.18	Heschl's gyrus morphology;	chr2:25833004	chr2:25328689~25328707:-
HNSC	cis	rs17730929	0.722	rs10517972	MIMAT0005923	hsa-miR-1269a	-3.95	9.05e-05	-0.49	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66263635	chr4:66276890~66276911:+
HNSC	cis	rs9807989	0.839	rs4988955	MIMAT0019927	hsa-miR-4772-3p	-3.95	9.16e-05	-0.16	-0.18	Asthma;	chr2:102351468	chr2:102432336~102432357:+
HNSC	cis	rs10492002	0.5	rs1921059	MIMAT0003287	hsa-miR-618	3.95	9.17e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81214788	chr12:80935796~80935818:-
HNSC	cis	rs1345301	1	rs13405355	MIMAT0019927	hsa-miR-4772-3p	3.94	9.34e-05	0.16	0.18	Waist circumference;	chr2:102261746	chr2:102432336~102432357:+
HNSC	cis	rs7072216	1	rs7072216	MIMAT0026738	hsa-miR-1287-3p	3.94	9.37e-05	0.17	0.18	Metabolite levels;	chr10:98397096	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs74444347	MIMAT0005951	hsa-miR-1307-3p	-3.94	9.41e-05	-0.21	-0.18	Birth weight;	chr10:103009518	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs12221335	MIMAT0005951	hsa-miR-1307-3p	-3.94	9.41e-05	-0.21	-0.18	Birth weight;	chr10:103009635	chr10:103394301~103394322:-
HNSC	cis	rs7829975	0.714	rs7823757	MIMAT0019728	hsa-miR-4660	3.94	9.45e-05	0.2	0.18	Mood instability;	chr8:8812667	chr8:9048453~9048475:+
HNSC	cis	rs9299	0.502	rs4793944	MIMAT0000253	hsa-miR-10a-5p	3.94	9.46e-05	0.22	0.18	Obesity;	chr17:48589942	chr17:48579904~48579926:-
HNSC	cis	rs9807989	0.801	rs10173193	MIMAT0019927	hsa-miR-4772-3p	-3.94	9.53e-05	-0.16	-0.18	Asthma;	chr2:102358590	chr2:102432336~102432357:+
HNSC	cis	rs992157	0.764	rs62183964	MIMAT0000083	hsa-miR-26b-5p	-3.93	9.76e-05	-0.11	-0.18	Colorectal cancer;	chr2:218321869	chr2:218402657~218402677:+
HNSC	cis	rs4553443	1	rs4553443	MIMAT0000226	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54929761	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs4553443	MIMAT0000226_1	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54929761	chr17:48632532~48632553:-
HNSC	cis	rs4553443	1	rs57844178	MIMAT0000226	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54930442	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs57844178	MIMAT0000226_1	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54930442	chr17:48632532~48632553:-
HNSC	cis	rs4553443	1	rs7977569	MIMAT0000226	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54931261	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs7977569	MIMAT0000226_1	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54931261	chr17:48632532~48632553:-
HNSC	cis	rs4553443	1	rs58728216	MIMAT0000226	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54931848	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs58728216	MIMAT0000226_1	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54931848	chr17:48632532~48632553:-
HNSC	cis	rs4553443	1	rs12371306	MIMAT0000226	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54932000	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs12371306	MIMAT0000226_1	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54932000	chr17:48632532~48632553:-
HNSC	cis	rs4553443	1	rs2101438	MIMAT0000226	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54932981	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs2101438	MIMAT0000226_1	hsa-miR-196a-5p	-3.93	9.78e-05	-0.24	-0.18	Cancer;	chr12:54932981	chr17:48632532~48632553:-
HNSC	cis	rs7829975	0.714	rs11784052	MIMAT0019728	hsa-miR-4660	3.93	9.79e-05	0.2	0.18	Mood instability;	chr8:8814452	chr8:9048453~9048475:+
HNSC	cis	rs284844	0.748	rs2482507	MIMAT0022727	hsa-miR-1307-5p	3.93	9.79e-05	0.21	0.18	Mean arterial pressure (long-term average);Diastolic blood pressure (long-term average);Systolic blood pressure (long-term average);	chr10:102801599	chr10:103394341~103394361:-
HNSC	cis	rs12368653	0.582	rs2307095	MIMAT0005582	hsa-miR-1228-5p	3.93	9.82e-05	0.22	0.18	Multiple sclerosis;	chr12:57632218	chr12:57194504~57194524:+
HNSC	cis	rs10492002	0.636	rs11610708	MIMAT0003287	hsa-miR-618	3.93	9.87e-05	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81138869	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.678	rs10506274	MIMAT0003287	hsa-miR-618	3.93	9.93e-05	0.21	0.18	Response to antidepressant treatment (citalopram);	chr12:81207685	chr12:80935796~80935818:-
HNSC	cis	rs9527	0.615	rs17725614	MIMAT0022727	hsa-miR-1307-5p	3.93	9.95e-05	0.16	0.18	Arsenic metabolism;	chr10:102925736	chr10:103394341~103394361:-
HNSC	cis	rs250677	0.687	rs40523	MIMAT0003249	hsa-miR-584-5p	-3.93	9.97e-05	-0.18	-0.18	Breast cancer;	chr5:149064623	chr5:149062373~149062394:-
HNSC	cis	rs17730929	0.722	rs35096368	MIMAT0005923	hsa-miR-1269a	-3.92	1e-04	-0.49	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66290884	chr4:66276890~66276911:+
HNSC	cis	rs79387448	0.701	rs11465586	MIMAT0019927	hsa-miR-4772-3p	-3.92	0.000101	-0.24	-0.18	Gut microbiota (bacterial taxa);	chr2:102366249	chr2:102432336~102432357:+
HNSC	cis	rs7594645	0.59	rs7605735	MIMAT0014995	hsa-miR-3130-5p	3.92	0.000101	0.28	0.18	Episodic memory;	chr2:206820890	chr2:206783276~206783296:-
HNSC	cis	rs7594645	0.59	rs7605735	MIMAT0014995_1	hsa-miR-3130-5p	3.92	0.000101	0.28	0.18	Episodic memory;	chr2:206820890	chr2:206783246~206783266:+
HNSC	cis	rs4921799	0.711	rs36001975	MIMAT0015020	hsa-miR-548v	-3.92	0.000102	-0.21	-0.18	Lung cancer;Adenocarcinoma;	chr8:17675856	chr8:17681588~17681609:-
HNSC	cis	rs9814567	0.762	rs13071253	MIMAT0019958	hsa-miR-4788	-3.92	0.000104	-0.22	-0.18	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134597811	chr3:134437836~134437857:+
HNSC	cis	rs10492002	0.678	rs11114788	MIMAT0003287	hsa-miR-618	3.91	0.000104	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81205782	chr12:80935796~80935818:-
HNSC	cis	rs9527	0.59	rs7898770	MIMAT0022727	hsa-miR-1307-5p	-3.91	0.000105	-0.16	-0.18	Arsenic metabolism;	chr10:102996879	chr10:103394341~103394361:-
HNSC	cis	rs4819852	0.958	rs758374	MIMAT0000455	hsa-miR-185-5p	-3.91	0.000105	-0.19	-0.18	Pulse pressure;	chr22:19984029	chr22:20033153~20033174:+
HNSC	cis	rs8064299	0.597	rs6501736	MIMAT0017994	hsa-miR-3615	-3.91	0.000106	-0.21	-0.18	Monocyte count;	chr17:74779219	chr17:74748663~74748683:+
HNSC	cis	rs7104764	0.957	rs3817629	MIMAT0026475	hsa-miR-210-5p	3.91	0.000106	0.26	0.18	Menarche (age at onset);	chr11:237312	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs10902110	MIMAT0026475	hsa-miR-210-5p	3.91	0.000106	0.26	0.18	Menarche (age at onset);	chr11:237648	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs7481993	MIMAT0026475	hsa-miR-210-5p	3.91	0.000106	0.26	0.18	Menarche (age at onset);	chr11:237875	chr11:568150~568171:-
HNSC	cis	rs9807989	0.801	rs10176664	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000106	-0.16	-0.18	Asthma;	chr2:102359712	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs6543123	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000106	-0.16	-0.18	Asthma;	chr2:102360736	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.801	rs11123925	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000106	-0.16	-0.18	Asthma;	chr2:102361051	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs10204837	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000106	-0.16	-0.18	Asthma;	chr2:102361270	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs3755276	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000106	-0.16	-0.18	Asthma;	chr2:102361999	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs9308857	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000106	-0.16	-0.18	Asthma;	chr2:102363164	chr2:102432336~102432357:+
HNSC	cis	rs74233809	0.591	rs284853	MIMAT0022727	hsa-miR-1307-5p	3.91	0.000107	0.23	0.18	Birth weight;	chr10:102814885	chr10:103394341~103394361:-
HNSC	cis	rs7829975	0.711	rs12682352	MIMAT0019728	hsa-miR-4660	3.91	0.000107	0.21	0.18	Mood instability;	chr8:8788736	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.881	rs4345897	MIMAT0026738	hsa-miR-1287-3p	3.91	0.000108	0.17	0.18	Metabolite levels;	chr10:98387303	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.881	rs2182169	MIMAT0026738	hsa-miR-1287-3p	3.91	0.000108	0.17	0.18	Metabolite levels;	chr10:98388247	chr10:98395232~98395253:-
HNSC	cis	rs17730929	0.858	rs7654127	MIMAT0005923	hsa-miR-1269a	-3.9	0.000108	-0.47	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66469633	chr4:66276890~66276911:+
HNSC	cis	rs7829975	0.742	rs7832968	MIMAT0019728	hsa-miR-4660	3.9	0.000108	0.21	0.18	Mood instability;	chr8:8795379	chr8:9048453~9048475:+
HNSC	cis	rs4819852	0.958	rs2240716	MIMAT0000455	hsa-miR-185-5p	-3.9	0.000109	-0.19	-0.18	Pulse pressure;	chr22:19982173	chr22:20033153~20033174:+
HNSC	cis	rs9807989	0.839	rs1420099	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.16	-0.18	Asthma;	chr2:102364083	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs10182710	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.16	-0.18	Asthma;	chr2:102364846	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs13392100	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.16	-0.18	Asthma;	chr2:102365634	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.592	rs6728945	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000109	-0.24	-0.18	Gut microbiota (bacterial taxa);	chr2:102370011	chr2:102432336~102432357:+
HNSC	cis	rs953492	0.863	rs2802722	MIMAT0019761	hsa-miR-4677-3p	-3.9	0.000111	-0.17	-0.18	Diastolic blood pressure;	chr1:243335231	chr1:243346225~243346246:+
HNSC	cis	rs10492002	0.638	rs12816473	MIMAT0003287	hsa-miR-618	3.9	0.000112	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81210642	chr12:80935796~80935818:-
HNSC	cis	rs7072216	0.77	rs1061123	MIMAT0026738	hsa-miR-1287-3p	3.9	0.000112	0.17	0.18	Metabolite levels;	chr10:98417240	chr10:98395232~98395253:-
HNSC	cis	rs79387448	0.808	rs77518775	MIMAT0019926	hsa-miR-4772-5p	-3.89	0.000114	-0.27	-0.18	Gut microbiota (bacterial taxa);	chr2:102621183	chr2:102432300~102432321:+
HNSC	cis	rs12134133	1	rs2802235	MIMAT0004673	hsa-miR-29c-5p	-3.89	0.000114	-0.13	-0.18	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207298454	chr1:207801903~207801924:-
HNSC	cis	rs7072216	0.922	rs4539242	MIMAT0026738	hsa-miR-1287-3p	3.89	0.000114	0.17	0.18	Metabolite levels;	chr10:98388301	chr10:98395232~98395253:-
HNSC	cis	rs7072216	0.881	rs2147896	MIMAT0026738	hsa-miR-1287-3p	3.89	0.000114	0.17	0.18	Metabolite levels;	chr10:98388419	chr10:98395232~98395253:-
HNSC	cis	rs4819852	0.958	rs12628032	MIMAT0000455	hsa-miR-185-5p	-3.89	0.000114	-0.19	-0.18	Pulse pressure;	chr22:19980457	chr22:20033153~20033174:+
HNSC	cis	rs4921799	0.711	rs2301542	MIMAT0015020	hsa-miR-548v	-3.89	0.000114	-0.2	-0.18	Lung cancer;Adenocarcinoma;	chr8:17676124	chr8:17681588~17681609:-
HNSC	cis	rs7851726	0.624	rs12347649	MIMAT0019208	hsa-miR-3074-5p	-3.89	0.000114	-0.17	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94901286	chr9:95086063~95086083:-
HNSC	cis	rs10492002	0.522	rs12305230	MIMAT0003287	hsa-miR-618	-3.89	0.000115	-0.2	-0.18	Response to antidepressant treatment (citalopram);	chr12:81233061	chr12:80935796~80935818:-
HNSC	cis	rs75358501	0.551	rs16838710	MIMAT0014995	hsa-miR-3130-5p	3.89	0.000115	0.19	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.551	rs16838710	MIMAT0014995_1	hsa-miR-3130-5p	3.89	0.000115	0.19	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783246~206783266:+
HNSC	cis	rs2980439	0.818	rs2948300	MIMAT0019728	hsa-miR-4660	3.89	0.000116	0.21	0.18	Neuroticism;	chr8:8248986	chr8:9048453~9048475:+
HNSC	cis	rs9814567	1	rs9841212	MIMAT0019958	hsa-miR-4788	3.89	0.000116	0.21	0.18	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134473096	chr3:134437836~134437857:+
HNSC	cis	rs4819852	0.958	rs2238786	MIMAT0000455	hsa-miR-185-5p	-3.89	0.000117	-0.19	-0.18	Pulse pressure;	chr22:19987921	chr22:20033153~20033174:+
HNSC	cis	rs9527	0.662	rs10786714	MIMAT0005951	hsa-miR-1307-3p	3.88	0.000118	0.14	0.18	Arsenic metabolism;	chr10:102838849	chr10:103394301~103394322:-
HNSC	cis	rs1133906	0.708	rs2157743	MIMAT0003328	hsa-miR-653-5p	3.88	0.000118	0.26	0.18	Systemic lupus erythematosus and Systemic sclerosis;	chr7:93138189	chr7:93482823~93482843:-
HNSC	cis	rs7072216	0.922	rs2296438	MIMAT0026738	hsa-miR-1287-3p	3.88	0.000119	0.17	0.18	Metabolite levels;	chr10:98387138	chr10:98395232~98395253:-
HNSC	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	3.88	0.000119	0.22	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	3.88	0.000119	0.22	0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
HNSC	cis	rs1014286	0.706	rs10171438	MIMAT0019927	hsa-miR-4772-3p	-3.88	0.00012	-0.16	-0.18	Serum protein levels (sST2);	chr2:102558917	chr2:102432336~102432357:+
HNSC	cis	rs7829975	0.511	rs2955578	MIMAT0019728	hsa-miR-4660	3.88	0.00012	0.21	0.18	Mood instability;	chr8:8279561	chr8:9048453~9048475:+
HNSC	cis	rs74233809	1	rs11191454	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.00012	-0.21	-0.18	Birth weight;	chr10:102900247	chr10:103394301~103394322:-
HNSC	cis	rs7851726	0.738	rs4744370	MIMAT0019208	hsa-miR-3074-5p	3.88	0.00012	0.17	0.18	Urinary albumin-to-creatinine ratio;	chr9:94715511	chr9:95086063~95086083:-
HNSC	cis	rs11892454	0.712	rs934073	MIMAT0026639	hsa-miR-1301-5p	3.88	0.00012	0.23	0.18	Heschl's gyrus morphology;	chr2:25714296	chr2:25328689~25328707:-
HNSC	cis	rs10492002	0.653	rs58316903	MIMAT0003287	hsa-miR-618	3.88	0.000121	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81202909	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.678	rs11835638	MIMAT0003287	hsa-miR-618	3.88	0.000121	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81206227	chr12:80935796~80935818:-
HNSC	cis	rs1133906	0.614	rs4729076	MIMAT0003328	hsa-miR-653-5p	3.88	0.000122	0.28	0.18	Systemic lupus erythematosus and Systemic sclerosis;	chr7:93228492	chr7:93482823~93482843:-
HNSC	cis	rs9987353	0.566	rs34491841	MIMAT0019728	hsa-miR-4660	-3.87	0.000124	-0.22	-0.18	Recombination measurement;	chr8:9208000	chr8:9048453~9048475:+
HNSC	cis	rs250677	0.687	rs36048	MIMAT0003249	hsa-miR-584-5p	3.87	0.000126	0.18	0.18	Breast cancer;	chr5:149062150	chr5:149062373~149062394:-
HNSC	cis	rs9807989	0.507	rs1420097	MIMAT0019927	hsa-miR-4772-3p	3.86	0.000127	0.15	0.18	Asthma;	chr2:102392894	chr2:102432336~102432357:+
HNSC	cis	rs11892454	0.674	rs10439496	MIMAT0026639	hsa-miR-1301-5p	3.86	0.000128	0.22	0.18	Heschl's gyrus morphology;	chr2:25716230	chr2:25328689~25328707:-
HNSC	cis	rs74233809	1	rs11191502	MIMAT0005951	hsa-miR-1307-3p	-3.86	0.000128	-0.21	-0.18	Birth weight;	chr10:103005737	chr10:103394301~103394322:-
HNSC	cis	rs2277912	0.762	rs72960734	MIMAT0014995	hsa-miR-3130-5p	3.86	0.000128	0.21	0.18	Height;	chr2:206713279	chr2:206783276~206783296:-
HNSC	cis	rs2277912	0.762	rs72960734	MIMAT0014995_1	hsa-miR-3130-5p	3.86	0.000128	0.21	0.18	Height;	chr2:206713279	chr2:206783246~206783266:+
HNSC	cis	rs9527	0.615	rs7917295	MIMAT0022727	hsa-miR-1307-5p	3.86	0.000129	0.16	0.18	Arsenic metabolism;	chr10:102941430	chr10:103394341~103394361:-
HNSC	cis	rs250677	1	rs250677	MIMAT0003249	hsa-miR-584-5p	3.86	0.000129	0.17	0.18	Breast cancer;	chr5:149053986	chr5:149062373~149062394:-
HNSC	cis	rs10492002	0.52	rs2701791	MIMAT0003287	hsa-miR-618	3.86	0.00013	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81133821	chr12:80935796~80935818:-
HNSC	cis	rs9527	0.615	rs11191485	MIMAT0022727	hsa-miR-1307-5p	3.86	0.00013	0.16	0.18	Arsenic metabolism;	chr10:102970059	chr10:103394341~103394361:-
HNSC	cis	rs2980439	0.818	rs2948294	MIMAT0019728	hsa-miR-4660	3.86	0.00013	0.2	0.18	Neuroticism;	chr8:8237439	chr8:9048453~9048475:+
HNSC	cis	rs250677	1	rs36080	MIMAT0003249	hsa-miR-584-5p	3.86	0.000132	0.17	0.18	Breast cancer;	chr5:149050888	chr5:149062373~149062394:-
HNSC	cis	rs9527	0.615	rs12248123	MIMAT0022727	hsa-miR-1307-5p	3.85	0.000133	0.15	0.18	Arsenic metabolism;	chr10:102975609	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.687	rs10786417	MIMAT0005878	hsa-miR-1287-5p	3.85	0.000133	0.18	0.18	Metabolite levels;	chr10:98394147	chr10:98395271~98395292:-
HNSC	cis	rs9814567	0.762	rs13093893	MIMAT0019958	hsa-miR-4788	-3.85	0.000133	-0.23	-0.18	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134573289	chr3:134437836~134437857:+
HNSC	cis	rs10492002	0.636	rs7294617	MIMAT0003287	hsa-miR-618	3.85	0.000134	0.2	0.18	Response to antidepressant treatment (citalopram);	chr12:81111846	chr12:80935796~80935818:-
HNSC	cis	rs4921799	0.662	rs34285970	MIMAT0015020	hsa-miR-548v	-3.85	0.000135	-0.19	-0.18	Lung cancer;Adenocarcinoma;	chr8:17677418	chr8:17681588~17681609:-
HNSC	cis	rs7072216	0.922	rs59667296	MIMAT0026738	hsa-miR-1287-3p	3.85	0.000135	0.16	0.18	Metabolite levels;	chr10:98386556	chr10:98395232~98395253:-
HNSC	cis	rs17730929	0.858	rs17729886	MIMAT0005923	hsa-miR-1269a	-3.85	0.000135	-0.52	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66448534	chr4:66276890~66276911:+
HNSC	cis	rs9807989	0.839	rs3771166	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000136	-0.16	-0.18	Asthma;	chr2:102369762	chr2:102432336~102432357:+
HNSC	cis	rs75358501	0.551	rs79761690	MIMAT0014995	hsa-miR-3130-5p	-3.85	0.000136	-0.21	-0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.551	rs79761690	MIMAT0014995_1	hsa-miR-3130-5p	-3.85	0.000136	-0.21	-0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783246~206783266:+
HNSC	cis	rs75358501	0.551	rs28619220	MIMAT0014995	hsa-miR-3130-5p	-3.85	0.000136	-0.21	-0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.551	rs28619220	MIMAT0014995_1	hsa-miR-3130-5p	-3.85	0.000136	-0.21	-0.18	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783246~206783266:+
HNSC	cis	rs1588265	0.536	rs11739760	MIMAT0004797	hsa-miR-582-3p	-3.85	0.000137	-0.2	-0.18	Asthma;	chr5:60257915	chr5:59703630~59703651:-
HNSC	cis	rs250677	0.687	rs250678	MIMAT0003249	hsa-miR-584-5p	3.84	0.000138	0.18	0.18	Breast cancer;	chr5:149055267	chr5:149062373~149062394:-
HNSC	cis	rs941898	0.957	rs2181102	MIMAT0004814	hsa-miR-654-3p	-3.84	0.000139	-0.08	-0.18	White matter hyperintensity burden;	chr14:100117612	chr14:101040269~101040290:+
HNSC	cis	rs74233809	1	rs11191551	MIMAT0005951	hsa-miR-1307-3p	-3.84	0.000139	-0.21	-0.18	Birth weight;	chr10:103091078	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs17094683	MIMAT0005951	hsa-miR-1307-3p	-3.84	0.000139	-0.21	-0.18	Birth weight;	chr10:103091544	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs12220743	MIMAT0005951	hsa-miR-1307-3p	-3.84	0.000139	-0.21	-0.18	Birth weight;	chr10:103092155	chr10:103394301~103394322:-
HNSC	cis	rs7104764	1	rs9795476	MIMAT0026475	hsa-miR-210-5p	3.84	0.00014	0.25	0.18	Menarche (age at onset);	chr11:235894	chr11:568150~568171:-
HNSC	cis	rs11892454	0.565	rs12713680	MIMAT0026639	hsa-miR-1301-5p	3.84	0.00014	0.22	0.18	Heschl's gyrus morphology;	chr2:25830974	chr2:25328689~25328707:-
HNSC	cis	rs7104764	1	rs10794302	MIMAT0026475	hsa-miR-210-5p	3.84	0.000141	0.25	0.18	Menarche (age at onset);	chr11:234102	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs6598069	MIMAT0026475	hsa-miR-210-5p	3.83	0.000144	0.26	0.18	Menarche (age at onset);	chr11:240664	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs2272563	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.26	0.18	Menarche (age at onset);	chr11:236871	chr11:568150~568171:-
HNSC	cis	rs7104764	0.917	rs1045288	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.26	0.18	Menarche (age at onset);	chr11:237087	chr11:568150~568171:-
HNSC	cis	rs7104764	0.917	rs6598068	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.25	0.18	Menarche (age at onset);	chr11:243092	chr11:568150~568171:-
HNSC	cis	rs7104764	0.917	rs6598067	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.25	0.18	Menarche (age at onset);	chr11:243093	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs6598065	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.25	0.18	Menarche (age at onset);	chr11:243211	chr11:568150~568171:-
HNSC	cis	rs7104764	0.957	rs6598064	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.25	0.18	Menarche (age at onset);	chr11:243557	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs6598063	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.25	0.18	Menarche (age at onset);	chr11:243672	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs6598062	MIMAT0026475	hsa-miR-210-5p	3.83	0.000145	0.25	0.18	Menarche (age at onset);	chr11:243712	chr11:568150~568171:-
HNSC	cis	rs12134133	1	rs2490261	MIMAT0004673	hsa-miR-29c-5p	-3.83	0.000146	-0.13	-0.18	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207304124	chr1:207801903~207801924:-
HNSC	cis	rs7829975	0.572	rs28446104	MIMAT0019728	hsa-miR-4660	-3.83	0.000146	-0.2	-0.18	Mood instability;	chr8:8938391	chr8:9048453~9048475:+
HNSC	cis	rs9527	0.615	rs10883810	MIMAT0022727	hsa-miR-1307-5p	3.83	0.000148	0.15	0.17	Arsenic metabolism;	chr10:102967467	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs10883811	MIMAT0022727	hsa-miR-1307-5p	3.83	0.000148	0.15	0.17	Arsenic metabolism;	chr10:102967522	chr10:103394341~103394361:-
HNSC	cis	rs7829975	0.742	rs12547493	MIMAT0019728	hsa-miR-4660	-3.83	0.000148	-0.21	-0.17	Mood instability;	chr8:8804024	chr8:9048453~9048475:+
HNSC	cis	rs250677	0.687	rs40522	MIMAT0003249	hsa-miR-584-5p	3.82	0.000149	0.18	0.17	Breast cancer;	chr5:149062732	chr5:149062373~149062394:-
HNSC	cis	rs7104764	1	rs6598066	MIMAT0026475	hsa-miR-210-5p	3.82	0.000149	0.26	0.17	Menarche (age at onset);	chr11:243185	chr11:568150~568171:-
HNSC	cis	rs79387448	0.701	rs76943877	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.00015	-0.24	-0.17	Gut microbiota (bacterial taxa);	chr2:102354217	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.839	rs1974675	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.00015	-0.16	-0.17	Asthma;	chr2:102369915	chr2:102432336~102432357:+
HNSC	cis	rs9527	0.615	rs1556960	MIMAT0022727	hsa-miR-1307-5p	3.82	0.00015	0.15	0.17	Arsenic metabolism;	chr10:102966916	chr10:103394341~103394361:-
HNSC	cis	rs4919687	0.514	rs3850699	MIMAT0022727	hsa-miR-1307-5p	3.82	0.000152	0.16	0.17	Colorectal cancer;	chr10:102654464	chr10:103394341~103394361:-
HNSC	cis	rs17730929	0.722	rs35324365	MIMAT0005923	hsa-miR-1269a	-3.82	0.000153	-0.47	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66306923	chr4:66276890~66276911:+
HNSC	cis	rs7649443	0.959	rs9826379	MIMAT0019973	hsa-miR-4797-3p	3.82	0.000153	0.22	0.17	Nonsyndromic cleft lip with cleft palate;	chr3:197100377	chr3:197293888~197293908:-
HNSC	cis	rs11892454	0.599	rs1076000	MIMAT0026639	hsa-miR-1301-5p	3.81	0.000155	0.22	0.17	Heschl's gyrus morphology;	chr2:25754487	chr2:25328689~25328707:-
HNSC	cis	rs10492002	0.563	rs4516036	MIMAT0003287	hsa-miR-618	3.81	0.000155	0.2	0.17	Response to antidepressant treatment (citalopram);	chr12:81115447	chr12:80935796~80935818:-
HNSC	cis	rs4851551	0.867	rs3917330	MIMAT0019927	hsa-miR-4772-3p	-3.81	0.000157	-0.32	-0.17	Blood protein levels;	chr2:102179965	chr2:102432336~102432357:+
HNSC	cis	rs4851551	0.867	rs3917331	MIMAT0019927	hsa-miR-4772-3p	-3.81	0.000157	-0.32	-0.17	Blood protein levels;	chr2:102179966	chr2:102432336~102432357:+
HNSC	cis	rs17730929	0.858	rs77846903	MIMAT0005923	hsa-miR-1269a	-3.81	0.000157	-0.51	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66456430	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.858	rs72902537	MIMAT0005923	hsa-miR-1269a	-3.81	0.000157	-0.51	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66463193	chr4:66276890~66276911:+
HNSC	cis	rs79387448	0.576	rs11902044	MIMAT0019927	hsa-miR-4772-3p	-3.81	0.000159	-0.24	-0.17	Gut microbiota (bacterial taxa);	chr2:102356074	chr2:102432336~102432357:+
HNSC	cis	rs1957429	0.731	rs10144554	MIMAT0004808	hsa-miR-625-3p	3.81	0.000159	0.25	0.17	Pediatric areal bone mineral density (radius);	chr14:64854796	chr14:65471153~65471174:+
HNSC	cis	rs992157	0.764	rs4672886	MIMAT0000083	hsa-miR-26b-5p	3.81	0.00016	0.11	0.17	Colorectal cancer;	chr2:218320822	chr2:218402657~218402677:+
HNSC	cis	rs9527	0.615	rs7096452	MIMAT0022727	hsa-miR-1307-5p	3.81	0.00016	0.15	0.17	Arsenic metabolism;	chr10:102976806	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs7080462	MIMAT0022727	hsa-miR-1307-5p	3.81	0.00016	0.15	0.17	Arsenic metabolism;	chr10:102976942	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs11191489	MIMAT0022727	hsa-miR-1307-5p	3.81	0.00016	0.15	0.17	Arsenic metabolism;	chr10:102980811	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.631	rs28572014	MIMAT0019728	hsa-miR-4660	-3.8	0.000161	-0.2	-0.17	Joint mobility (Beighton score);	chr8:8936097	chr8:9048453~9048475:+
HNSC	cis	rs8064299	0.597	rs2053748	MIMAT0017994	hsa-miR-3615	3.8	0.000161	0.2	0.17	Monocyte count;	chr17:74779772	chr17:74748663~74748683:+
HNSC	cis	rs7104764	1	rs7483951	MIMAT0026475	hsa-miR-210-5p	3.8	0.000162	0.25	0.17	Menarche (age at onset);	chr11:231758	chr11:568150~568171:-
HNSC	cis	rs7829975	0.539	rs71537846	MIMAT0019728	hsa-miR-4660	-3.8	0.000162	-0.21	-0.17	Mood instability;	chr8:8684610	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.577	rs940030	MIMAT0019728	hsa-miR-4660	-3.8	0.000163	-0.21	-0.17	Mood instability;	chr8:8689418	chr8:9048453~9048475:+
HNSC	cis	rs4921799	0.662	rs3739411	MIMAT0015020	hsa-miR-548v	-3.8	0.000164	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17672771	chr8:17681588~17681609:-
HNSC	cis	rs11892454	0.565	rs13418205	MIMAT0026639	hsa-miR-1301-5p	3.8	0.000166	0.22	0.17	Heschl's gyrus morphology;	chr2:25827477	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.527	rs13022069	MIMAT0026639	hsa-miR-1301-5p	3.8	0.000166	0.22	0.17	Heschl's gyrus morphology;	chr2:25844817	chr2:25328689~25328707:-
HNSC	cis	rs9527	0.622	rs12779263	MIMAT0022727	hsa-miR-1307-5p	3.8	0.000166	0.16	0.17	Arsenic metabolism;	chr10:103126776	chr10:103394341~103394361:-
HNSC	cis	rs11892454	0.565	rs10199550	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000167	0.22	0.17	Heschl's gyrus morphology;	chr2:25855662	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs10187156	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000167	0.22	0.17	Heschl's gyrus morphology;	chr2:25864526	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs11897276	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000167	0.22	0.17	Heschl's gyrus morphology;	chr2:25867544	chr2:25328689~25328707:-
HNSC	cis	rs9814567	0.574	rs7650509	MIMAT0019958	hsa-miR-4788	-3.79	0.000168	-0.19	-0.17	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134452129	chr3:134437836~134437857:+
HNSC	cis	rs10492002	0.613	rs1921036	MIMAT0003287	hsa-miR-618	3.79	0.000169	0.2	0.17	Response to antidepressant treatment (citalopram);	chr12:81212083	chr12:80935796~80935818:-
HNSC	cis	rs7829975	0.56	rs17154599	MIMAT0019728	hsa-miR-4660	-3.79	0.000169	-0.21	-0.17	Mood instability;	chr8:8693908	chr8:9048453~9048475:+
HNSC	cis	rs250677	0.687	rs36044	MIMAT0003249	hsa-miR-584-5p	3.79	0.000169	0.18	0.17	Breast cancer;	chr5:149061565	chr5:149062373~149062394:-
HNSC	cis	rs250677	0.687	rs36046	MIMAT0003249	hsa-miR-584-5p	3.79	0.000169	0.18	0.17	Breast cancer;	chr5:149061694	chr5:149062373~149062394:-
HNSC	cis	rs2963826	0.565	rs4235477	MIMAT0003247	hsa-miR-582-5p	3.79	0.00017	0.19	0.17	Obesity-related traits;	chr5:59765456	chr5:59703666~59703688:-
HNSC	cis	rs250677	1	rs28173	MIMAT0003249	hsa-miR-584-5p	3.79	0.00017	0.17	0.17	Breast cancer;	chr5:149044010	chr5:149062373~149062394:-
HNSC	cis	rs3740393	0.562	rs72845847	MIMAT0022727	hsa-miR-1307-5p	-3.79	0.00017	-0.2	-0.17	Microalbuminuria;	chr10:102771849	chr10:103394341~103394361:-
HNSC	cis	rs7104764	1	rs7395328	MIMAT0026475	hsa-miR-210-5p	3.79	0.00017	0.25	0.17	Menarche (age at onset);	chr11:242624	chr11:568150~568171:-
HNSC	cis	rs79387448	0.701	rs10515921	MIMAT0019927	hsa-miR-4772-3p	-3.79	0.00017	-0.24	-0.17	Gut microbiota (bacterial taxa);	chr2:102364558	chr2:102432336~102432357:+
HNSC	cis	rs79387448	0.701	rs11465584	MIMAT0019927	hsa-miR-4772-3p	-3.79	0.00017	-0.24	-0.17	Gut microbiota (bacterial taxa);	chr2:102366169	chr2:102432336~102432357:+
HNSC	cis	rs11992186	0.597	rs77717027	MIMAT0019728	hsa-miR-4660	-3.79	0.000171	-0.21	-0.17	Neuroticism;	chr8:8734122	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.511	rs1401390	MIMAT0019728	hsa-miR-4660	3.79	0.000171	0.2	0.17	Mood instability;	chr8:8278888	chr8:9048453~9048475:+
HNSC	cis	rs250677	1	rs250676	MIMAT0003249	hsa-miR-584-5p	3.79	0.000171	0.17	0.17	Breast cancer;	chr5:149045955	chr5:149062373~149062394:-
HNSC	cis	rs11892454	0.565	rs56397444	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000172	0.22	0.17	Heschl's gyrus morphology;	chr2:25804283	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs10207926	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000172	0.22	0.17	Heschl's gyrus morphology;	chr2:25806538	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.526	rs10210497	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000172	0.22	0.17	Heschl's gyrus morphology;	chr2:25806616	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs10174199	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000172	0.22	0.17	Heschl's gyrus morphology;	chr2:25810618	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs35926307	MIMAT0026639	hsa-miR-1301-5p	3.79	0.000172	0.22	0.17	Heschl's gyrus morphology;	chr2:25820663	chr2:25328689~25328707:-
HNSC	cis	rs4921799	0.64	rs11990915	MIMAT0015020	hsa-miR-548v	-3.79	0.000172	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17667519	chr8:17681588~17681609:-
HNSC	cis	rs4553443	1	rs12369902	MIMAT0000226	hsa-miR-196a-5p	-3.79	0.000173	-0.23	-0.17	Cancer;	chr12:54928983	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs12369902	MIMAT0000226_1	hsa-miR-196a-5p	-3.79	0.000173	-0.23	-0.17	Cancer;	chr12:54928983	chr17:48632532~48632553:-
HNSC	cis	rs7829975	0.517	rs12542733	MIMAT0019728	hsa-miR-4660	-3.79	0.000173	-0.19	-0.17	Mood instability;	chr8:8967348	chr8:9048453~9048475:+
HNSC	cis	rs4553443	1	rs58133630	MIMAT0000226	hsa-miR-196a-5p	-3.79	0.000173	-0.23	-0.17	Cancer;	chr12:54930497	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs58133630	MIMAT0000226_1	hsa-miR-196a-5p	-3.79	0.000173	-0.23	-0.17	Cancer;	chr12:54930497	chr17:48632532~48632553:-
HNSC	cis	rs3096644	1	rs3096644	MIMAT0004555	hsa-miR-10a-3p	3.78	0.000174	0.21	0.17	Metabolite levels (Dihydroxy docosatrienoic acid);	chr17:48680213	chr17:48579864~48579885:-
HNSC	cis	rs250677	0.652	rs250680	MIMAT0003249	hsa-miR-584-5p	3.78	0.000175	0.18	0.17	Breast cancer;	chr5:149056461	chr5:149062373~149062394:-
HNSC	cis	rs250677	0.687	rs3095947	MIMAT0003249	hsa-miR-584-5p	3.78	0.000175	0.18	0.17	Breast cancer;	chr5:149057165	chr5:149062373~149062394:-
HNSC	cis	rs11892454	0.565	rs13422139	MIMAT0026639	hsa-miR-1301-5p	3.78	0.000176	0.22	0.17	Heschl's gyrus morphology;	chr2:25843701	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs55946759	MIMAT0026639	hsa-miR-1301-5p	3.78	0.000177	0.22	0.17	Heschl's gyrus morphology;	chr2:25745953	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs7609372	MIMAT0026639	hsa-miR-1301-5p	3.78	0.000177	0.22	0.17	Heschl's gyrus morphology;	chr2:25746694	chr2:25328689~25328707:-
HNSC	cis	rs10492002	0.522	rs1921067	MIMAT0003287	hsa-miR-618	3.78	0.000177	0.2	0.17	Response to antidepressant treatment (citalopram);	chr12:81224809	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.522	rs7132250	MIMAT0003287	hsa-miR-618	3.78	0.000177	0.2	0.17	Response to antidepressant treatment (citalopram);	chr12:81218124	chr12:80935796~80935818:-
HNSC	cis	rs11892454	0.565	rs9309434	MIMAT0026639	hsa-miR-1301-5p	-3.78	0.000178	-0.22	-0.17	Heschl's gyrus morphology;	chr2:25853557	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs13425195	MIMAT0026639	hsa-miR-1301-5p	3.78	0.000178	0.22	0.17	Heschl's gyrus morphology;	chr2:25859343	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs7572629	MIMAT0026639	hsa-miR-1301-5p	3.78	0.000178	0.22	0.17	Heschl's gyrus morphology;	chr2:25731333	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs3731639	MIMAT0026639	hsa-miR-1301-5p	3.78	0.000178	0.22	0.17	Heschl's gyrus morphology;	chr2:25734667	chr2:25328689~25328707:-
HNSC	cis	rs10492002	0.563	rs4466902	MIMAT0003287	hsa-miR-618	-3.78	0.000179	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81116043	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.587	rs4354754	MIMAT0003287	hsa-miR-618	-3.78	0.000179	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81121005	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.563	rs5027920	MIMAT0003287	hsa-miR-618	-3.78	0.00018	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81118979	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.522	rs2293651	MIMAT0003287	hsa-miR-618	3.78	0.000181	0.2	0.17	Response to antidepressant treatment (citalopram);	chr12:81231185	chr12:80935796~80935818:-
HNSC	cis	rs12368653	0.607	rs7966795	MIMAT0005582	hsa-miR-1228-5p	3.78	0.000181	0.21	0.17	Multiple sclerosis;	chr12:57637630	chr12:57194504~57194524:+
HNSC	cis	rs11892454	0.599	rs11888512	MIMAT0026639	hsa-miR-1301-5p	3.77	0.000181	0.22	0.17	Heschl's gyrus morphology;	chr2:25761341	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.566	rs11888724	MIMAT0026639	hsa-miR-1301-5p	3.77	0.000181	0.22	0.17	Heschl's gyrus morphology;	chr2:25761772	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.566	rs11893562	MIMAT0026639	hsa-miR-1301-5p	3.77	0.000181	0.22	0.17	Heschl's gyrus morphology;	chr2:25761826	chr2:25328689~25328707:-
HNSC	cis	rs7104764	1	rs10400248	MIMAT0026475	hsa-miR-210-5p	3.77	0.000181	0.25	0.17	Menarche (age at onset);	chr11:247029	chr11:568150~568171:-
HNSC	cis	rs9807989	0.839	rs1362348	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000182	-0.16	-0.17	Asthma;	chr2:102368164	chr2:102432336~102432357:+
HNSC	cis	rs10492002	0.563	rs4240723	MIMAT0003287	hsa-miR-618	-3.77	0.000183	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81116673	chr12:80935796~80935818:-
HNSC	cis	rs1588265	0.531	rs10434525	MIMAT0003247	hsa-miR-582-5p	3.77	0.000183	0.2	0.17	Asthma;	chr5:60260634	chr5:59703666~59703688:-
HNSC	cis	rs9987353	0.518	rs4841110	MIMAT0019728	hsa-miR-4660	3.77	0.000183	0.21	0.17	Recombination measurement;	chr8:9228513	chr8:9048453~9048475:+
HNSC	cis	rs10492002	0.563	rs10778789	MIMAT0003287	hsa-miR-618	-3.77	0.000183	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81113973	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.541	rs7302831	MIMAT0003287	hsa-miR-618	-3.77	0.000183	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81114185	chr12:80935796~80935818:-
HNSC	cis	rs10492002	1	rs1435964	MIMAT0003287	hsa-miR-618	-3.77	0.000183	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81148436	chr12:80935796~80935818:-
HNSC	cis	rs11892454	0.599	rs7560429	MIMAT0026639	hsa-miR-1301-5p	3.77	0.000183	0.22	0.17	Heschl's gyrus morphology;	chr2:25785136	chr2:25328689~25328707:-
HNSC	cis	rs7829975	0.56	rs6994131	MIMAT0019728	hsa-miR-4660	-3.77	0.000185	-0.21	-0.17	Mood instability;	chr8:8693448	chr8:9048453~9048475:+
HNSC	cis	rs7104764	1	rs6598061	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:243853	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs10902112	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244106	chr11:568150~568171:-
HNSC	cis	rs7104764	0.917	rs7107362	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244108	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs7128044	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244115	chr11:568150~568171:-
HNSC	cis	rs7104764	0.957	rs7116130	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244129	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs7128029	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244141	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs1128320	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244167	chr11:568150~568171:-
HNSC	cis	rs7104764	0.957	rs1128321	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244171	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs2272565	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:244414	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs10902113	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:245523	chr11:568150~568171:-
HNSC	cis	rs7104764	1	rs7482591	MIMAT0026475	hsa-miR-210-5p	3.77	0.000185	0.25	0.17	Menarche (age at onset);	chr11:245861	chr11:568150~568171:-
HNSC	cis	rs7829975	0.557	rs7816427	MIMAT0019728	hsa-miR-4660	-3.77	0.000185	-0.21	-0.17	Mood instability;	chr8:8688374	chr8:9048453~9048475:+
HNSC	cis	rs11892454	0.599	rs10202756	MIMAT0026639	hsa-miR-1301-5p	3.77	0.000187	0.22	0.17	Heschl's gyrus morphology;	chr2:25769963	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs35701447	MIMAT0026639	hsa-miR-1301-5p	3.77	0.000188	0.22	0.17	Heschl's gyrus morphology;	chr2:25789022	chr2:25328689~25328707:-
HNSC	cis	rs7072216	0.922	rs4488133	MIMAT0026738	hsa-miR-1287-3p	-3.76	0.000188	-0.16	-0.17	Metabolite levels;	chr10:98399379	chr10:98395232~98395253:-
HNSC	cis	rs3790645	1	rs383913	MIMAT0018191	hsa-miR-3917	3.76	0.000188	0.19	0.17	Glucose homeostasis traits;	chr1:26566815	chr1:25906384~25906403:-
HNSC	cis	rs79387448	0.614	rs985523	MIMAT0019927	hsa-miR-4772-3p	-3.76	0.000188	-0.23	-0.17	Gut microbiota (bacterial taxa);	chr2:102337916	chr2:102432336~102432357:+
HNSC	cis	rs11892454	0.599	rs919205	MIMAT0026639	hsa-miR-1301-5p	3.76	0.000189	0.22	0.17	Heschl's gyrus morphology;	chr2:25733576	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.561	rs7591277	MIMAT0026639	hsa-miR-1301-5p	3.76	0.000189	0.22	0.17	Heschl's gyrus morphology;	chr2:25736054	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs10153560	MIMAT0026639	hsa-miR-1301-5p	3.76	0.000189	0.22	0.17	Heschl's gyrus morphology;	chr2:25738714	chr2:25328689~25328707:-
HNSC	cis	rs250677	0.687	rs10040624	MIMAT0003249	hsa-miR-584-5p	3.76	0.000189	0.18	0.17	Breast cancer;	chr5:149058016	chr5:149062373~149062394:-
HNSC	cis	rs4921799	0.711	rs2269695	MIMAT0015020	hsa-miR-548v	-3.76	0.00019	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17674735	chr8:17681588~17681609:-
HNSC	cis	rs7072216	0.687	rs11189586	MIMAT0005878	hsa-miR-1287-5p	3.76	0.00019	0.18	0.17	Metabolite levels;	chr10:98394339	chr10:98395271~98395292:-
HNSC	cis	rs953492	0.698	rs58823746	MIMAT0019761	hsa-miR-4677-3p	-3.76	0.00019	-0.17	-0.17	Diastolic blood pressure;	chr1:243280874	chr1:243346225~243346246:+
HNSC	cis	rs7829975	0.511	rs1543238	MIMAT0019728	hsa-miR-4660	3.76	0.00019	0.2	0.17	Mood instability;	chr8:8277287	chr8:9048453~9048475:+
HNSC	cis	rs250677	0.524	rs40521	MIMAT0003249	hsa-miR-584-5p	-3.76	0.000191	-0.16	-0.17	Breast cancer;	chr5:149060076	chr5:149062373~149062394:-
HNSC	cis	rs992157	0.764	rs3731861	MIMAT0000083	hsa-miR-26b-5p	3.76	0.000191	0.11	0.17	Colorectal cancer;	chr2:218326533	chr2:218402657~218402677:+
HNSC	cis	rs11892454	0.565	rs2891480	MIMAT0026639	hsa-miR-1301-5p	3.76	0.000192	0.22	0.17	Heschl's gyrus morphology;	chr2:25861328	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs10171348	MIMAT0026639	hsa-miR-1301-5p	3.76	0.000192	0.22	0.17	Heschl's gyrus morphology;	chr2:25753906	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs10194371	MIMAT0026639	hsa-miR-1301-5p	3.76	0.000192	0.22	0.17	Heschl's gyrus morphology;	chr2:25754096	chr2:25328689~25328707:-
HNSC	cis	rs9527	0.59	rs11191513	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000192	0.15	0.17	Arsenic metabolism;	chr10:103013227	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.59	rs10509764	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000192	0.15	0.17	Arsenic metabolism;	chr10:103016718	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.59	rs6584537	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000192	0.15	0.17	Arsenic metabolism;	chr10:103018510	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.569	rs78193706	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000192	0.15	0.17	Arsenic metabolism;	chr10:103020807	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.59	rs7906754	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000192	0.15	0.17	Arsenic metabolism;	chr10:103022800	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs4917991	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000192	0.15	0.17	Arsenic metabolism;	chr10:103024076	chr10:103394341~103394361:-
HNSC	cis	rs8064299	0.597	rs6501737	MIMAT0017994	hsa-miR-3615	3.76	0.000192	0.2	0.17	Monocyte count;	chr17:74784691	chr17:74748663~74748683:+
HNSC	cis	rs10492002	0.8	rs7311803	MIMAT0003287	hsa-miR-618	3.76	0.000192	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81152414	chr12:80935796~80935818:-
HNSC	cis	rs953492	0.698	rs61833914	MIMAT0019761	hsa-miR-4677-3p	-3.76	0.000192	-0.17	-0.17	Diastolic blood pressure;	chr1:243276745	chr1:243346225~243346246:+
HNSC	cis	rs11892454	0.599	rs890681	MIMAT0026639	hsa-miR-1301-5p	3.76	0.000192	0.22	0.17	Heschl's gyrus morphology;	chr2:25755618	chr2:25328689~25328707:-
HNSC	cis	rs7829975	0.593	rs2979241	MIMAT0019728	hsa-miR-4660	3.76	0.000193	0.2	0.17	Mood instability;	chr8:8445843	chr8:9048453~9048475:+
HNSC	cis	rs4819852	0.958	rs2238792	MIMAT0000455	hsa-miR-185-5p	-3.76	0.000193	-0.18	-0.17	Pulse pressure;	chr22:19995690	chr22:20033153~20033174:+
HNSC	cis	rs8074700	0.539	rs3096648	MIMAT0004555	hsa-miR-10a-3p	-3.76	0.000193	-0.21	-0.17	Body mass index in non-asthmatics;	chr17:48676462	chr17:48579864~48579885:-
HNSC	cis	rs9527	0.668	rs7092815	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000193	0.15	0.17	Arsenic metabolism;	chr10:102976588	chr10:103394341~103394361:-
HNSC	cis	rs4919687	0.55	rs12780827	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000194	0.15	0.17	Colorectal cancer;	chr10:102708197	chr10:103394341~103394361:-
HNSC	cis	rs8064299	0.584	rs2384957	MIMAT0017994	hsa-miR-3615	-3.76	0.000195	-0.2	-0.17	Monocyte count;	chr17:74788491	chr17:74748663~74748683:+
HNSC	cis	rs7786765	0.511	rs1108233	MIMAT0003328	hsa-miR-653-5p	3.75	0.000196	0.19	0.17	Body mass index;	chr7:93461926	chr7:93482823~93482843:-
HNSC	cis	rs6519955	0.86	rs8136098	MIMAT0019911	hsa-miR-4762-3p	3.75	0.000196	0.2	0.17	Dupuytren's disease;	chr22:46029766	chr22:45760572~45760593:+
HNSC	cis	rs7829975	0.582	rs11783950	MIMAT0019728	hsa-miR-4660	-3.75	0.000196	-0.2	-0.17	Mood instability;	chr8:8740321	chr8:9048453~9048475:+
HNSC	cis	rs1588265	0.531	rs10434525	MIMAT0004797	hsa-miR-582-3p	3.75	0.000196	0.19	0.17	Asthma;	chr5:60260634	chr5:59703630~59703651:-
HNSC	cis	rs7072216	0.77	rs1739	MIMAT0026738	hsa-miR-1287-3p	3.75	0.000197	0.17	0.17	Metabolite levels;	chr10:98416582	chr10:98395232~98395253:-
HNSC	cis	rs11892454	0.599	rs66878742	MIMAT0026639	hsa-miR-1301-5p	3.75	0.000197	0.22	0.17	Heschl's gyrus morphology;	chr2:25787398	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs13410396	MIMAT0026639	hsa-miR-1301-5p	3.75	0.000197	0.22	0.17	Heschl's gyrus morphology;	chr2:25787550	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.565	rs13021454	MIMAT0026639	hsa-miR-1301-5p	3.75	0.000198	0.22	0.17	Heschl's gyrus morphology;	chr2:25844570	chr2:25328689~25328707:-
HNSC	cis	rs4851551	1	rs4851552	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000198	-0.34	-0.17	Blood protein levels;	chr2:102185873	chr2:102432336~102432357:+
HNSC	cis	rs11892454	0.533	rs7592985	MIMAT0026639	hsa-miR-1301-5p	3.75	0.000199	0.22	0.17	Heschl's gyrus morphology;	chr2:25877358	chr2:25328689~25328707:-
HNSC	cis	rs7072216	0.687	rs11597425	MIMAT0005878	hsa-miR-1287-5p	3.75	0.000201	0.18	0.17	Metabolite levels;	chr10:98394445	chr10:98395271~98395292:-
HNSC	cis	rs7072216	0.687	rs11597428	MIMAT0005878	hsa-miR-1287-5p	3.75	0.000201	0.18	0.17	Metabolite levels;	chr10:98394490	chr10:98395271~98395292:-
HNSC	cis	rs17730929	0.858	rs1877517	MIMAT0005923	hsa-miR-1269a	-3.74	0.000203	-0.49	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66435876	chr4:66276890~66276911:+
HNSC	cis	rs2871473	1	rs1030024	MIMAT0019927	hsa-miR-4772-3p	3.74	0.000204	0.18	0.17	Blood protein levels;	chr2:102489310	chr2:102432336~102432357:+
HNSC	cis	rs11892454	0.599	rs890680	MIMAT0026639	hsa-miR-1301-5p	3.74	0.000204	0.22	0.17	Heschl's gyrus morphology;	chr2:25756509	chr2:25328689~25328707:-
HNSC	cis	rs7104764	0.957	rs56357554	MIMAT0026475	hsa-miR-210-5p	-3.74	0.000204	-0.25	-0.17	Menarche (age at onset);	chr11:204715	chr11:568150~568171:-
HNSC	cis	rs79387448	0.701	rs3752659	MIMAT0019927	hsa-miR-4772-3p	-3.74	0.000205	-0.22	-0.17	Gut microbiota (bacterial taxa);	chr2:102385138	chr2:102432336~102432357:+
HNSC	cis	rs9329221	0.617	rs483916	MIMAT0019728	hsa-miR-4660	-3.74	0.000205	-0.19	-0.17	Neuroticism;	chr8:9936091	chr8:9048453~9048475:+
HNSC	cis	rs4553443	1	rs11171168	MIMAT0000226	hsa-miR-196a-5p	-3.74	0.000206	-0.22	-0.17	Cancer;	chr12:54928194	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs11171168	MIMAT0000226_1	hsa-miR-196a-5p	-3.74	0.000206	-0.22	-0.17	Cancer;	chr12:54928194	chr17:48632532~48632553:-
HNSC	cis	rs4851551	1	rs3917329	MIMAT0019927	hsa-miR-4772-3p	3.74	0.000206	0.32	0.17	Blood protein levels;	chr2:102179403	chr2:102432336~102432357:+
HNSC	cis	rs10492002	0.613	rs61934664	MIMAT0003287	hsa-miR-618	3.74	0.000208	0.2	0.17	Response to antidepressant treatment (citalopram);	chr12:81214279	chr12:80935796~80935818:-
HNSC	cis	rs250677	0.687	rs42364	MIMAT0003249	hsa-miR-584-5p	3.74	0.000208	0.18	0.17	Breast cancer;	chr5:149059295	chr5:149062373~149062394:-
HNSC	cis	rs250677	1	rs36069	MIMAT0003249	hsa-miR-584-5p	3.74	0.000209	0.17	0.17	Breast cancer;	chr5:149037690	chr5:149062373~149062394:-
HNSC	cis	rs453301	0.631	rs13250781	MIMAT0019728	hsa-miR-4660	-3.74	0.000209	-0.2	-0.17	Joint mobility (Beighton score);	chr8:8935833	chr8:9048453~9048475:+
HNSC	cis	rs3790645	0.874	rs9438508	MIMAT0018191	hsa-miR-3917	3.74	0.000209	0.19	0.17	Glucose homeostasis traits;	chr1:26566578	chr1:25906384~25906403:-
HNSC	cis	rs59372292	0.597	rs17160495	MIMAT0021017	hsa-miR-4999-5p	-3.74	0.000209	-0.23	-0.17	Coronary artery disease;	chr19:8451394	chr19:8389340~8389360:-
HNSC	cis	rs941898	0.957	rs3783337	MIMAT0004814	hsa-miR-654-3p	3.74	0.00021	0.08	0.17	White matter hyperintensity burden;	chr14:100128941	chr14:101040269~101040290:+
HNSC	cis	rs7829975	0.684	rs488904	MIMAT0019728	hsa-miR-4660	-3.74	0.000211	-0.2	-0.17	Mood instability;	chr8:8730061	chr8:9048453~9048475:+
HNSC	cis	rs9527	0.59	rs10883818	MIMAT0022727	hsa-miR-1307-5p	3.74	0.000211	0.15	0.17	Arsenic metabolism;	chr10:102999829	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.641	rs10786732	MIMAT0022727	hsa-miR-1307-5p	3.74	0.000211	0.15	0.17	Arsenic metabolism;	chr10:103002778	chr10:103394341~103394361:-
HNSC	cis	rs941898	0.957	rs941900	MIMAT0004814	hsa-miR-654-3p	3.74	0.000211	0.08	0.17	White matter hyperintensity burden;	chr14:100137062	chr14:101040269~101040290:+
HNSC	cis	rs4819852	0.958	rs9606203	MIMAT0000455	hsa-miR-185-5p	-3.73	0.000213	-0.18	-0.17	Pulse pressure;	chr22:19984595	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.958	rs2238784	MIMAT0000455	hsa-miR-185-5p	-3.73	0.000213	-0.18	-0.17	Pulse pressure;	chr22:19985036	chr22:20033153~20033174:+
HNSC	cis	rs74233809	1	rs732998	MIMAT0005951	hsa-miR-1307-3p	3.73	0.000215	0.2	0.17	Birth weight;	chr10:103138144	chr10:103394301~103394322:-
HNSC	cis	rs7829975	0.582	rs6983150	MIMAT0019728	hsa-miR-4660	-3.73	0.000216	-0.19	-0.17	Mood instability;	chr8:8934916	chr8:9048453~9048475:+
HNSC	cis	rs4553443	0.934	rs61956801	MIMAT0000226	hsa-miR-196a-5p	-3.73	0.000217	-0.22	-0.17	Cancer;	chr12:54926771	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.934	rs61956801	MIMAT0000226_1	hsa-miR-196a-5p	-3.73	0.000217	-0.22	-0.17	Cancer;	chr12:54926771	chr17:48632532~48632553:-
HNSC	cis	rs6163	0.508	rs11191381	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000217	0.16	0.17	Waist circumference;Hip circumference;	chr10:102733687	chr10:103394341~103394361:-
HNSC	cis	rs6163	0.54	rs11191385	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000217	0.16	0.17	Waist circumference;Hip circumference;	chr10:102753292	chr10:103394341~103394361:-
HNSC	cis	rs7894407	0.76	rs1163072	MIMAT0005951	hsa-miR-1307-3p	3.73	0.000217	0.12	0.17	White matter hyperintensity burden;	chr10:103264621	chr10:103394301~103394322:-
HNSC	cis	rs3850699	0.666	rs7905481	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000218	0.15	0.17	Prostate cancer;	chr10:102716535	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs11191514	MIMAT0005951	hsa-miR-1307-3p	-3.73	0.000218	-0.2	-0.17	Birth weight;	chr10:103013607	chr10:103394301~103394322:-
HNSC	cis	rs11892454	0.533	rs10469884	MIMAT0026639	hsa-miR-1301-5p	3.73	0.000218	0.22	0.17	Heschl's gyrus morphology;	chr2:25878763	chr2:25328689~25328707:-
HNSC	cis	rs4553443	0.872	rs1817687	MIMAT0000226	hsa-miR-196a-5p	-3.73	0.000218	-0.23	-0.17	Cancer;	chr12:54930251	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs1817687	MIMAT0000226_1	hsa-miR-196a-5p	-3.73	0.000218	-0.23	-0.17	Cancer;	chr12:54930251	chr17:48632532~48632553:-
HNSC	cis	rs4553443	0.872	rs61956809	MIMAT0000226	hsa-miR-196a-5p	-3.73	0.000218	-0.23	-0.17	Cancer;	chr12:54932302	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs61956809	MIMAT0000226_1	hsa-miR-196a-5p	-3.73	0.000218	-0.23	-0.17	Cancer;	chr12:54932302	chr17:48632532~48632553:-
HNSC	cis	rs4553443	0.872	rs11171172	MIMAT0000226	hsa-miR-196a-5p	-3.73	0.000218	-0.23	-0.17	Cancer;	chr12:54932511	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs11171172	MIMAT0000226_1	hsa-miR-196a-5p	-3.73	0.000218	-0.23	-0.17	Cancer;	chr12:54932511	chr17:48632532~48632553:-
HNSC	cis	rs4919687	0.55	rs7904396	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000219	0.15	0.17	Colorectal cancer;	chr10:102697081	chr10:103394341~103394361:-
HNSC	cis	rs7104764	0.957	rs1045454	MIMAT0026475	hsa-miR-210-5p	-3.72	0.00022	-0.25	-0.17	Menarche (age at onset);	chr11:204228	chr11:568150~568171:-
HNSC	cis	rs9527	0.59	rs11191547	MIMAT0022727	hsa-miR-1307-5p	3.72	0.000221	0.15	0.17	Arsenic metabolism;	chr10:103083391	chr10:103394341~103394361:-
HNSC	cis	rs3790645	1	rs3127013	MIMAT0018191	hsa-miR-3917	3.72	0.000221	0.19	0.17	Glucose homeostasis traits;	chr1:26564869	chr1:25906384~25906403:-
HNSC	cis	rs4921799	0.662	rs7465342	MIMAT0015020	hsa-miR-548v	3.72	0.000221	0.2	0.17	Lung cancer;Adenocarcinoma;	chr8:17679039	chr8:17681588~17681609:-
HNSC	cis	rs1133906	0.808	rs793	MIMAT0003328	hsa-miR-653-5p	-3.72	0.000221	-0.26	-0.17	Systemic lupus erythematosus and Systemic sclerosis;	chr7:93207003	chr7:93482823~93482843:-
HNSC	cis	rs7868228	1	rs10119803	MIMAT0000089	hsa-miR-31-5p	-3.72	0.000221	-0.18	-0.17	Gut microbiome composition (winter);	chr9:21666067	chr9:21512158~21512178:-
HNSC	cis	rs79387448	0.614	rs6719130	MIMAT0019927	hsa-miR-4772-3p	-3.72	0.000221	-0.23	-0.17	Gut microbiota (bacterial taxa);	chr2:102341776	chr2:102432336~102432357:+
HNSC	cis	rs11892454	0.565	rs10191905	MIMAT0026639	hsa-miR-1301-5p	3.72	0.000223	0.21	0.17	Heschl's gyrus morphology;	chr2:25795975	chr2:25328689~25328707:-
HNSC	cis	rs13221576	0.569	rs2188266	MIMAT0003328	hsa-miR-653-5p	-3.72	0.000224	-0.3	-0.17	Intelligence;	chr7:94355267	chr7:93482823~93482843:-
HNSC	cis	rs1018697	0.761	rs7904281	MIMAT0022727	hsa-miR-1307-5p	3.72	0.000224	0.14	0.17	Colorectal adenoma (advanced);	chr10:102785079	chr10:103394341~103394361:-
HNSC	cis	rs953492	0.831	rs2802723	MIMAT0019761	hsa-miR-4677-3p	-3.72	0.000224	-0.17	-0.17	Diastolic blood pressure;	chr1:243335010	chr1:243346225~243346246:+
HNSC	cis	rs8064299	0.597	rs2016126	MIMAT0017994	hsa-miR-3615	-3.72	0.000225	-0.19	-0.17	Monocyte count;	chr17:74788793	chr17:74748663~74748683:+
HNSC	cis	rs10492002	0.522	rs1921071	MIMAT0003287	hsa-miR-618	3.72	0.000225	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81228039	chr12:80935796~80935818:-
HNSC	cis	rs1957429	0.808	rs1570296	MIMAT0004808	hsa-miR-625-3p	3.72	0.000225	0.25	0.17	Pediatric areal bone mineral density (radius);	chr14:64865576	chr14:65471153~65471174:+
HNSC	cis	rs1957429	0.808	rs11628910	MIMAT0004808	hsa-miR-625-3p	3.72	0.000225	0.25	0.17	Pediatric areal bone mineral density (radius);	chr14:64865674	chr14:65471153~65471174:+
HNSC	cis	rs79387448	0.638	rs74731686	MIMAT0019927	hsa-miR-4772-3p	-3.72	0.000226	-0.22	-0.17	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432336~102432357:+
HNSC	cis	rs9527	0.615	rs11191401	MIMAT0005951	hsa-miR-1307-3p	3.72	0.000226	0.14	0.17	Arsenic metabolism;	chr10:102813646	chr10:103394301~103394322:-
HNSC	cis	rs4790312	0.905	rs4790311	MIMAT0000426	hsa-miR-132-3p	3.72	0.000226	0.19	0.17	Left atrial antero-posterior diameter;	chr17:2075894	chr17:2049929~2049950:-
HNSC	cis	rs74233809	1	rs11191505	MIMAT0005951	hsa-miR-1307-3p	-3.72	0.000227	-0.2	-0.17	Birth weight;	chr10:103007134	chr10:103394301~103394322:-
HNSC	cis	rs9814567	0.806	rs4245903	MIMAT0019958	hsa-miR-4788	3.72	0.000227	0.19	0.17	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134598232	chr3:134437836~134437857:+
HNSC	cis	rs7829975	0.572	rs28730413	MIMAT0019728	hsa-miR-4660	-3.72	0.000227	-0.2	-0.17	Mood instability;	chr8:8937937	chr8:9048453~9048475:+
HNSC	cis	rs7104764	1	rs7104764	MIMAT0026475	hsa-miR-210-5p	3.71	0.00023	0.24	0.17	Menarche (age at onset);	chr11:229977	chr11:568150~568171:-
HNSC	cis	rs7104764	0.957	rs3829998	MIMAT0026475	hsa-miR-210-5p	3.71	0.00023	0.24	0.17	Menarche (age at onset);	chr11:230751	chr11:568150~568171:-
HNSC	cis	rs11892454	0.533	rs10193672	MIMAT0026639	hsa-miR-1301-5p	3.71	0.000231	0.22	0.17	Heschl's gyrus morphology;	chr2:25881395	chr2:25328689~25328707:-
HNSC	cis	rs7894407	0.892	rs10883859	MIMAT0005951	hsa-miR-1307-3p	3.71	0.000231	0.13	0.17	White matter hyperintensity burden;	chr10:103368377	chr10:103394301~103394322:-
HNSC	cis	rs4553443	0.872	rs2087246	MIMAT0000226	hsa-miR-196a-5p	-3.71	0.000232	-0.23	-0.17	Cancer;	chr12:54933144	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs2087246	MIMAT0000226_1	hsa-miR-196a-5p	-3.71	0.000232	-0.23	-0.17	Cancer;	chr12:54933144	chr17:48632532~48632553:-
HNSC	cis	rs7826238	0.594	rs2948285	MIMAT0019728	hsa-miR-4660	3.71	0.000232	0.2	0.17	Systolic blood pressure;	chr8:8273016	chr8:9048453~9048475:+
HNSC	cis	rs4553443	0.872	rs11838203	MIMAT0000226	hsa-miR-196a-5p	-3.71	0.000233	-0.23	-0.17	Cancer;	chr12:54937131	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs11838203	MIMAT0000226_1	hsa-miR-196a-5p	-3.71	0.000233	-0.23	-0.17	Cancer;	chr12:54937131	chr17:48632532~48632553:-
HNSC	cis	rs4553443	1	rs58200145	MIMAT0000226	hsa-miR-196a-5p	-3.71	0.000233	-0.22	-0.17	Cancer;	chr12:54928506	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs58200145	MIMAT0000226_1	hsa-miR-196a-5p	-3.71	0.000233	-0.22	-0.17	Cancer;	chr12:54928506	chr17:48632532~48632553:-
HNSC	cis	rs4553443	0.872	rs1488035	MIMAT0000226	hsa-miR-196a-5p	-3.71	0.000233	-0.22	-0.17	Cancer;	chr12:54928592	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs1488035	MIMAT0000226_1	hsa-miR-196a-5p	-3.71	0.000233	-0.22	-0.17	Cancer;	chr12:54928592	chr17:48632532~48632553:-
HNSC	cis	rs4553443	1	rs1488036	MIMAT0000226	hsa-miR-196a-5p	-3.71	0.000233	-0.22	-0.17	Cancer;	chr12:54928741	chr12:53991762~53991783:+
HNSC	cis	rs4553443	1	rs1488036	MIMAT0000226_1	hsa-miR-196a-5p	-3.71	0.000233	-0.22	-0.17	Cancer;	chr12:54928741	chr17:48632532~48632553:-
HNSC	cis	rs60015123	0.85	rs12580543	MIMAT0000432	hsa-miR-141-3p	3.71	0.000234	0.2	0.17	Red cell distribution width;	chr12:6992881	chr12:6964155~6964176:+
HNSC	cis	rs7829975	0.511	rs2948286	MIMAT0019728	hsa-miR-4660	3.71	0.000234	0.2	0.17	Mood instability;	chr8:8272638	chr8:9048453~9048475:+
HNSC	cis	rs6028446	0.564	rs6124142	MIMAT0005919	hsa-miR-548o-3p	3.71	0.000234	0.22	0.17	Chin dimples;	chr20:39374170	chr20:38516607~38516628:+
HNSC	cis	rs6028446	0.564	rs6124142	MIMAT0005919_1	hsa-miR-548o-3p	3.71	0.000234	0.22	0.17	Chin dimples;	chr20:39374170	chr7:102405748~102405769:-
HNSC	cis	rs9987353	0.84	rs329994	MIMAT0019728	hsa-miR-4660	-3.71	0.000235	-0.21	-0.17	Recombination measurement;	chr8:9265723	chr8:9048453~9048475:+
HNSC	cis	rs7104764	0.957	rs3782120	MIMAT0026475	hsa-miR-210-5p	-3.71	0.000235	-0.24	-0.17	Menarche (age at onset);	chr11:206089	chr11:568150~568171:-
HNSC	cis	rs2272306	0.614	rs822685	MIMAT0000226	hsa-miR-196a-5p	-3.7	0.000239	-0.31	-0.17	Obesity-related traits;	chr12:53120133	chr12:53991762~53991783:+
HNSC	cis	rs2272306	0.614	rs822685	MIMAT0000226_1	hsa-miR-196a-5p	-3.7	0.000239	-0.31	-0.17	Obesity-related traits;	chr12:53120133	chr17:48632532~48632553:-
HNSC	cis	rs1957429	0.634	rs59000318	MIMAT0004808	hsa-miR-625-3p	-3.7	0.000239	-0.25	-0.17	Pediatric areal bone mineral density (radius);	chr14:64952755	chr14:65471153~65471174:+
HNSC	cis	rs12712133	1	rs12712133	MIMAT0019927	hsa-miR-4772-3p	3.7	0.000239	0.15	0.17	Primary biliary cholangitis;	chr2:102249813	chr2:102432336~102432357:+
HNSC	cis	rs3790645	1	rs34062688	MIMAT0018191	hsa-miR-3917	3.7	0.000239	0.19	0.17	Glucose homeostasis traits;	chr1:26560659	chr1:25906384~25906403:-
HNSC	cis	rs7210990	0.931	rs1029809	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000241	0.21	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16252921	chr17:16282058~16282078:+
HNSC	cis	rs4790312	0.875	rs9901671	MIMAT0000426	hsa-miR-132-3p	3.7	0.000241	0.19	0.17	Left atrial antero-posterior diameter;	chr17:2075190	chr17:2049929~2049950:-
HNSC	cis	rs7829975	0.539	rs940031	MIMAT0019728	hsa-miR-4660	-3.7	0.000241	-0.2	-0.17	Mood instability;	chr8:8689338	chr8:9048453~9048475:+
HNSC	cis	rs6601327	0.641	rs10102170	MIMAT0019728	hsa-miR-4660	3.7	0.000242	0.19	0.17	Multiple myeloma (hyperdiploidy);	chr8:9753960	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.597	rs7001187	MIMAT0019728	hsa-miR-4660	-3.7	0.000243	-0.2	-0.17	Joint mobility (Beighton score);	chr8:8935272	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.582	rs6982832	MIMAT0019728	hsa-miR-4660	-3.7	0.000244	-0.19	-0.17	Mood instability;	chr8:8934707	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.714	rs4841040	MIMAT0019728	hsa-miR-4660	3.7	0.000245	0.2	0.17	Mood instability;	chr8:8797017	chr8:9048453~9048475:+
HNSC	cis	rs8064299	0.597	rs4789097	MIMAT0017994	hsa-miR-3615	3.69	0.000246	0.2	0.17	Monocyte count;	chr17:74785069	chr17:74748663~74748683:+
HNSC	cis	rs7072216	0.687	rs10883087	MIMAT0005878	hsa-miR-1287-5p	3.69	0.000247	0.17	0.17	Metabolite levels;	chr10:98397233	chr10:98395271~98395292:-
HNSC	cis	rs250677	0.687	rs250673	MIMAT0003249	hsa-miR-584-5p	3.69	0.000247	0.18	0.17	Breast cancer;	chr5:149066235	chr5:149062373~149062394:-
HNSC	cis	rs250677	0.687	rs250672	MIMAT0003249	hsa-miR-584-5p	3.69	0.000247	0.18	0.17	Breast cancer;	chr5:149066547	chr5:149062373~149062394:-
HNSC	cis	rs10492002	0.566	rs1882189	MIMAT0003287	hsa-miR-618	3.69	0.000248	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81215480	chr12:80935796~80935818:-
HNSC	cis	rs7072216	0.687	rs4551689	MIMAT0005878	hsa-miR-1287-5p	-3.69	0.000249	-0.17	-0.17	Metabolite levels;	chr10:98397836	chr10:98395271~98395292:-
HNSC	cis	rs74233809	1	rs12217501	MIMAT0005951	hsa-miR-1307-3p	-3.69	0.00025	-0.21	-0.17	Birth weight;	chr10:103092132	chr10:103394301~103394322:-
HNSC	cis	rs11892454	0.565	rs6748220	MIMAT0026639	hsa-miR-1301-5p	3.69	0.00025	0.22	0.17	Heschl's gyrus morphology;	chr2:25878534	chr2:25328689~25328707:-
HNSC	cis	rs11174650	0.502	rs74395314	MIMAT0000415	hsa-let-7i-5p	-3.69	0.00025	-0.23	-0.17	Sense of smell;	chr12:62820135	chr12:62603691~62603712:+
HNSC	cis	rs74233809	1	rs12219901	MIMAT0005951	hsa-miR-1307-3p	-3.69	0.000251	-0.21	-0.17	Birth weight;	chr10:103081210	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs10458729	MIMAT0005951	hsa-miR-1307-3p	-3.69	0.000251	-0.21	-0.17	Birth weight;	chr10:103081722	chr10:103394301~103394322:-
HNSC	cis	rs12134133	1	rs2782846	MIMAT0004673	hsa-miR-29c-5p	-3.69	0.000252	-0.12	-0.17	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207300495	chr1:207801903~207801924:-
HNSC	cis	rs4919687	0.577	rs12765459	MIMAT0022727	hsa-miR-1307-5p	3.69	0.000252	0.16	0.17	Colorectal cancer;	chr10:102705930	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.687	rs10786418	MIMAT0005878	hsa-miR-1287-5p	3.69	0.000252	0.17	0.17	Metabolite levels;	chr10:98397611	chr10:98395271~98395292:-
HNSC	cis	rs1656966	1	rs1656966	MIMAT0005900	hsa-miR-1248	-3.69	0.000252	-0.16	-0.17	Myopia (pathological);	chr3:186748463	chr3:186786675~186786701:+
HNSC	cis	rs12682352	0.605	rs60707155	MIMAT0019728	hsa-miR-4660	3.69	0.000252	0.2	0.17	Neuroticism;	chr8:8866905	chr8:9048453~9048475:+
HNSC	cis	rs8140097	0.566	rs7287398	MIMAT0022726	hsa-miR-1306-5p	-3.69	0.000254	-0.25	-0.17	Recurrent major depressive disorder;	chr22:19571767	chr22:20086072~20086093:+
HNSC	cis	rs8140097	0.566	rs13057770	MIMAT0022726	hsa-miR-1306-5p	-3.69	0.000254	-0.25	-0.17	Recurrent major depressive disorder;	chr22:19572105	chr22:20086072~20086093:+
HNSC	cis	rs4919687	0.55	rs12783444	MIMAT0022727	hsa-miR-1307-5p	3.69	0.000254	0.15	0.17	Colorectal cancer;	chr10:102720902	chr10:103394341~103394361:-
HNSC	cis	rs250677	0.687	rs250667	MIMAT0003249	hsa-miR-584-5p	-3.69	0.000255	-0.17	-0.17	Breast cancer;	chr5:149075571	chr5:149062373~149062394:-
HNSC	cis	rs6601327	0.613	rs10094989	MIMAT0019728	hsa-miR-4660	3.69	0.000255	0.19	0.17	Multiple myeloma (hyperdiploidy);	chr8:9754499	chr8:9048453~9048475:+
HNSC	cis	rs7072216	0.77	rs1737	MIMAT0026738	hsa-miR-1287-3p	3.68	0.000256	0.16	0.17	Metabolite levels;	chr10:98416609	chr10:98395232~98395253:-
HNSC	cis	rs12134133	1	rs2802237	MIMAT0004673	hsa-miR-29c-5p	-3.68	0.000256	-0.12	-0.17	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207300825	chr1:207801903~207801924:-
HNSC	cis	rs11992186	0.597	rs11781841	MIMAT0019728	hsa-miR-4660	-3.68	0.000257	-0.21	-0.17	Neuroticism;	chr8:8737753	chr8:9048453~9048475:+
HNSC	cis	rs11892454	0.712	rs13409567	MIMAT0026639	hsa-miR-1301-5p	3.68	0.000257	0.22	0.17	Heschl's gyrus morphology;	chr2:25719381	chr2:25328689~25328707:-
HNSC	cis	rs10492002	0.508	rs2574733	MIMAT0003287	hsa-miR-618	-3.68	0.000258	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81135426	chr12:80935796~80935818:-
HNSC	cis	rs7829975	0.577	rs940032	MIMAT0019728	hsa-miR-4660	-3.68	0.000259	-0.2	-0.17	Mood instability;	chr8:8688833	chr8:9048453~9048475:+
HNSC	cis	rs7931462	0.655	rs12272268	MIMAT0022720	hsa-miR-1304-3p	3.68	0.00026	0.44	0.17	DNA methylation (parent-of-origin);	chr11:92975633	chr11:93733691~93733712:-
HNSC	cis	rs10492002	0.52	rs2525843	MIMAT0003287	hsa-miR-618	-3.68	0.000262	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81136021	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.52	rs2525842	MIMAT0003287	hsa-miR-618	-3.68	0.000262	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81136165	chr12:80935796~80935818:-
HNSC	cis	rs7072216	0.687	rs10786416	MIMAT0005878	hsa-miR-1287-5p	3.68	0.000263	0.17	0.17	Metabolite levels;	chr10:98393843	chr10:98395271~98395292:-
HNSC	cis	rs17730929	0.722	rs35759060	MIMAT0005923	hsa-miR-1269a	-3.68	0.000264	-0.46	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66280452	chr4:66276890~66276911:+
HNSC	cis	rs3790645	1	rs1064196	MIMAT0018191	hsa-miR-3917	-3.68	0.000265	-0.19	-0.17	Glucose homeostasis traits;	chr1:26561101	chr1:25906384~25906403:-
HNSC	cis	rs12134133	1	rs2564973	MIMAT0004673	hsa-miR-29c-5p	-3.68	0.000266	-0.12	-0.17	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207306759	chr1:207801903~207801924:-
HNSC	cis	rs12134133	1	rs2782840	MIMAT0004673	hsa-miR-29c-5p	-3.68	0.000266	-0.12	-0.17	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207310838	chr1:207801903~207801924:-
HNSC	cis	rs7851726	0.646	rs10993387	MIMAT0019208	hsa-miR-3074-5p	-3.67	0.000266	-0.17	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94900214	chr9:95086063~95086083:-
HNSC	cis	rs10492002	0.76	rs4842386	MIMAT0003287	hsa-miR-618	3.67	0.000266	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81175542	chr12:80935796~80935818:-
HNSC	cis	rs2302612	0.718	rs6742931	MIMAT0019926	hsa-miR-4772-5p	3.67	0.000266	0.2	0.17	Serum protein levels (sST2);	chr2:102234783	chr2:102432300~102432321:+
HNSC	cis	rs7104764	0.879	rs6598070	MIMAT0026475	hsa-miR-210-5p	3.67	0.000266	0.25	0.17	Menarche (age at onset);	chr11:225466	chr11:568150~568171:-
HNSC	cis	rs7829975	0.742	rs882462	MIMAT0019728	hsa-miR-4660	3.67	0.000267	0.2	0.17	Mood instability;	chr8:8821020	chr8:9048453~9048475:+
HNSC	cis	rs7851726	0.668	rs10761361	MIMAT0019208	hsa-miR-3074-5p	-3.67	0.000267	-0.17	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94882260	chr9:95086063~95086083:-
HNSC	cis	rs941898	1	rs941898	MIMAT0004814	hsa-miR-654-3p	3.67	0.00027	0.08	0.17	White matter hyperintensity burden;	chr14:100133100	chr14:101040269~101040290:+
HNSC	cis	rs2963826	0.565	rs4235477	MIMAT0004797	hsa-miR-582-3p	3.67	0.00027	0.17	0.17	Obesity-related traits;	chr5:59765456	chr5:59703630~59703651:-
HNSC	cis	rs7829975	0.807	rs519019	MIMAT0019728	hsa-miR-4660	-3.67	0.00027	-0.2	-0.17	Mood instability;	chr8:8737594	chr8:9048453~9048475:+
HNSC	cis	rs12134133	1	rs28371614	MIMAT0004673	hsa-miR-29c-5p	-3.67	0.00027	-0.12	-0.17	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207331929	chr1:207801903~207801924:-
HNSC	cis	rs59372292	0.597	rs34337793	MIMAT0021017	hsa-miR-4999-5p	3.67	0.00027	0.22	0.17	Coronary artery disease;	chr19:8454339	chr19:8389340~8389360:-
HNSC	cis	rs941898	0.957	rs7159195	MIMAT0004814	hsa-miR-654-3p	3.67	0.000271	0.08	0.17	White matter hyperintensity burden;	chr14:100116993	chr14:101040269~101040290:+
HNSC	cis	rs941898	0.836	rs7158754	MIMAT0004814	hsa-miR-654-3p	3.67	0.000271	0.08	0.17	White matter hyperintensity burden;	chr14:100117012	chr14:101040269~101040290:+
HNSC	cis	rs10492002	0.638	rs12826108	MIMAT0003287	hsa-miR-618	3.67	0.000273	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81209590	chr12:80935796~80935818:-
HNSC	cis	rs250677	0.687	rs250671	MIMAT0003249	hsa-miR-584-5p	3.67	0.000276	0.18	0.17	Breast cancer;	chr5:149066960	chr5:149062373~149062394:-
HNSC	cis	rs250677	0.652	rs250670	MIMAT0003249	hsa-miR-584-5p	3.67	0.000276	0.18	0.17	Breast cancer;	chr5:149067083	chr5:149062373~149062394:-
HNSC	cis	rs250677	0.687	rs168750	MIMAT0003249	hsa-miR-584-5p	3.67	0.000276	0.18	0.17	Breast cancer;	chr5:149067193	chr5:149062373~149062394:-
HNSC	cis	rs4921799	0.711	rs2269699	MIMAT0015020	hsa-miR-548v	-3.66	0.000276	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17675110	chr8:17681588~17681609:-
HNSC	cis	rs250677	0.524	rs183140	MIMAT0003249	hsa-miR-584-5p	3.66	0.000279	0.16	0.17	Breast cancer;	chr5:149059240	chr5:149062373~149062394:-
HNSC	cis	rs7829975	0.577	rs79495969	MIMAT0019728	hsa-miR-4660	-3.66	0.000281	-0.21	-0.17	Mood instability;	chr8:8687740	chr8:9048453~9048475:+
HNSC	cis	rs11892454	0.674	rs6706535	MIMAT0026639	hsa-miR-1301-5p	3.66	0.000284	0.21	0.17	Heschl's gyrus morphology;	chr2:25721802	chr2:25328689~25328707:-
HNSC	cis	rs10492002	0.573	rs17303475	MIMAT0003287	hsa-miR-618	3.66	0.000285	0.19	0.17	Response to antidepressant treatment (citalopram);	chr12:81226665	chr12:80935796~80935818:-
HNSC	cis	rs17730929	0.858	rs7693354	MIMAT0005923	hsa-miR-1269a	-3.66	0.000286	-0.48	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66461109	chr4:66276890~66276911:+
HNSC	cis	rs4819852	0.752	rs4819527	MIMAT0000455	hsa-miR-185-5p	-3.65	0.000287	-0.17	-0.17	Pulse pressure;	chr22:19990499	chr22:20033153~20033174:+
HNSC	cis	rs7210990	0.724	rs9916868	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000291	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16029506	chr17:16282058~16282078:+
HNSC	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma;	chr2:102426252	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma;	chr2:102427407	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma;	chr2:102427715	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma;	chr2:102431747	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma;	chr2:102432120	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma;	chr2:102432614	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-3.65	0.000291	-0.14	-0.17	Asthma;	chr2:102433405	chr2:102432336~102432357:+
HNSC	cis	rs17109512	1	rs17109512	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000294	0.37	0.17	Aspartate aminotransferase levels;	chr10:98367794	chr10:98395271~98395292:-
HNSC	cis	rs11174650	0.605	rs75297928	MIMAT0000415	hsa-let-7i-5p	-3.64	0.000298	-0.24	-0.17	Sense of smell;	chr12:62820196	chr12:62603691~62603712:+
HNSC	cis	rs3790645	1	rs392814	MIMAT0018191	hsa-miR-3917	3.64	0.000299	0.19	0.17	Glucose homeostasis traits;	chr1:26565518	chr1:25906384~25906403:-
HNSC	cis	rs7104764	0.957	rs519592	MIMAT0026475	hsa-miR-210-5p	3.64	0.000302	0.24	0.17	Menarche (age at onset);	chr11:236811	chr11:568150~568171:-
HNSC	cis	rs17730929	0.659	rs1033095	MIMAT0005923	hsa-miR-1269a	3.64	0.000303	0.36	0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66366293	chr4:66276890~66276911:+
HNSC	cis	rs4553443	0.872	rs11171169	MIMAT0000226	hsa-miR-196a-5p	3.64	0.000304	0.22	0.17	Cancer;	chr12:54929651	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs11171169	MIMAT0000226_1	hsa-miR-196a-5p	3.64	0.000304	0.22	0.17	Cancer;	chr12:54929651	chr17:48632532~48632553:-
HNSC	cis	rs7072216	0.77	rs7909131	MIMAT0026738	hsa-miR-1287-3p	3.64	0.000308	0.16	0.17	Metabolite levels;	chr10:98411714	chr10:98395232~98395253:-
HNSC	cis	rs4819852	0.958	rs1034564	MIMAT0000455	hsa-miR-185-5p	3.64	0.000308	0.17	0.17	Pulse pressure;	chr22:19996490	chr22:20033153~20033174:+
HNSC	cis	rs992157	0.764	rs10932774	MIMAT0000083	hsa-miR-26b-5p	-3.64	0.000309	-0.11	-0.17	Colorectal cancer;	chr2:218326846	chr2:218402657~218402677:+
HNSC	cis	rs11671653	1	rs8112837	MIMAT0027486	hsa-miR-6793-5p	3.63	0.000309	0.4	0.17	LDL cholesterol;	chr19:10726354	chr19:10828978~10828999:+
HNSC	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-3.63	0.00031	-0.15	-0.17	Asthma;	chr2:102370999	chr2:102432336~102432357:+
HNSC	cis	rs7792596	0.861	rs6970279	MIMAT0003328	hsa-miR-653-5p	3.63	0.000311	0.23	0.17	Intelligence;	chr7:94385577	chr7:93482823~93482843:-
HNSC	cis	rs3790645	1	rs897641	MIMAT0018191	hsa-miR-3917	3.63	0.000311	0.19	0.17	Glucose homeostasis traits;	chr1:26555315	chr1:25906384~25906403:-
HNSC	cis	rs79387448	0.701	rs11465596	MIMAT0019927	hsa-miR-4772-3p	-3.63	0.000311	-0.23	-0.17	Gut microbiota (bacterial taxa);	chr2:102370633	chr2:102432336~102432357:+
HNSC	cis	rs7829975	0.511	rs2980512	MIMAT0019728	hsa-miR-4660	3.63	0.000313	0.19	0.17	Mood instability;	chr8:8283379	chr8:9048453~9048475:+
HNSC	cis	rs6519955	0.897	rs4073601	MIMAT0019911	hsa-miR-4762-3p	3.63	0.000314	0.19	0.17	Dupuytren's disease;	chr22:46038806	chr22:45760572~45760593:+
HNSC	cis	rs12134133	1	rs2782848	MIMAT0004673	hsa-miR-29c-5p	-3.63	0.000315	-0.12	-0.17	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207293407	chr1:207801903~207801924:-
HNSC	cis	rs59372292	0.597	rs11259985	MIMAT0021017	hsa-miR-4999-5p	3.63	0.000315	0.22	0.17	Coronary artery disease;	chr19:8451793	chr19:8389340~8389360:-
HNSC	cis	rs4790312	0.901	rs8078625	MIMAT0000426	hsa-miR-132-3p	3.63	0.000316	0.18	0.17	Left atrial antero-posterior diameter;	chr17:2075040	chr17:2049929~2049950:-
HNSC	cis	rs7210990	0.724	rs35168566	MIMAT0005942	hsa-miR-1288-3p	3.63	0.000316	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16026773	chr17:16282058~16282078:+
HNSC	cis	rs744016	0.645	rs8138884	MIMAT0005875	hsa-miR-548j-5p	-3.63	0.000318	-0.3	-0.17	RR interval (heart rate);	chr22:26602835	chr22:26555274~26555295:-
HNSC	cis	rs744016	0.645	rs4822747	MIMAT0005875	hsa-miR-548j-5p	-3.63	0.000318	-0.3	-0.17	RR interval (heart rate);	chr22:26605725	chr22:26555274~26555295:-
HNSC	cis	rs4919687	0.544	rs34269636	MIMAT0022727	hsa-miR-1307-5p	3.63	0.000318	0.16	0.17	Colorectal cancer;	chr10:102650842	chr10:103394341~103394361:-
HNSC	cis	rs941898	0.957	rs3783332	MIMAT0004814	hsa-miR-654-3p	3.63	0.000321	0.08	0.17	White matter hyperintensity burden;	chr14:100120420	chr14:101040269~101040290:+
HNSC	cis	rs7104764	1	rs2293167	MIMAT0026475	hsa-miR-210-5p	-3.62	0.000321	-0.24	-0.17	Menarche (age at onset);	chr11:211644	chr11:568150~568171:-
HNSC	cis	rs4919687	0.544	rs12764219	MIMAT0022727	hsa-miR-1307-5p	3.62	0.000322	0.16	0.17	Colorectal cancer;	chr10:102639138	chr10:103394341~103394361:-
HNSC	cis	rs4819852	0.752	rs2238783	MIMAT0000455	hsa-miR-185-5p	-3.62	0.000325	-0.17	-0.17	Pulse pressure;	chr22:19984929	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.752	rs917478	MIMAT0000455	hsa-miR-185-5p	-3.62	0.000325	-0.17	-0.17	Pulse pressure;	chr22:19985301	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.752	rs917479	MIMAT0000455	hsa-miR-185-5p	-3.62	0.000325	-0.17	-0.17	Pulse pressure;	chr22:19985682	chr22:20033153~20033174:+
HNSC	cis	rs1345301	1	rs12475055	MIMAT0019927	hsa-miR-4772-3p	-3.62	0.000327	-0.15	-0.17	Waist circumference;	chr2:102262431	chr2:102432336~102432357:+
HNSC	cis	rs7829975	0.84	rs555617	MIMAT0019728	hsa-miR-4660	-3.62	0.000328	-0.2	-0.17	Mood instability;	chr8:8735335	chr8:9048453~9048475:+
HNSC	cis	rs9409565	0.826	rs2139189	MIMAT0019208	hsa-miR-3074-5p	3.62	0.000328	0.17	0.17	Colorectal cancer (alcohol consumption interaction);	chr9:94476256	chr9:95086063~95086083:-
HNSC	cis	rs2948294	0.588	rs7011221	MIMAT0019728	hsa-miR-4660	3.62	0.000328	0.21	0.17	Red cell distribution width;	chr8:8256724	chr8:9048453~9048475:+
HNSC	cis	rs4819852	0.752	rs2238782	MIMAT0000455	hsa-miR-185-5p	-3.62	0.00033	-0.17	-0.17	Pulse pressure;	chr22:19983060	chr22:20033153~20033174:+
HNSC	cis	rs4553443	0.872	rs7304166	MIMAT0000226	hsa-miR-196a-5p	-3.62	0.00033	-0.23	-0.17	Cancer;	chr12:54934717	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs7304166	MIMAT0000226_1	hsa-miR-196a-5p	-3.62	0.00033	-0.23	-0.17	Cancer;	chr12:54934717	chr17:48632532~48632553:-
HNSC	cis	rs12134133	1	rs28371583	MIMAT0004673	hsa-miR-29c-5p	-3.62	0.000331	-0.12	-0.17	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207321334	chr1:207801903~207801924:-
HNSC	cis	rs4819852	0.706	rs2240717	MIMAT0000455	hsa-miR-185-5p	-3.62	0.000331	-0.17	-0.17	Pulse pressure;	chr22:19981583	chr22:20033153~20033174:+
HNSC	cis	rs9527	0.59	rs12246739	MIMAT0022727	hsa-miR-1307-5p	-3.62	0.000331	-0.14	-0.17	Arsenic metabolism;	chr10:103027262	chr10:103394341~103394361:-
HNSC	cis	rs7072216	0.687	rs7097625	MIMAT0005878	hsa-miR-1287-5p	3.62	0.000332	0.17	0.17	Metabolite levels;	chr10:98399165	chr10:98395271~98395292:-
HNSC	cis	rs7104764	1	rs1128322	MIMAT0026475	hsa-miR-210-5p	-3.61	0.000333	-0.24	-0.17	Menarche (age at onset);	chr11:244197	chr11:568150~568171:-
HNSC	cis	rs10492002	0.52	rs2701788	MIMAT0003287	hsa-miR-618	-3.61	0.000334	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81125954	chr12:80935796~80935818:-
HNSC	cis	rs10492002	0.52	rs2574746	MIMAT0003287	hsa-miR-618	-3.61	0.000334	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81125969	chr12:80935796~80935818:-
HNSC	cis	rs189798	0.592	rs10111263	MIMAT0019728	hsa-miR-4660	-3.61	0.000335	-0.19	-0.17	Myopia (pathological);	chr8:9111923	chr8:9048453~9048475:+
HNSC	cis	rs10021731	0.577	rs34941812	MIMAT0003242	hsa-miR-577	-3.61	0.000337	-0.18	-0.17	Optic disc area;	chr4:114673260	chr4:114656774~114656794:+
HNSC	cis	rs7829975	0.714	rs11777085	MIMAT0019728	hsa-miR-4660	3.61	0.000338	0.19	0.17	Mood instability;	chr8:8814919	chr8:9048453~9048475:+
HNSC	cis	rs4819852	1	rs1034566	MIMAT0000455	hsa-miR-185-5p	-3.61	0.000339	-0.18	-0.17	Pulse pressure;	chr22:19996754	chr22:20033153~20033174:+
HNSC	cis	rs2963826	0.552	rs6450529	MIMAT0004797	hsa-miR-582-3p	3.61	0.00034	0.17	0.17	Obesity-related traits;	chr5:59759235	chr5:59703630~59703651:-
HNSC	cis	rs10492002	0.52	rs2574741	MIMAT0003287	hsa-miR-618	-3.61	0.000342	-0.19	-0.17	Response to antidepressant treatment (citalopram);	chr12:81128065	chr12:80935796~80935818:-
HNSC	cis	rs7104764	1	rs6598074	MIMAT0026475	hsa-miR-210-5p	3.61	0.000342	0.24	0.17	Menarche (age at onset);	chr11:219398	chr11:568150~568171:-
HNSC	cis	rs4553443	0.872	rs11171175	MIMAT0000226	hsa-miR-196a-5p	-3.61	0.000342	-0.23	-0.17	Cancer;	chr12:54936547	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.872	rs11171175	MIMAT0000226_1	hsa-miR-196a-5p	-3.61	0.000342	-0.23	-0.17	Cancer;	chr12:54936547	chr17:48632532~48632553:-
HNSC	cis	rs17695224	0.545	rs4802884	MIMAT0000066	hsa-let-7e-5p	-3.61	0.000343	-0.12	-0.17	HDL cholesterol;HDL cholesterol levels;	chr19:51845202	chr19:51692793~51692814:+
HNSC	cis	rs74233809	1	rs12221193	MIMAT0005951	hsa-miR-1307-3p	-3.61	0.000344	-0.2	-0.17	Birth weight;	chr10:102905510	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs77180047	MIMAT0005951	hsa-miR-1307-3p	-3.61	0.000344	-0.2	-0.17	Birth weight;	chr10:102907000	chr10:103394301~103394322:-
HNSC	cis	rs17695224	0.545	rs11666614	MIMAT0000066	hsa-let-7e-5p	-3.61	0.000344	-0.12	-0.17	HDL cholesterol;HDL cholesterol levels;	chr19:51842833	chr19:51692793~51692814:+
HNSC	cis	rs3790645	1	rs657227	MIMAT0018191	hsa-miR-3917	3.61	0.000345	0.18	0.17	Glucose homeostasis traits;	chr1:26565613	chr1:25906384~25906403:-
HNSC	cis	rs3790645	1	rs396997	MIMAT0018191	hsa-miR-3917	3.61	0.000345	0.18	0.17	Glucose homeostasis traits;	chr1:26566576	chr1:25906384~25906403:-
HNSC	cis	rs3790645	1	rs369385	MIMAT0018191	hsa-miR-3917	3.61	0.000345	0.18	0.17	Glucose homeostasis traits;	chr1:26566738	chr1:25906384~25906403:-
HNSC	cis	rs17730929	0.722	rs35892988	MIMAT0005923	hsa-miR-1269a	-3.61	0.000345	-0.46	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66299108	chr4:66276890~66276911:+
HNSC	cis	rs17730929	0.722	rs34697146	MIMAT0005923	hsa-miR-1269a	-3.61	0.000345	-0.46	-0.17	Colorectal cancer (SNP x SNP interaction);	chr4:66300336	chr4:66276890~66276911:+
HNSC	cis	rs3790645	1	rs3790645	MIMAT0018191	hsa-miR-3917	3.6	0.000346	0.19	0.17	Glucose homeostasis traits;	chr1:26558373	chr1:25906384~25906403:-
HNSC	cis	rs17695224	0.545	rs7252805	MIMAT0000066	hsa-let-7e-5p	-3.6	0.000348	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51840169	chr19:51692793~51692814:+
HNSC	cis	rs1957429	0.808	rs7144718	MIMAT0004808	hsa-miR-625-3p	3.6	0.000348	0.24	0.16	Pediatric areal bone mineral density (radius);	chr14:64867113	chr14:65471153~65471174:+
HNSC	cis	rs1957429	0.808	rs7149922	MIMAT0004808	hsa-miR-625-3p	3.6	0.000348	0.24	0.16	Pediatric areal bone mineral density (radius);	chr14:64867823	chr14:65471153~65471174:+
HNSC	cis	rs1957429	0.808	rs11158564	MIMAT0004808	hsa-miR-625-3p	3.6	0.000348	0.24	0.16	Pediatric areal bone mineral density (radius);	chr14:64868364	chr14:65471153~65471174:+
HNSC	cis	rs17730929	0.722	rs13151607	MIMAT0005923	hsa-miR-1269a	-3.6	0.00035	-0.45	-0.16	Colorectal cancer (SNP x SNP interaction);	chr4:66294789	chr4:66276890~66276911:+
HNSC	cis	rs9527	0.59	rs10883820	MIMAT0022727	hsa-miR-1307-5p	-3.6	0.00035	-0.14	-0.16	Arsenic metabolism;	chr10:103004904	chr10:103394341~103394361:-
HNSC	cis	rs13221576	0.569	rs17166228	MIMAT0003328	hsa-miR-653-5p	-3.6	0.000351	-0.32	-0.16	Intelligence;	chr7:94386933	chr7:93482823~93482843:-
HNSC	cis	rs56052703	0.702	rs10421428	MIMAT0004496	hsa-miR-23a-5p	-3.6	0.000351	-0.18	-0.16	Proteinuria and chronic kidney disease;	chr19:13322534	chr19:13836630~13836651:-
HNSC	cis	rs1018697	0.518	rs2250301	MIMAT0005951	hsa-miR-1307-3p	-3.6	0.000351	-0.13	-0.16	Colorectal adenoma (advanced);	chr10:102788636	chr10:103394301~103394322:-
HNSC	cis	rs7829975	0.606	rs6422352	MIMAT0019728	hsa-miR-4660	-3.6	0.000352	-0.19	-0.16	Mood instability;	chr8:8936683	chr8:9048453~9048475:+
HNSC	cis	rs7829975	0.606	rs891570	MIMAT0019728	hsa-miR-4660	-3.6	0.000352	-0.19	-0.16	Mood instability;	chr8:8936944	chr8:9048453~9048475:+
HNSC	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	3.6	0.000352	0.14	0.16	Asthma;	chr2:102377873	chr2:102432336~102432357:+
HNSC	cis	rs59372292	0.597	rs2081197	MIMAT0021017	hsa-miR-4999-5p	3.6	0.000352	0.22	0.16	Coronary artery disease;	chr19:8448452	chr19:8389340~8389360:-
HNSC	cis	rs59372292	0.597	rs11666117	MIMAT0021017	hsa-miR-4999-5p	3.6	0.000352	0.22	0.16	Coronary artery disease;	chr19:8449010	chr19:8389340~8389360:-
HNSC	cis	rs59372292	0.619	rs11259983	MIMAT0021017	hsa-miR-4999-5p	3.6	0.000352	0.22	0.16	Coronary artery disease;	chr19:8450491	chr19:8389340~8389360:-
HNSC	cis	rs8074700	0.539	rs3096647	MIMAT0004555	hsa-miR-10a-3p	3.6	0.000353	0.2	0.16	Body mass index in non-asthmatics;	chr17:48676717	chr17:48579864~48579885:-
HNSC	cis	rs4553443	0.813	rs12368135	MIMAT0000226	hsa-miR-196a-5p	-3.6	0.000355	-0.22	-0.16	Cancer;	chr12:54929003	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.813	rs12368135	MIMAT0000226_1	hsa-miR-196a-5p	-3.6	0.000355	-0.22	-0.16	Cancer;	chr12:54929003	chr17:48632532~48632553:-
HNSC	cis	rs4553443	0.967	rs59872891	MIMAT0000226	hsa-miR-196a-5p	-3.6	0.000355	-0.22	-0.16	Cancer;	chr12:54928174	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.967	rs59872891	MIMAT0000226_1	hsa-miR-196a-5p	-3.6	0.000355	-0.22	-0.16	Cancer;	chr12:54928174	chr17:48632532~48632553:-
HNSC	cis	rs1957429	0.901	rs2884308	MIMAT0004808	hsa-miR-625-3p	-3.6	0.000356	-0.24	-0.16	Pediatric areal bone mineral density (radius);	chr14:64883688	chr14:65471153~65471174:+
HNSC	cis	rs1555895	0.576	rs12413228	MIMAT0027103	hsa-miR-5699-5p	-3.6	0.000356	-0.19	-0.16	Survival in rectal cancer;	chr10:803290	chr10:641748~641769:-
HNSC	cis	rs7209460	0.518	rs6503222	MIMAT0000426	hsa-miR-132-3p	3.6	0.000357	0.18	0.16	Coronary artery disease;Total body bone mineral density;	chr17:2074568	chr17:2049929~2049950:-
HNSC	cis	rs1018697	0.966	rs6584526	MIMAT0022727	hsa-miR-1307-5p	3.6	0.000358	0.13	0.16	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.615	rs10883781	MIMAT0005951	hsa-miR-1307-3p	3.6	0.000358	0.13	0.16	Arsenic metabolism;	chr10:102821373	chr10:103394301~103394322:-
HNSC	cis	rs12134133	1	rs1429904	MIMAT0004673	hsa-miR-29c-5p	-3.6	0.000358	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207288539	chr1:207801903~207801924:-
HNSC	cis	rs12134133	1	rs2782854	MIMAT0004673	hsa-miR-29c-5p	-3.6	0.000358	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207289369	chr1:207801903~207801924:-
HNSC	cis	rs74233809	0.534	rs176185	MIMAT0022727	hsa-miR-1307-5p	3.59	0.00036	0.22	0.16	Birth weight;	chr10:102796297	chr10:103394341~103394361:-
HNSC	cis	rs9299	0.778	rs11079830	MIMAT0000253	hsa-miR-10a-5p	-3.59	0.000361	-0.19	-0.16	Obesity;	chr17:48605268	chr17:48579904~48579926:-
HNSC	cis	rs7072216	0.77	rs7896828	MIMAT0026738	hsa-miR-1287-3p	3.59	0.000362	0.16	0.16	Metabolite levels;	chr10:98410750	chr10:98395232~98395253:-
HNSC	cis	rs1014286	0.706	rs4851019	MIMAT0019927	hsa-miR-4772-3p	3.59	0.000362	0.14	0.16	Serum protein levels (sST2);	chr2:102561106	chr2:102432336~102432357:+
HNSC	cis	rs17109512	1	rs17109512	MIMAT0026738	hsa-miR-1287-3p	3.59	0.000364	0.34	0.16	Aspartate aminotransferase levels;	chr10:98367794	chr10:98395232~98395253:-
HNSC	cis	rs74233809	1	rs10883815	MIMAT0005951	hsa-miR-1307-3p	-3.59	0.000365	-0.2	-0.16	Birth weight;	chr10:102979422	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs112390216	MIMAT0005951	hsa-miR-1307-3p	-3.59	0.000365	-0.2	-0.16	Birth weight;	chr10:102981274	chr10:103394301~103394322:-
HNSC	cis	rs4553443	0.813	rs12368165	MIMAT0000226	hsa-miR-196a-5p	-3.59	0.000366	-0.22	-0.16	Cancer;	chr12:54929001	chr12:53991762~53991783:+
HNSC	cis	rs4553443	0.813	rs12368165	MIMAT0000226_1	hsa-miR-196a-5p	-3.59	0.000366	-0.22	-0.16	Cancer;	chr12:54929001	chr17:48632532~48632553:-
HNSC	cis	rs56052703	0.702	rs76893841	MIMAT0004501	hsa-miR-27a-5p	3.59	0.000368	0.23	0.16	Proteinuria and chronic kidney disease;	chr19:13321964	chr19:13836487~13836508:-
HNSC	cis	rs2871473	1	rs2871473	MIMAT0019927	hsa-miR-4772-3p	-3.59	0.000369	-0.18	-0.16	Blood protein levels;	chr2:102490821	chr2:102432336~102432357:+
HNSC	cis	rs1014286	0.706	rs10196579	MIMAT0019927	hsa-miR-4772-3p	3.59	0.00037	0.14	0.16	Serum protein levels (sST2);	chr2:102553722	chr2:102432336~102432357:+
HNSC	cis	rs1014286	0.706	rs2310295	MIMAT0019927	hsa-miR-4772-3p	3.59	0.00037	0.14	0.16	Serum protein levels (sST2);	chr2:102554607	chr2:102432336~102432357:+
HNSC	cis	rs17730929	0.722	rs34110728	MIMAT0005923	hsa-miR-1269a	-3.59	0.000371	-0.44	-0.16	Colorectal cancer (SNP x SNP interaction);	chr4:66290892	chr4:66276890~66276911:+
HNSC	cis	rs941898	0.574	rs8006662	MIMAT0004814	hsa-miR-654-3p	-3.59	0.000372	-0.08	-0.16	White matter hyperintensity burden;	chr14:100111553	chr14:101040269~101040290:+
HNSC	cis	rs9814567	1	rs1863913	MIMAT0019958	hsa-miR-4788	3.59	0.000372	0.19	0.16	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134481363	chr3:134437836~134437857:+
HNSC	cis	rs1588265	0.61	rs57587828	MIMAT0003247	hsa-miR-582-5p	-3.58	0.000374	-0.19	-0.16	Asthma;	chr5:60240522	chr5:59703666~59703688:-
HNSC	cis	rs250677	0.687	rs2915809	MIMAT0003249	hsa-miR-584-5p	3.58	0.000374	0.17	0.16	Breast cancer;	chr5:149072548	chr5:149062373~149062394:-
HNSC	cis	rs250677	0.687	rs250663	MIMAT0003249	hsa-miR-584-5p	3.58	0.000374	0.17	0.16	Breast cancer;	chr5:149073554	chr5:149062373~149062394:-
HNSC	cis	rs2963826	0.552	rs6450529	MIMAT0003247	hsa-miR-582-5p	3.58	0.000375	0.18	0.16	Obesity-related traits;	chr5:59759235	chr5:59703666~59703688:-
HNSC	cis	rs6601327	0.613	rs12677507	MIMAT0019728	hsa-miR-4660	-3.58	0.000375	-0.19	-0.16	Multiple myeloma (hyperdiploidy);	chr8:9624177	chr8:9048453~9048475:+
HNSC	cis	rs17001239	0.557	rs1740082	MIMAT0004658	hsa-miR-155-3p	3.58	0.000375	0.3	0.16	Cognitive performance;	chr21:25563060	chr21:25574022~25574043:+
HNSC	cis	rs17001239	0.85	rs4143370	MIMAT0004658	hsa-miR-155-3p	3.58	0.000375	0.3	0.16	Cognitive performance;	chr21:25564661	chr21:25574022~25574043:+
HNSC	cis	rs11743006	0.626	rs1821472	MIMAT0004911	hsa-miR-874-3p	3.58	0.000375	0.25	0.16	Mathematical ability;	chr5:137161166	chr5:137647582~137647603:-
HNSC	cis	rs11743006	0.626	rs11748042	MIMAT0004911	hsa-miR-874-3p	3.58	0.000375	0.25	0.16	Mathematical ability;	chr5:137161542	chr5:137647582~137647603:-
HNSC	cis	rs59372292	0.597	rs17160491	MIMAT0021017	hsa-miR-4999-5p	3.58	0.000376	0.22	0.16	Coronary artery disease;	chr19:8448056	chr19:8389340~8389360:-
HNSC	cis	rs13221576	0.569	rs13240027	MIMAT0003328	hsa-miR-653-5p	-3.58	0.000376	-0.31	-0.16	Intelligence;	chr7:94386207	chr7:93482823~93482843:-
HNSC	cis	rs4921799	0.711	rs2269697	MIMAT0015020	hsa-miR-548v	-3.58	0.000378	-0.19	-0.16	Lung cancer;Adenocarcinoma;	chr8:17674945	chr8:17681588~17681609:-
HNSC	cis	rs7104764	1	rs6598060	MIMAT0026475	hsa-miR-210-5p	3.58	0.000378	0.23	0.16	Menarche (age at onset);	chr11:243987	chr11:568150~568171:-
HNSC	cis	rs7829975	0.617	rs4841072	MIMAT0019728	hsa-miR-4660	-3.58	0.000378	-0.19	-0.16	Mood instability;	chr8:8933743	chr8:9048453~9048475:+
HNSC	cis	rs3790645	1	rs444482	MIMAT0018191	hsa-miR-3917	3.58	0.000378	0.18	0.16	Glucose homeostasis traits;	chr1:26564157	chr1:25906384~25906403:-
HNSC	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102388870	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102389644	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102389988	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102374753	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102379885	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs7584093	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102381261	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102381819	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102382514	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102382943	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102394452	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102399227	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102402540	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102402571	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102403325	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.00038	-0.14	-0.16	Asthma;	chr2:102403679	chr2:102432336~102432357:+
HNSC	cis	rs13221576	0.569	rs71562852	MIMAT0003328	hsa-miR-653-5p	-3.58	0.000381	-0.31	-0.16	Intelligence;	chr7:94384939	chr7:93482823~93482843:-
HNSC	cis	rs6163	0.508	rs12776506	MIMAT0022727	hsa-miR-1307-5p	3.58	0.000381	0.15	0.16	Waist circumference;Hip circumference;	chr10:102773071	chr10:103394341~103394361:-
HNSC	cis	rs1957429	0.808	rs6573580	MIMAT0004808	hsa-miR-625-3p	3.58	0.000382	0.24	0.16	Pediatric areal bone mineral density (radius);	chr14:64865048	chr14:65471153~65471174:+
HNSC	cis	rs1957429	0.808	rs6573581	MIMAT0004808	hsa-miR-625-3p	3.58	0.000382	0.24	0.16	Pediatric areal bone mineral density (radius);	chr14:64865237	chr14:65471153~65471174:+
HNSC	cis	rs74233809	0.515	rs72841270	MIMAT0022727	hsa-miR-1307-5p	-3.58	0.000382	-0.19	-0.16	Birth weight;	chr10:102882480	chr10:103394341~103394361:-
HNSC	cis	rs1741464	0.555	rs230703	MIMAT0003294	hsa-miR-625-5p	-3.58	0.000383	-0.19	-0.16	Reticulocyte fraction of red cells;Reticulocyte count;	chr14:64800751	chr14:65471116~65471136:+
HNSC	cis	rs250677	0.687	rs250679	MIMAT0003249	hsa-miR-584-5p	-3.58	0.000383	-0.17	-0.16	Breast cancer;	chr5:149055389	chr5:149062373~149062394:-
HNSC	cis	rs1014286	0.641	rs10172553	MIMAT0019927	hsa-miR-4772-3p	3.58	0.000383	0.14	0.16	Serum protein levels (sST2);	chr2:102536516	chr2:102432336~102432357:+
HNSC	cis	rs1014286	0.706	rs6761291	MIMAT0019927	hsa-miR-4772-3p	3.58	0.000383	0.14	0.16	Serum protein levels (sST2);	chr2:102538610	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.000384	-0.14	-0.16	Asthma;	chr2:102404807	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.000384	-0.14	-0.16	Asthma;	chr2:102407218	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-3.58	0.000384	-0.14	-0.16	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
HNSC	cis	rs7072216	0.687	rs7924303	MIMAT0005878	hsa-miR-1287-5p	-3.58	0.000385	-0.17	-0.16	Metabolite levels;	chr10:98396206	chr10:98395271~98395292:-
HNSC	cis	rs9807989	0.507	rs1833174	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000389	-0.14	-0.16	Asthma;	chr2:102418383	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102411180	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102411191	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.548	rs6543127	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma (childhood onset);	chr2:102411841	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.524	rs4851576	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102412435	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs4851577	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102412461	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs4851579	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102412524	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs1592459	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102415109	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs1592458	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102415289	chr2:102432336~102432357:+
HNSC	cis	rs9807989	0.507	rs2160201	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.00039	-0.14	-0.16	Asthma;	chr2:102417501	chr2:102432336~102432357:+
HNSC	cis	rs3790645	0.958	rs7543005	MIMAT0018191	hsa-miR-3917	3.57	0.00039	0.18	0.16	Glucose homeostasis traits;	chr1:26552885	chr1:25906384~25906403:-
HNSC	cis	rs74233809	1	rs11191453	MIMAT0005951	hsa-miR-1307-3p	-3.57	0.00039	-0.2	-0.16	Birth weight;	chr10:102900095	chr10:103394301~103394322:-
HNSC	cis	rs4851551	0.867	rs3171845	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000391	-0.29	-0.16	Blood protein levels;	chr2:102174921	chr2:102432336~102432357:+
HNSC	cis	rs74233809	1	rs943037	MIMAT0005951	hsa-miR-1307-3p	-3.57	0.000391	-0.2	-0.16	Birth weight;	chr10:103076162	chr10:103394301~103394322:-
HNSC	cis	rs12134133	1	rs7553157	MIMAT0004673	hsa-miR-29c-5p	-3.57	0.000392	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207283922	chr1:207801903~207801924:-
HNSC	cis	rs9527	0.59	rs10786744	MIMAT0022727	hsa-miR-1307-5p	-3.57	0.000394	-0.14	-0.16	Arsenic metabolism;	chr10:103185271	chr10:103394341~103394361:-
HNSC	cis	rs79387448	0.638	rs7600961	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000395	-0.21	-0.16	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432336~102432357:+
HNSC	cis	rs74233809	1	rs77860422	MIMAT0005951	hsa-miR-1307-3p	-3.57	0.000396	-0.2	-0.16	Birth weight;	chr10:102988252	chr10:103394301~103394322:-
HNSC	cis	rs75358501	0.551	rs13394079	MIMAT0014994	hsa-miR-3130-3p	3.57	0.000399	0.26	0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783245~206783265:-
HNSC	cis	rs75358501	0.551	rs13394079	MIMAT0014994_1	hsa-miR-3130-3p	3.57	0.000399	0.26	0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783277~206783297:+
HNSC	cis	rs7829975	0.511	rs2980426	MIMAT0019728	hsa-miR-4660	3.57	4e-04	0.19	0.16	Mood instability;	chr8:8288087	chr8:9048453~9048475:+
HNSC	cis	rs4988958	0.565	rs1035125	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000401	-0.14	-0.16	Asthma (childhood onset);	chr2:102417379	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000402	-0.14	-0.16	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
HNSC	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-3.57	0.000402	-0.14	-0.16	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
HNSC	cis	rs11892454	0.599	rs28562485	MIMAT0026639	hsa-miR-1301-5p	3.56	0.000402	0.21	0.16	Heschl's gyrus morphology;	chr2:25776342	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs34357652	MIMAT0026639	hsa-miR-1301-5p	3.56	0.000402	0.21	0.16	Heschl's gyrus morphology;	chr2:25776544	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.599	rs17680961	MIMAT0026639	hsa-miR-1301-5p	3.56	0.000402	0.21	0.16	Heschl's gyrus morphology;	chr2:25777655	chr2:25328689~25328707:-
HNSC	cis	rs11892454	0.523	rs13004909	MIMAT0026639	hsa-miR-1301-5p	3.56	0.000402	0.21	0.16	Heschl's gyrus morphology;	chr2:25779436	chr2:25328689~25328707:-
HNSC	cis	rs4919687	0.55	rs11191371	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000402	0.14	0.16	Colorectal cancer;	chr10:102700140	chr10:103394341~103394361:-
HNSC	cis	rs7104764	1	rs10902114	MIMAT0026475	hsa-miR-210-5p	3.56	0.000405	0.24	0.16	Menarche (age at onset);	chr11:246234	chr11:568150~568171:-
HNSC	cis	rs17695224	0.565	rs61681419	MIMAT0000689	hsa-miR-99b-5p	-3.56	0.000406	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51830726	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.545	rs13346095	MIMAT0000689	hsa-miR-99b-5p	-3.56	0.000406	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51831092	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.5	rs13346104	MIMAT0000689	hsa-miR-99b-5p	-3.56	0.000406	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51831173	chr19:51692618~51692639:+
HNSC	cis	rs250677	0.687	rs2963484	MIMAT0003249	hsa-miR-584-5p	3.56	0.000407	0.17	0.16	Breast cancer;	chr5:149071564	chr5:149062373~149062394:-
HNSC	cis	rs9527	0.545	rs10218853	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000407	0.14	0.16	Arsenic metabolism;	chr10:103037030	chr10:103394341~103394361:-
HNSC	cis	rs2948294	0.588	rs12544596	MIMAT0019728	hsa-miR-4660	3.56	0.000408	0.2	0.16	Red cell distribution width;	chr8:8258824	chr8:9048453~9048475:+
HNSC	cis	rs17695224	0.5	rs4802877	MIMAT0000689	hsa-miR-99b-5p	-3.56	0.000408	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51831991	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.52	rs4801898	MIMAT0000689	hsa-miR-99b-5p	-3.56	0.000408	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51832064	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.545	rs17761960	MIMAT0000689	hsa-miR-99b-5p	-3.56	0.000408	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51832275	chr19:51692618~51692639:+
HNSC	cis	rs3096644	0.544	rs112734318	MIMAT0000253	hsa-miR-10a-5p	3.56	0.000409	0.2	0.16	Metabolite levels (Dihydroxy docosatrienoic acid);	chr17:48687101	chr17:48579904~48579926:-
HNSC	cis	rs9527	0.615	rs7899622	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000409	0.14	0.16	Arsenic metabolism;	chr10:102967576	chr10:103394341~103394361:-
HNSC	cis	rs453301	0.571	rs2929456	MIMAT0019728	hsa-miR-4660	-3.56	0.000411	-0.18	-0.16	Joint mobility (Beighton score);	chr8:9225906	chr8:9048453~9048475:+
HNSC	cis	rs10993397	0.528	rs356665	MIMAT0019208	hsa-miR-3074-5p	-3.56	0.000413	-0.16	-0.16	Polycystic ovary syndrome;	chr9:95298349	chr9:95086063~95086083:-
HNSC	cis	rs9527	0.59	rs7087459	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.14	0.16	Arsenic metabolism;	chr10:103031242	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.59	rs7088200	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.14	0.16	Arsenic metabolism;	chr10:103033478	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.59	rs7920868	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.14	0.16	Arsenic metabolism;	chr10:103035652	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs35125602	MIMAT0005951	hsa-miR-1307-3p	-3.56	0.000414	-0.19	-0.16	Birth weight;	chr10:102896282	chr10:103394301~103394322:-
HNSC	cis	rs9527	0.59	rs10883839	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000414	0.15	0.16	Arsenic metabolism;	chr10:103160584	chr10:103394341~103394361:-
HNSC	cis	rs3745672	1	rs11880710	MIMAT0022473	hsa-miR-5684	3.56	0.000416	0.33	0.16	Multiple sclerosis;	chr19:12046080	chr19:12787132~12787151:+
HNSC	cis	rs9527	0.59	rs12415388	MIMAT0022727	hsa-miR-1307-5p	3.56	0.000416	0.14	0.16	Arsenic metabolism;	chr10:103036588	chr10:103394341~103394361:-
HNSC	cis	rs17695224	0.545	rs8099997	MIMAT0000066	hsa-let-7e-5p	-3.55	0.000417	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51842216	chr19:51692793~51692814:+
HNSC	cis	rs7851726	0.668	rs10821410	MIMAT0019208	hsa-miR-3074-5p	-3.55	0.000418	-0.16	-0.16	Urinary albumin-to-creatinine ratio;	chr9:94880731	chr9:95086063~95086083:-
HNSC	cis	rs941898	0.874	rs11160570	MIMAT0004814	hsa-miR-654-3p	3.55	0.000418	0.08	0.16	White matter hyperintensity burden;	chr14:100115299	chr14:101040269~101040290:+
HNSC	cis	rs953492	0.83	rs2451669	MIMAT0019761	hsa-miR-4677-3p	-3.55	0.000419	-0.16	-0.16	Diastolic blood pressure;	chr1:243329822	chr1:243346225~243346246:+
HNSC	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-3.55	0.00042	-0.14	-0.16	Asthma;	chr2:102410644	chr2:102432336~102432357:+
HNSC	cis	rs10492002	0.606	rs7313154	MIMAT0003287	hsa-miR-618	3.55	0.000421	0.18	0.16	Response to antidepressant treatment (citalopram);	chr12:81179128	chr12:80935796~80935818:-
HNSC	cis	rs1014286	0.706	rs4851615	MIMAT0019927	hsa-miR-4772-3p	-3.55	0.000421	-0.14	-0.16	Serum protein levels (sST2);	chr2:102530540	chr2:102432336~102432357:+
HNSC	cis	rs17730929	0.79	rs58788152	MIMAT0005923	hsa-miR-1269a	-3.55	0.000423	-0.44	-0.16	Colorectal cancer (SNP x SNP interaction);	chr4:66477494	chr4:66276890~66276911:+
HNSC	cis	rs250677	0.687	rs40149	MIMAT0003249	hsa-miR-584-5p	3.55	0.000424	0.17	0.16	Breast cancer;	chr5:149064712	chr5:149062373~149062394:-
HNSC	cis	rs6101567	0.57	rs6101544	MIMAT0005919	hsa-miR-548o-3p	-3.55	0.000425	-0.21	-0.16	Nose size;	chr20:39445431	chr20:38516607~38516628:+
HNSC	cis	rs6101567	0.57	rs6101544	MIMAT0005919_1	hsa-miR-548o-3p	-3.55	0.000425	-0.21	-0.16	Nose size;	chr20:39445431	chr7:102405748~102405769:-
HNSC	cis	rs4819852	0.752	rs4819526	MIMAT0000455	hsa-miR-185-5p	-3.55	0.000425	-0.16	-0.16	Pulse pressure;	chr22:19986509	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.752	rs9605043	MIMAT0000455	hsa-miR-185-5p	-3.55	0.000425	-0.16	-0.16	Pulse pressure;	chr22:19986821	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.752	rs7284393	MIMAT0000455	hsa-miR-185-5p	-3.55	0.000425	-0.16	-0.16	Pulse pressure;	chr22:19987060	chr22:20033153~20033174:+
HNSC	cis	rs4819852	0.736	rs7292055	MIMAT0000455	hsa-miR-185-5p	-3.55	0.000425	-0.16	-0.16	Pulse pressure;	chr22:19987131	chr22:20033153~20033174:+
HNSC	cis	rs75358501	0.551	rs12471939	MIMAT0014995	hsa-miR-3130-5p	-3.55	0.000426	-0.19	-0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783276~206783296:-
HNSC	cis	rs75358501	0.551	rs12471939	MIMAT0014995_1	hsa-miR-3130-5p	-3.55	0.000426	-0.19	-0.16	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783246~206783266:+
HNSC	cis	rs17695224	0.565	rs7248523	MIMAT0000689	hsa-miR-99b-5p	-3.55	0.000428	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51833888	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.585	rs10406893	MIMAT0000689	hsa-miR-99b-5p	-3.55	0.000428	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51833901	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.545	rs10406732	MIMAT0000689	hsa-miR-99b-5p	-3.55	0.000428	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51833974	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.519	rs2159654	MIMAT0000689	hsa-miR-99b-5p	-3.55	0.000428	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51834004	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.5	rs2159655	MIMAT0000689	hsa-miR-99b-5p	-3.55	0.000428	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51834006	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.527	rs2903546	MIMAT0000689	hsa-miR-99b-5p	-3.55	0.000428	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51834082	chr19:51692618~51692639:+
HNSC	cis	rs17695224	0.527	rs7250063	MIMAT0000689	hsa-miR-99b-5p	-3.55	0.000428	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51834447	chr19:51692618~51692639:+
HNSC	cis	rs453301	0.631	rs17700611	MIMAT0019728	hsa-miR-4660	-3.55	0.000428	-0.19	-0.16	Joint mobility (Beighton score);	chr8:8936144	chr8:9048453~9048475:+
HNSC	cis	rs453301	0.657	rs36056437	MIMAT0019728	hsa-miR-4660	-3.55	0.000429	-0.19	-0.16	Joint mobility (Beighton score);	chr8:8935355	chr8:9048453~9048475:+
HNSC	cis	rs7851726	0.668	rs7862219	MIMAT0019208	hsa-miR-3074-5p	-3.55	0.00043	-0.16	-0.16	Urinary albumin-to-creatinine ratio;	chr9:94889948	chr9:95086063~95086083:-
HNSC	cis	rs9814567	0.537	rs9879993	MIMAT0019958	hsa-miR-4788	-3.55	0.000431	-0.19	-0.16	Neurocognitive impairment in HIV-1 infection (dichotomous);	chr3:134443717	chr3:134437836~134437857:+
HNSC	cis	rs2277912	1	rs56243714	MIMAT0014995	hsa-miR-3130-5p	3.55	0.000431	0.21	0.16	Height;	chr2:206776345	chr2:206783276~206783296:-
HNSC	cis	rs2277912	1	rs56243714	MIMAT0014995_1	hsa-miR-3130-5p	3.55	0.000431	0.21	0.16	Height;	chr2:206776345	chr2:206783246~206783266:+
HNSC	cis	rs7829975	0.774	rs1703982	MIMAT0019728	hsa-miR-4660	-3.54	0.000433	-0.19	-0.16	Mood instability;	chr8:8740878	chr8:9048453~9048475:+
HNSC	cis	rs10492002	0.606	rs1316810	MIMAT0003287	hsa-miR-618	-3.54	0.000433	-0.18	-0.16	Response to antidepressant treatment (citalopram);	chr12:81189670	chr12:80935796~80935818:-
HNSC	cis	rs4919687	0.55	rs11191372	MIMAT0022727	hsa-miR-1307-5p	3.54	0.000433	0.14	0.16	Colorectal cancer;	chr10:102702430	chr10:103394341~103394361:-
HNSC	cis	rs11671653	1	rs11671653	MIMAT0027486	hsa-miR-6793-5p	-3.54	0.000434	-0.37	-0.16	LDL cholesterol;	chr19:10727810	chr19:10828978~10828999:+
HNSC	cis	rs17730929	0.858	rs80253017	MIMAT0005923	hsa-miR-1269a	-3.54	0.000434	-0.47	-0.16	Colorectal cancer (SNP x SNP interaction);	chr4:66434930	chr4:66276890~66276911:+
HNSC	cis	rs4919687	0.55	rs12784517	MIMAT0022727	hsa-miR-1307-5p	3.54	0.000434	0.14	0.16	Colorectal cancer;	chr10:102705213	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.521	rs12259163	MIMAT0022727	hsa-miR-1307-5p	3.54	0.000439	0.14	0.16	Arsenic metabolism;	chr10:103201720	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs12221064	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.00044	-0.2	-0.16	Birth weight;	chr10:102917369	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs77602510	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.00044	-0.2	-0.16	Birth weight;	chr10:102922845	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs78821730	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.00044	-0.2	-0.16	Birth weight;	chr10:102924787	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs5011520	MIMAT0005951	hsa-miR-1307-3p	-3.54	0.00044	-0.2	-0.16	Birth weight;	chr10:102937759	chr10:103394301~103394322:-
HNSC	cis	rs11892454	0.565	rs878223	MIMAT0026639	hsa-miR-1301-5p	3.54	0.00044	0.21	0.16	Heschl's gyrus morphology;	chr2:25815796	chr2:25328689~25328707:-
HNSC	cis	rs10492002	0.606	rs12816013	MIMAT0003287	hsa-miR-618	3.54	0.000441	0.18	0.16	Response to antidepressant treatment (citalopram);	chr12:81171909	chr12:80935796~80935818:-
HNSC	cis	rs17695224	0.5	rs4802876	MIMAT0000689	hsa-miR-99b-5p	-3.54	0.000441	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51831964	chr19:51692618~51692639:+
HNSC	cis	rs11892454	0.599	rs7605347	MIMAT0026639	hsa-miR-1301-5p	3.54	0.000443	0.2	0.16	Heschl's gyrus morphology;	chr2:25780361	chr2:25328689~25328707:-
HNSC	cis	rs12134133	0.962	rs2039543	MIMAT0004673	hsa-miR-29c-5p	-3.54	0.000443	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207294228	chr1:207801903~207801924:-
HNSC	cis	rs12134133	1	rs2802232	MIMAT0004673	hsa-miR-29c-5p	-3.54	0.000443	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207294806	chr1:207801903~207801924:-
HNSC	cis	rs12134133	0.962	rs2782847	MIMAT0004673	hsa-miR-29c-5p	-3.54	0.000443	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207295766	chr1:207801903~207801924:-
HNSC	cis	rs7829975	0.659	rs4382480	MIMAT0019728	hsa-miR-4660	3.54	0.000445	0.18	0.16	Mood instability;	chr8:8863963	chr8:9048453~9048475:+
HNSC	cis	rs8064299	0.56	rs11077763	MIMAT0017994	hsa-miR-3615	-3.54	0.000447	-0.19	-0.16	Monocyte count;	chr17:74789890	chr17:74748663~74748683:+
HNSC	cis	rs9299	0.778	rs11079830	MIMAT0004555	hsa-miR-10a-3p	-3.54	0.000448	-0.19	-0.16	Obesity;	chr17:48605268	chr17:48579864~48579885:-
HNSC	cis	rs4921799	0.64	rs6984355	MIMAT0015020	hsa-miR-548v	-3.53	0.000449	-0.18	-0.16	Lung cancer;Adenocarcinoma;	chr8:17667303	chr8:17681588~17681609:-
HNSC	cis	rs11892454	0.599	rs6729339	MIMAT0026639	hsa-miR-1301-5p	3.53	0.00045	0.21	0.16	Heschl's gyrus morphology;	chr2:25749310	chr2:25328689~25328707:-
HNSC	cis	rs9807989	0.507	rs3732124	MIMAT0019927	hsa-miR-4772-3p	3.53	0.000451	0.14	0.16	Asthma;	chr2:102401592	chr2:102432336~102432357:+
HNSC	cis	rs7829975	0.577	rs7816329	MIMAT0019728	hsa-miR-4660	-3.53	0.000452	-0.2	-0.16	Mood instability;	chr8:8686333	chr8:9048453~9048475:+
HNSC	cis	rs17695224	0.5	rs4801897	MIMAT0000689	hsa-miR-99b-5p	-3.53	0.000454	-0.12	-0.16	HDL cholesterol;HDL cholesterol levels;	chr19:51831942	chr19:51692618~51692639:+
HNSC	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	3.53	0.000455	0.14	0.16	Asthma;	chr2:102393077	chr2:102432336~102432357:+
HNSC	cis	rs3790645	0.958	rs12723936	MIMAT0018191	hsa-miR-3917	3.53	0.000456	0.18	0.16	Glucose homeostasis traits;	chr1:26546063	chr1:25906384~25906403:-
HNSC	cis	rs10021731	0.782	rs12650319	MIMAT0003242	hsa-miR-577	3.53	0.000456	0.17	0.16	Optic disc area;	chr4:114594734	chr4:114656774~114656794:+
HNSC	cis	rs10021731	0.809	rs12647519	MIMAT0003242	hsa-miR-577	3.53	0.000456	0.17	0.16	Optic disc area;	chr4:114594742	chr4:114656774~114656794:+
HNSC	cis	rs7868228	1	rs10119803	MIMAT0004504	hsa-miR-31-3p	-3.53	0.000461	-0.16	-0.16	Gut microbiome composition (winter);	chr9:21666067	chr9:21512121~21512142:-
HNSC	cis	rs1018697	0.518	rs2790914	MIMAT0005951	hsa-miR-1307-3p	-3.53	0.000462	-0.13	-0.16	Colorectal adenoma (advanced);	chr10:102808261	chr10:103394301~103394322:-
HNSC	cis	rs10492002	0.613	rs35987499	MIMAT0003287	hsa-miR-618	3.53	0.000462	0.18	0.16	Response to antidepressant treatment (citalopram);	chr12:81233020	chr12:80935796~80935818:-
HNSC	cis	rs74233809	1	rs76752100	MIMAT0005951	hsa-miR-1307-3p	-3.53	0.000463	-0.19	-0.16	Birth weight;	chr10:103034329	chr10:103394301~103394322:-
HNSC	cis	rs7786765	0.511	rs12154758	MIMAT0003328	hsa-miR-653-5p	3.53	0.000463	0.18	0.16	Body mass index;	chr7:93467919	chr7:93482823~93482843:-
HNSC	cis	rs11892454	0.565	rs35430508	MIMAT0026639	hsa-miR-1301-5p	3.53	0.000465	0.2	0.16	Heschl's gyrus morphology;	chr2:25814668	chr2:25328689~25328707:-
HNSC	cis	rs8064299	0.597	rs2166703	MIMAT0017994	hsa-miR-3615	-3.53	0.000465	-0.19	-0.16	Monocyte count;	chr17:74785673	chr17:74748663~74748683:+
HNSC	cis	rs8064299	0.597	rs9944506	MIMAT0017994	hsa-miR-3615	-3.53	0.000465	-0.19	-0.16	Monocyte count;	chr17:74786587	chr17:74748663~74748683:+
HNSC	cis	rs7072216	0.615	rs6584195	MIMAT0005878	hsa-miR-1287-5p	3.52	0.000467	0.16	0.16	Metabolite levels;	chr10:98400990	chr10:98395271~98395292:-
HNSC	cis	rs3790645	0.958	rs1466286	MIMAT0018191	hsa-miR-3917	3.52	0.00047	0.18	0.16	Glucose homeostasis traits;	chr1:26544239	chr1:25906384~25906403:-
HNSC	cis	rs16843742	0.628	rs76673846	MIMAT0000257	hsa-miR-181b-5p	3.52	0.00047	0.22	0.16	Vitiligo;	chr1:198834218	chr1:198858925~198858947:-
HNSC	cis	rs16843742	0.628	rs76673846	MIMAT0000257_1	hsa-miR-181b-5p	3.52	0.00047	0.22	0.16	Vitiligo;	chr1:198834218	chr9:124693725~124693747:+
HNSC	cis	rs74233809	1	rs77787671	MIMAT0005951	hsa-miR-1307-3p	-3.52	0.000471	-0.19	-0.16	Birth weight;	chr10:103016448	chr10:103394301~103394322:-
HNSC	cis	rs74233809	1	rs11191519	MIMAT0005951	hsa-miR-1307-3p	-3.52	0.000471	-0.19	-0.16	Birth weight;	chr10:103025161	chr10:103394301~103394322:-
HNSC	cis	rs2871473	0.951	rs1030025	MIMAT0019927	hsa-miR-4772-3p	-3.52	0.000471	-0.17	-0.16	Blood protein levels;	chr2:102489152	chr2:102432336~102432357:+
HNSC	cis	rs10170266	0.685	rs818014	MIMAT0014994	hsa-miR-3130-3p	3.52	0.000472	0.2	0.16	Reticulocyte fraction of red cells;	chr2:206039337	chr2:206783245~206783265:-
HNSC	cis	rs10170266	0.685	rs818014	MIMAT0014994_1	hsa-miR-3130-3p	3.52	0.000472	0.2	0.16	Reticulocyte fraction of red cells;	chr2:206039337	chr2:206783277~206783297:+
HNSC	cis	rs7829975	0.567	rs6601273	MIMAT0019728	hsa-miR-4660	-3.52	0.000472	-0.19	-0.16	Mood instability;	chr8:8939009	chr8:9048453~9048475:+
HNSC	cis	rs74233809	1	rs10883808	MIMAT0005951	hsa-miR-1307-3p	-3.52	0.000474	-0.19	-0.16	Birth weight;	chr10:102961369	chr10:103394301~103394322:-
HNSC	cis	rs12134133	0.962	rs2564970	MIMAT0004673	hsa-miR-29c-5p	-3.52	0.000476	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207290696	chr1:207801903~207801924:-
HNSC	cis	rs12134133	1	rs2782851	MIMAT0004673	hsa-miR-29c-5p	-3.52	0.000476	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207291717	chr1:207801903~207801924:-
HNSC	cis	rs12134133	1	rs2782850	MIMAT0004673	hsa-miR-29c-5p	-3.52	0.000476	-0.12	-0.16	Blood protein levels;Posterior cortical atrophy and Alzheimer's disease;	chr1:207292092	chr1:207801903~207801924:-
HNSC	cis	rs8064299	0.597	rs7210318	MIMAT0017994	hsa-miR-3615	-3.52	0.000476	-0.19	-0.16	Monocyte count;	chr17:74787246	chr17:74748663~74748683:+
HNSC	cis	rs9527	0.83	rs11191442	MIMAT0022727	hsa-miR-1307-5p	3.52	0.000477	0.15	0.16	Arsenic metabolism;	chr10:102883839	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.83	rs12249194	MIMAT0022727	hsa-miR-1307-5p	3.52	0.000477	0.15	0.16	Arsenic metabolism;	chr10:102883941	chr10:103394341~103394361:-
HNSC	cis	rs9527	0.59	rs12785223	MIMAT0022727	hsa-miR-1307-5p	-3.52	0.000478	-0.14	-0.16	Arsenic metabolism;	chr10:103084254	chr10:103394341~103394361:-
HNSC	cis	rs4919687	0.55	rs10748828	MIMAT0022727	hsa-miR-1307-5p	-3.52	0.000479	-0.14	-0.16	Colorectal cancer;	chr10:102697037	chr10:103394341~103394361:-
HNSC	cis	rs74233809	1	rs12219027	MIMAT0005951	hsa-miR-1307-3p	-3.52	0.000479	-0.19	-0.16	Birth weight;	chr10:103051446	chr10:103394301~103394322:-
HNSC	cis	rs10021731	0.809	rs12650546	MIMAT0003242	hsa-miR-577	3.52	0.00048	0.17	0.16	Optic disc area;	chr4:114578518	chr4:114656774~114656794:+
HNSC	cis	rs453301	0.624	rs330049	MIMAT0019728	hsa-miR-4660	3.52	0.00048	0.18	0.16	Joint mobility (Beighton score);	chr8:9229789	chr8:9048453~9048475:+
HNSC	trans	rs4755351	0.553	rs11032157	MIMAT0019943	hsa-miR-4781-3p	6.73	5.07e-11	0.41	0.3	Lung cancer in ever smokers;	chr11:33137020	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs10836023	MIMAT0019943	hsa-miR-4781-3p	6.66	7.93e-11	0.42	0.3	Lung cancer in ever smokers;	chr11:33103500	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.527	rs12420035	MIMAT0019943	hsa-miR-4781-3p	6.64	9.03e-11	0.42	0.29	Lung cancer in ever smokers;	chr11:33089941	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs11032156	MIMAT0019943	hsa-miR-4781-3p	6.59	1.22e-10	0.41	0.29	Lung cancer in ever smokers;	chr11:33136596	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs10836024	MIMAT0019943	hsa-miR-4781-3p	6.58	1.31e-10	0.41	0.29	Lung cancer in ever smokers;	chr11:33126018	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs11032154	MIMAT0019943	hsa-miR-4781-3p	6.58	1.31e-10	0.41	0.29	Lung cancer in ever smokers;	chr11:33133718	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs11032158	MIMAT0019943	hsa-miR-4781-3p	6.58	1.31e-10	0.41	0.29	Lung cancer in ever smokers;	chr11:33139744	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs11032165	MIMAT0019943	hsa-miR-4781-3p	6.58	1.31e-10	0.41	0.29	Lung cancer in ever smokers;	chr11:33142571	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs10767991	MIMAT0019943	hsa-miR-4781-3p	6.58	1.31e-10	0.41	0.29	Lung cancer in ever smokers;	chr11:33147618	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.553	rs61887100	MIMAT0019943	hsa-miR-4781-3p	6.58	1.31e-10	0.41	0.29	Lung cancer in ever smokers;	chr11:33148844	chr1:54054124~54054145:+
HNSC	trans	rs4755351	0.504	rs7945332	MIMAT0019943	hsa-miR-4781-3p	6.02	3.57e-09	0.36	0.27	Lung cancer in ever smokers;	chr11:33166607	chr1:54054124~54054145:+
HNSC	trans	rs12136712	0.598	rs1286231	MIMAT0000442	hsa-miR-9-3p	5.99	4.17e-09	0.28	0.27	Coronary artery disease;	chr1:115158841	chr1:156420354~156420375:-
HNSC	trans	rs12136712	0.598	rs1286231	MIMAT0000442_1	hsa-miR-9-3p	5.99	4.17e-09	0.28	0.27	Coronary artery disease;	chr1:115158841	chr15:89368071~89368092:+
HNSC	trans	rs12136712	0.598	rs1286231	MIMAT0000442_2	hsa-miR-9-3p	5.99	4.17e-09	0.28	0.27	Coronary artery disease;	chr1:115158841	chr5:88666866~88666887:-
HNSC	trans	rs12957516	0.741	rs16969210	MIMAT0000069	hsa-miR-16-5p	-5.93	5.8e-09	-0.16	-0.27	Educational attainment (college completion);	chr18:37684232	chr13:50049027~50049048:-
HNSC	trans	rs12957516	0.741	rs16969210	MIMAT0000069_1	hsa-miR-16-5p	-5.93	5.8e-09	-0.16	-0.27	Educational attainment (college completion);	chr18:37684232	chr3:160404754~160404775:+
HNSC	trans	rs2162440	0.509	rs28608748	MIMAT0000069	hsa-miR-16-5p	-5.73	1.8e-08	-0.16	-0.26	Telomere length;	chr18:37683502	chr13:50049027~50049048:-
HNSC	trans	rs2162440	0.509	rs28608748	MIMAT0000069_1	hsa-miR-16-5p	-5.73	1.8e-08	-0.16	-0.26	Telomere length;	chr18:37683502	chr3:160404754~160404775:+
HNSC	trans	rs1795061	0.561	rs1021639	MIMAT0000689	hsa-miR-99b-5p	-5.65	2.74e-08	-0.24	-0.25	Abdominal aortic aneurysm;	chr1:214230538	chr19:51692618~51692639:+
HNSC	trans	rs12136712	0.573	rs1286226	MIMAT0000442	hsa-miR-9-3p	-5.61	3.44e-08	-0.26	-0.25	Coronary artery disease;	chr1:115168440	chr1:156420354~156420375:-
HNSC	trans	rs12136712	0.573	rs1286226	MIMAT0000442_1	hsa-miR-9-3p	-5.61	3.44e-08	-0.26	-0.25	Coronary artery disease;	chr1:115168440	chr15:89368071~89368092:+
HNSC	trans	rs12136712	0.573	rs1286226	MIMAT0000442_2	hsa-miR-9-3p	-5.61	3.44e-08	-0.26	-0.25	Coronary artery disease;	chr1:115168440	chr5:88666866~88666887:-
HNSC	trans	rs1258763	1	rs1258757	MIMAT0003296	hsa-miR-627-5p	5.6	3.59e-08	0.29	0.25	Orofacial clefts;	chr15:32759483	chr15:42199630~42199651:-
HNSC	trans	rs1258763	1	rs1258756	MIMAT0003296	hsa-miR-627-5p	5.6	3.59e-08	0.29	0.25	Orofacial clefts;	chr15:32759609	chr15:42199630~42199651:-
HNSC	trans	rs1258763	1	rs1258758	MIMAT0003296	hsa-miR-627-5p	5.59	3.91e-08	0.29	0.25	Orofacial clefts;	chr15:32759405	chr15:42199630~42199651:-